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ABSTRACT
An abstract of
o f the dissertation of
o f Shilah Amal Bonnett for the Doctor of
o f Philosophy in
Chemistry presented October 4, 2007.

Title: The Characterization of
o f tRNA Modifying Enzymes SAdenosylmethionine:tRNA Ribosyltransferase-Isomerase (QueA) and A Novel
Type IIGGTP
T P Cyclohydrolase

Queuosine is a hypermodified nucleoside located in the wobble position of
o f bacterial
and eukaryotic tRNAs coding for Asp, Tyr, His and Asn. The biosynthesis involves
the participation of
o f S-adenosyl-methionine:tRNA ribosyltransferase-isomerase (QueA)
and a GTP cyclohydrolase-I. QueA catalyzes the transfer and isomerization of
o f the
ribosyl moiety from AdoMet to preQi
preQ 1 modified tRNA. Substrate analogs of
o f AdoMet
were used to elucidate important substrate-enzyme interactions and to test key steps in
the proposed chemical mechanism. Replacing AdoMet with SeAdoMet had little
effect upon substrate binding but exhibited 30-fold reduction in kcat, consistent with
C-5’ as the first catalytic step. 7-deazaAdoMet failed to function as a
deprotonation at C-5'
o f QueA, but exhibited a K;
Km for
substrate of
Ki that was only slightly higher than the Km

AdoMet, suggesting that N-7 is critical for catalysis but not substrate binding. Neither
the 2'2 ’- or 3'-deoxyAdoMet
3’-deoxyAdoMet exhibited activity with QueA, however both analogs had a
K; of
o f only 2-fold higher than the Km
Km of
o f AdoMet.
Ki

Reported here is the identification and characterization of
o f the C001469
CO G 1469 protein family
as a novel Type-I OTP
GTP cyclohydrolase (OCYH)
(GCYH) that catalyzes the conversion of
o f OTP
GTP
to 7,8-dihydroneopterin-triphosphate in ~20%
-20% of
o f bacteria and most archaea. The
COG 1469 proteins and the genes that encode them were renamed GCYH-IB and folE
folE--

2, respectively, whereas the canonical cyclohydrolase, was renamed GCYH-IA. B.
subtilis and N. gonorrhoeae GCYH-IB
GC YH-IB are homotrimers that were maximally active in

the presence of
o f manganese. GDP also functioned as a substrate; however the removal
of
o f they-phosphate
the y-phosphate resulted in a ~30-fold decrease in kcaJKm,
kcat/Km. Inhibition analysis with
N. gonorrhoeae OCYH-1B
GCYH-IB demonstrated that 8-oxoGTP
8 -oxoGTP functioned as a potent

inhibitor with a Ki
Kj 45-fold lower than the Km
Km for GTP. Although the 7-deazaGTP did
not function as a substrate for OCYH-IB,
GCYH-IB, it exhibited a Ki
K; 7-fold higher than the Km
Km
for GTP. The Ki
Kj for 2 '-deoxyOTP
’-deoxyGTP was 24-fold higher than the Km
K m of
o f GTP. H245 of
of
N. gonorrhoeae GCYH-IB was believed to function analogous to that ofHl
o f H I 79 of
o f E.

coli FolE which facilitates the elimination of
o f C-8
C - 8 from OTP.
GTP. However, H245 mutants
were still able to catalyze the elimination of
o f C-8,
C- 8 , suggesting that H245 is not involved
o f GTP.
in the deformylation of

2
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Introduction
Transfer RNA (tRNA)
Transfer RNA (tRNA) plays a crucial role in biology; it participates in the translation
of the genetic code and functions by delivering the specified amino acid to the
growing peptide chain. It is a small RNA molecule composed of
o f 75-90 nt that has a
well defined secondary ((cloverleaf)
cloverleaf) and tertiary (3D L-shaped) structure. A common
feature of
o f all tRNAs are the presence of
o f three stem-loop moieties; the D-loop which
often contains a dihydrouridine; T-loop which contains a conserved TljJC
T\\iC sequence
(ribothymidine (T), pseudouridine (ljl),
(vp), and cytosine(C)); and the anticodon stem-loop,
which contains the three nucleotide sequence involved in the recognition and
translation of
o f the corresponding 3-nucleotide codon region of
o f the mRNA.

A fascinating aspect of
o f tRNA is the occurrence modified nucleosides which are an
integral part of tRNA maturation. Modifications take place post-transcriptionally
through the action of
o f various enzymes. To date, more than a 100 distinct modified
nucleosides have been characterized in RNA from all domains of life [1,
2]. tRNA
[1,2].
contains proportionally more modified nucleosides than any other nucleic acid within
the cell [3]. Approximately 1% of
o f bacterial genomes code for enzymes involved in
tRNA modification [4]. On average 10%, and in some cases up to 25%, of
o f the
o f a particular tRNA are modified [2]. While some modifications are
nucleosides of

conserved across the three domains, the occurrence, location and distribution of
of
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modified nucleosides varies depending upon the domain, species, and specificity of
of
the tRNA [2].
[2],

Modified nucleosides are derived from the four common nucleosides adenosine (A),
guanosine (G), cytosine (C) and uridine (U). The nature of
o f tRNA modification varies
considerably, from the simple introduction of
o f chemical substituents in the base or
ribose moiety to extensive modification (hypermodification) of
o f the canonical base
resulting in the formation of a structurally complex base or nucleoside. While the
former is typically mediated by a single enzyme, the later entails radical structural
changes of
o f the base and can require multiple enzymatic steps [2].
[2 ].

Except for a few cases, most of
o f the modified nucleosides found in tRNA are not.well
not well
characterized with respect to the overall biosynthetic pathway and physiological
function. In general, it is believed that modifications located outside the anticodon
region influence the structural integrity of
o f the tRNA, while modifications occurring
within and/or around the anticodon region are thought to influence the efficiency and
fidelity of
o f translation [5, 6].
6 ].

7-Deazaguanine Derivatives: Archaeosine and Queuosine
o f chemistry and structure, archaeosine (G*) [7] and queuosine (Q) [8]
[8 ] are
In terms of
o f the most complex hypermodified nucleosides identified in tRNA (Figure 1).
two of

While both modified
modified·nucleosides
nucleosides share the unusual 7-deazaguanosine core structure in

2

which the N-7 atom of
o f the base is replaced with a carbon, queuosine contains an
aminomethyl cyclopentendiol side chain at position 7, whereas archaeosine contains a
formamidino side chain;
chain. 'Archaeosine
Archaeosine is present exclusively in archaeal tRNAs
containing a genetically encoded G at position 15 of
o f the D-loop, a site not modified in
any other tRNA outside this domain (Figure 1) [9]. While the exact physiological role
of archaeosine is unclear, its location at the critical D-loop and T-stem interface
suggests a role in maintaining the structural integrity of
o f the tRNA molecule.

Queuosine and its derivatives, in contrast, are found exclusively in bacteria and
eukaryotes, with the exception of yeast (Saccharomyces cerevisiae) and Mycoplasma,
at position 34 (the wobble position) in the anticodon of tRNAs coding for asparagine,
aspartic acid, histidine and tyrosine (Figure 1) [[10,
10, 11]. The physiological role of
of
queuosine has yet to emerge, but it is known to have an influence on translational
of
frameshift events essential for retroviral protein synthesis [12-14], the ability of

pathogenic bacteria to invade and proliferate in human tissue [15], tyrosine
biosynthesis in mammals [16], eukaryotic cell proliferation and development [17, 18],
[19-21],
neoplastic transformation [19-21
], hypoxic stress management [22], and signal

23-26] and most importantly the modulation of
transduction pathways [19,
[19,23-26]
translational fidelity which is consistent with its location in the anticodon ((codoncodonanticodon interaction) [[5],
5].
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Biosynthesis of Archaeosine and·Queuosine
and Queuosine
The de novo biosynthesis of
o f archaeosine and queuosine by archaea and bacteria,
respectively, is only partially understood (Figure 2). While the biosynthetic pathway
has primarily been studied with respect to queuosine, given the fact that both
archaeosine and queuosine share an unusual 7-deazaguanosine core structure, the

logs in both domains, and the structural similarity of
presence of ykvJKL homo
homologs
o f the
preQo (7-cyano-7-deazaguanine) intermediate to archaeosine, the steps leading up to
preQo are identical in both pathways. Early studies had shown that OTP
GTP was the

metabolic precursor to queuosine which is converted to the precursor preQo
preQ0 through a
number of
o f enzymes [27], three of
o f which have been recently identified, YkvJKL
(QueCDE) [28]. While the fate ofN-7
o f N-7 has yet to be determined, the transformation
involves the loss of C-8
C - 8 from guanine suggesting OTP
GTP cyclohydrolase like chemistry
[27]. In archaea, preQo
preQ 0 is directly incorporated into the appropriate tRNA replacing
the genetically encoded guanine in a reaction catalyzed by the enzyme tRNA guanine
transglycosylase (ArcTOT;
preQ 0 is further
(ArcTGT; EC 2.4.2.29) [29, 30]. Once incorporated, preQo
modified with the addition of
o f ammonia to the nitrile group of
o f preQo to give
archaeosine, a step catalyzed by an unidentified enzyme. In bacteria, preQ 0o15
is reduced
preQ 1 (7-aminomethyl-7-deazaguanine) in an NADPH dependent reaction catalyzed
to preQi
by YkvM (QueF, NADPFl:7-cyano-7deazaguanine
NADPH:7-cyano-7deazaguanine oxidoreductase) and subsequently
o f the appropriate tRNA by a bacterial TGT
inserted into the wobble position of

(BacTGT; EC 2.4.2.29) [31]. Once incorporated, preQ1
preQi is further modified to oQ
(epoxyqueuosine-tRNA) in an S-adenosylmethionine (AdoMet, SAM) dependent step
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catalyzed by the enzyme S-adenosylmethionine:tRNA
S-adenosylmethionine :tRNA ribosyltransferase-isomerase
(QueA) [32, 33]. Finally, oQ is reduced to Q-tRNA (queuosine-tRNA) by an
unidentified enzyme (34].
[34].

Unlike bacteria, eukaryotes lack the ability to synthesize queuosine de novo. Instead,
eukaryotes obtain free queuine base from the diet and intestinal flora [35].
[35], Once
acquired the queuine base is directly inserted into the appropriate tRNA in a
transglycosylation reaction catalyzed by eukaryotic tRNA-guanine transglycosylase
(TGT) [36]. In some mammalian queuosine containing tRNAs, queuosine can be
further modified in a tRNA-queuine glyxosyltransferase catalyzed glycosylation
reaction between D-mannose or D-galactose with the C-5'
C-5’ hydroxyl group of
o f the
cyclopentendiol moiety to generate manQ and galQ, respectively (Figure 1). ManQ is
present in tRNAs coding for aspartic acid, whereas galQ is found in tyrosyl specific
tRNA [37]. Recently, a truncated glutamyl-tRNA synthetase (mini-GluRS; YadB)
was discovered in bacteria to activate and attach a glutamate residue onto the queuine
o f tRNA coding for aspartic acid [38].
base of

QueA
o f queuosine; the
QueA catalyzes the penultimate step in the biosynthesis of
o f the ribosyl moiety from AdoMet to
unprecedented transfer and isomerization of

preQ1-tRNA to give epoxyqueuosine modified tRNA (oQ-tRNA) (Figure 3). The
preQi-tRNA
reaction is accompanied by the rearrangement of
o f the ribosyl moiety and the
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elimination of methionine and adenine from AdoMet [32, 33]. An unusual feature of
of
the QueA catalyzed reaction is the nature of
o f the ribosyl donor [32, 33]. AdoMet is a
known essential metabolite in many biological systems and functions as a methyl
donor in various methylation reactions involving DNA, RNA, lipids, proteins, and
various small molecules [39]; as well as a precursor of
o f the aminopropyl group in
polyamines and as a precursor of
o f glutathione (GSH) in trans-sulfuration reactions [40].

AdoMet is also involved in the formation of
o f substrate or protein radicals in the newly
identified Radical SAM class of enzymes [[41,
41, 42].

Recent kinetic analysis has reported that QueA follows an ordered sequential bi-ter
preQ 1-tRNA binds to the enzyme followed by AdoMet forming a
mechanism in which preQi-tRNA
ternary complex. The formation of
o f the ternary complex is followed by reaction and
the release of
o f products in the following order: adenine, methionine and oQ-tRNA
(Figure 4) [43]. A chemical mechanism has been proposed for the reaction catalyzed
by QueA and is consistent with the kinetic mechanism and biochemical studies carried

out to date (Figure 5) [44]. The first step of
o f the proposed chemical mechanism
involves the deprotonation of
o f AdoMet at C-5'
C-5’ to give the sulfonium ylide I. The
o f adenine
subsequent opening of the ribose ring and the subsequent elimination of

preQ1 methylamine at Cgenerates the vinyl sulfonium II. Nucleophilic attack of
o f the preQi
4'
4 ’ generatesthe
generates the sulfonium ylide III which subsequently attacks the C-1'
C - l’ aldehyde to
Sn2 attack of
o f the alkoxy oxygen on the
give the alkoxy-carbocycle IV. Intramolecular SN2
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adjacent carbon results in the formation of
o f oQ-tRNA and the elimination of
methionine.

GTP Cyclohydrolase
Early biochemical studies suggests the involvement of
o f a GTP cyclohydrolase like

I; 27]. The basis of
enzyme in the first step of
o f the queuosine biosynthetic pathway [I
[11,
this conjecture stems from early labeling experiments in which Salmonella
14
typhimuruim was administered [2- 14
14C] guanine and [8[8 - 14C] guanine [11, 27]. In these
14
studies, incorporation of
o f the isotope was observed with [2[2- 14C] guanine but not with
14
[8[8 - l4 C] guanine suggesting that C~8
C - 8 was eliminated in the process, an observation

reminiscent to the biosynthesis of
o f pterins, folic acids, flavins [45] and antibiotics
toyocamycin [46,
47] and tubercidin [48].
[46,47]
[48],

There are three known classes of
o f GTP cyclohydrolase (GCYH; Figure 6),
6 ), each of
which catalyzes the cleavage of
o f the C8-N9 bond of
o f the guanine ring. GTP
cyclohydrolase-III (GCYH-III) has recently been discovered in archaea, and catalyzes
not only the hydrolysis of
o f the guanine ring but the release of
o f pyrophosphate to give the
monophosphory
lated N-formyl product, 2-amino-5-fortny
lamino-6--ribosylaminomonophosphorylated
2-amino-5-formylamino-6-ribosylamino4(3H)-pyrimidinone
6 ) [49]. The physiological role of
o f GCYH-111
GCYH-III in
4(3
H)-pyrimidinone (FAPy) (Figure 6)

archaea has yet to emerge [49]. GTP cyclohydrolase-II (GCYH-11;
(GCYH-II; RibA; EC
3.5.4.25), encoded by ribA, catalyzes the conversion of GTP to 2,5-diamino-6hydroxy-4-(5-phosphoribosylamino
)-pyrimidine (APy), a precursor to flavins
hydroxy-4-(5-phosphoribosylamino)-pyrimidine
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(riboflavin and deazariboflavin) (Figure 6).
6 ). Not only does it catalyzes the hydrolysis
of
o f the guanine ring but the elimination of
o f C-8
C - 8 as formate followed by the release of
of
pyrophosphate to give the monophosphorylated product [50]. OTP
GTP cyclohydrolase-I

fo!E,
(OCYH-I;
(GCYH-I; FolE; EC 3.5.4.16), encoded by fo
lE , catalyzes the conversion of
o f OTP
GTP to
',2' ,3 '-hydroxypropyl-7,8dihydroneopterin triphosphate (H2NTP;
(H 2NTP; 6-D-threo-1
6-D-;/zreo-l,,2’,3’-hydroxypropyl-7,8dihydroneopteim 3'-triphosphate),
3’-triphosphate), a precursor to folates and pterins (Figure 6).
6 ). The
conversion involves the hydrolysis and removal of
o f C-8
C - 8 as formate followed by the
rearrangement of
o f the ribosyl moiety to give the pterin system [51-53]. Theoretically

OCYH-I
GCYH-I or OCYH-II
GCYH-1I could catalyze the first step in the biosynthesis of
o f archaeosine
and queuosine, however OCYH-II
GCYH-II is an unlikely candidate because it has been
demonstrated that an E. coli OCYH-II
GCYH-II (ribA)
{ribA) mutant still generated queuosine
modified tRNA [54].
[54], On the other hand, a distinct cyclohydrolase-like enzyme may

be responsible for the initial conversion of
o f GTP in the biosynthesis of
o f archaeosine and
queuosme.
queuosine.

Until recently, tgt and queA were the only known genes involved in the biosynthesis of
queuosine that had been identified, cloned and the proteins encoded by them
co
characterized. Using comparative genomics techniques de Crecy-Lagard and co-

workers (Department of Microbiology and Cell Science, University of
o f Florida)
identified four previously uncharacterized bacterial gene families, ykvJKLM, encoding
enzymes involved in the biosynthesis of
o f queuosine [28]. Based on its sequence
homology to FolE, YkvM was initially depicted as a OTP
GTP cyclohydrolase-like enzyme
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and was therefore hypothesized to catalyze the first step in the biosynthesis of
queuosine. Upon biochemical analysis it was discovered that YkvM did not contain
OTP
GTP cyclohydrolase activity, instead it catalyzes the NADPH dependent reduction of
preQo to preQi.
preQ1. These finding lead us to reexamine all sequenced genomes by
comparative genomic analysis in search for an uncharacterized gene that may encode a
cyclohydrolase-like enzyme and to evaluate the potential involvement of
o f GCYH-1
GCYH-I in
the biosynthesis of
o f queuosine.

Insight into the early steps of
o f the queuosine pathway was provided by the fact that the
gcM, QueD) was annotated as a 6-pyruvoyl
YkvK homolog in E. coli (Y
(YgcM,
6 -pyruvoyl
tetrahydropterin synthase (PTPS), an essential enzyme that catalyzes the second step
of
o f the BH
BH44 pathway, the conversion of H2NTP
H 2NTP to PTP (Figure 7). Although glycosidic
forms of
o f BH4'have
BH4 have been identified in cyanobacteria and Chlorobium [55-57],
biopterins and derivatives thereof have no known function in bacteria and archaea.

Furthermore, those organisms that contain an YkvK homolog lack a sepiapterin
gcM has been
reductase (SR), which catalyzes the final step in the BH
BH44 pathway. Y
YgcM
reported to catalyze the conversion of H22NTP to BH
BH44 in the presence of
o f SR,
o f PTP (Figure 8).
8 ). However in absence of SR, Y
YgcM
suggesting the formation of
gcM was

shown to catalyze the cleavage of
o f the C6
C 6 side chain of
o f H2NTP
H 2NTP and sepiapterin
8 ). These findings not only support the early
generating 7,8-dihydropterin (Figure 8).

biochemical
biochemical studies but suggest the involvement of GCYH-1
GCYH-I in queuosine
biosynthesis.
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GCHY-I catalyzes the formation of
o f dihydroneopterin triphosphate and formate from
OTP
GTP through a mechanistically complex ring expansion reaction (Figure 9). A
chemical mechanism has been proposed and is consistent with crystallography and
biochemical studies, including mutagenesis, NMR analysis and transient state kinetics

[52, 58-61].
58-61], The conversion of
o f OTP
GTP to dihydroneopterin triphosphate is initiated with
the reversible hydrolysis of
o f OTP
GTP at C8-N9 via a nucleophilic attack of
o f a zinc activated
water molecule to form an N-formyl intermediate, FAPy (Figure 9, compound 4),
nd
which undergoes a 22nd
hydrolysis reaction with the subsequent loss of
o f C-8
C - 8 as formate

to generate APy (Figure 9, compound 6).
6 ). The ribosyl moiety undergoes ring opening
and an Amadori rearrangement followed by cyclization to give the pterin ring.
)

In most bacteria, fungi and plants OCYH-1
GCYH-I catalyzes the first and rate limiting step in
the de novo biosynthesis oftetrahydrofolate
of tetrahydrofolate (THF) (Figure 10) [62].
[62], Homologs of
GCYH-I have been observed in higher eukaryotes including mammals and catalyzes
OCYH-1

the first and rate limiting step in the biosynthesis of
o f tetrahydrobiopterins (BH4;
(BH 4 ; [6R][6 R][L -erythro-r,2’-dihydroxypropyl]-2-amino-4-hydroxy-5,6,7,8-tetrahydropteridine),
',2' -dihydroxypropyl]-2-amino-4-hydroxy-5 ,6, 7,8-tetrahydropteridine), a
[L-erythro-l
{

compound ubiquitous in higher animals ((vertebrates
vertebrates and insects) (Figure 10) [[62],
62]. It
has been demonstrated that a type I OTP
GTP cyclohydrolase catalyzes the first committed
step in the biosynthesis of
o f methanopterin in archaea, however, no genes have been
identified in any archaeal genome to encode a OCYH-1
GCYH-I [63].
[63],
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Folates are essential cofactors involved in one carbon transfer reactions in the
biosynthesis of purines, formylmethyonyl-tRNA, thymidylate, panthothenate, glycine,
52]. While fol
ate is essential for normal
serine and methionine in all domains of life [[52].
folate
growth and development, animals lack the ability to synthesize THF de novo and must
acquire folate from a dietary source [64]. Since the genes encoding enzymes involved
in folate biosynthesis have not been found in mammals they constitute an attractive
target for antimicrobial chemotherapy [65-67]. The biosynthesis of
o f tetrahydrofolate
involves the dephosphorylation of
o f dihydroneopterin triphosphate, a reaction proposed
to be catalyzed by specific and non-specific pyrophosphatase and phosphorylase [68].
[6 8 ].

It has been demonstrated that dihydroneopterin triphosphate can be chemically
converted to the monophosphorylated species in the presence of
o f divalent metal ions,
2
2
+ or Ca
+ [69], however, the concentrations utilized in those studies were ·
such as Mg
Mg2+
Ca2+

well·above
well above the physiological concentrations. Regardless of
o f the underlying means in
o f dihydroneopterin triphosphate, the resulting product, 7
7,8the dephosphorylation of
,8-

dihydroneopterin, is converted to THF by the enzymes encoded by folBKPCA
fo!BKPCA in E.
c o li.
coli.

Tetrahydrobiopterin is an essential cofactor for nitric oxide synthases [70], glycerol
ether monooxygenases [71] and various aromatic amino acid hydroxy
lases such as
hydroxylases
phenylalanine hydroxylase, tyrosine hydroxylase and tryptophan hydroxylase [52, 72-

74]. Dihydroneopterin triphosphate is converted to tetrahydrobiopterin (BH44 )) by the
sequential action of 6-pyruvoyl
6 -pyruvoyl tetrahydropterin synthase (PTPS; E.C. 4.6.1.10) and
11

sepiapterin reductase (SR; E.C,
E.C. 1.1.1.153) (Figure 7) [75].
[75], While the participation of
of a
type I OTP
GTP cyclohydrolase in the biosynthesis of
o f folates and pterins has been well
established, its involvement in the biosynthesis of
o f queuosine remains unclear.

· To determine if the participation of
o f GCYH-1
GCYH-I in the biosynthesis of
o f queuosine was a
viable hypothesis a comparative genomic analysis was conducted by de Crecy-Lagard.
All sequenced genomes were analyzed in which two genes of
o f the de novo folate
biosynthetic pathway,
pathway,/o/P
fo lP andfo!K,
and folK, which encode dihydropteroate synthase (DHPS)
and 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase (HPPK), respectively,
were utilized as signature genes. Since metabolic intermediates in the conversion of
of
H2NTP to 77,8-dihydrohydroxymethylpterin
,8-dihydrohydroxymethylpterin pyrophosphate are not transported in
bacteria, all organisms containing both thefolP
the fo lP andfolK
and fo lK genes should contain afolE
a fo lE

homolog that encodes a GCHY-I [76]. Since clustering of
o f genes of
o f a common
pathway is frequently observed in bacterial genomes, a gene clustering and

distribution analysis was conducted. The analysis revealed thatfo!E
that fo lE clustered with
known queuosine biosynthesis genes in a number of
o f organisms (Figure 11
11).
). However,
fo
lE was absent in a large number of bacteria genomes that contain both queuosine
fo/E

,ykvJKLM, and more importantly other folate biosynthesis genes,folBKPCA.
genes,fo/BKPCA. Based
on these findings it was predicted that another unidentified protein family was
o f GTP to H2NTP
H 2NTP in those organisms lacking/a/£.
lacking folE.
responsible for conversion of
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Utilizing the newly developed SEED database, which allows the identification of
of
protein families that follow a defined phylogenetic distribution profile, all sequenced
genomes were searched for protein families that were present in those organisms that
lacked afo!E
a fo lE homolog and were absent in E. coli, which contains/a/£.
contains folE . The search
resulted in the identification of
o f five protein families that followed the defined
phylogenetic criteria. Of
O f the 5, only COG1469
COG 1469 was of
o f unknown function that clustered
with folate or queuosine biosynthetic genes in a number of
o f organisms (Figure 12).
Based on this analysis we proposed that COG 1469 genes would encode the missing
GCYH-I enzyme in those organisms lacking/a/£.
lacking folE.

The scope of
o f my research entails the further characterization of
o f QueA and the
1469 proteins. In order to gain further insight into QueA
biochemical analysis of
o f COG
COG1469
catalysis, experiments were designed to elucidate important substrate-enzyme
interactions and to test key steps in the proposed chemical mechanism by utilizing the
following AdoMet analogs; 2'-dAdoMet,
2 ’-dAdoMet, 3'-dAdoMet,
3’-dAdoMet, SeAdoMet, and 7deazaAdoMet (TubMet) (Figure 13). Reported here are the results from the substrate
and inhibition studies utilizing the AdoMet analogs and their mechanistic and
structural implications on catalysis are discussed.

The work presented here also describes the cloning, purification, and characterization
of COG1469 proteins from T. maritima, N. gonorrhoeae, and B. subtilis. In addition
o f the COG 1469 proteins, biochemical characterization
to the functional identification of
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including divalent metal analysis, steady-state kinetics, and site directed mutagenesis

was conducted. Inhibition analysis with COG1469
COG 1469 fromN.
from jV. gonorrhoeae was also
carried out with the following substrate analogs; 8-oxoGTP, 7-deazaGTP and 2'dGTP
2 ’dGTP
(Figure 14). Presented here are the results from these studies and their mechanistic
and structural implications upon catalysis are discussed.
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Experimental Procedures
Chemicals and Reagents
All reagents, salts and buffers were of the highest quality grade, and were purchased
from Sigma unless otherwise noted. Millipore ultrapure water was used for all
solutions. Ampicillin, DTT, kanamycin sulfate and isopropyl-1-thio-B-Disopropyl- 1-thio-B-D4C]Glucose, Lgalactopyranoside (IPTG) were purchased from RPI Corporation. [U-1
[U-14C]Glucose,
4C]-guanine were purchased from Moravek.
[1C-14C] methionine, and [8-1
[8-14C]-guanine
), DEAE-cellulose,
Benzoylated-naphthoylated DEAE-cellulose (BND-cellulose
(BND-cellulose),
activated charcoal, Dowex-50WX4, and Sephadex-G25 were purchased from Sigma.
NACsTm resin was from BRL Life Technologies, Inc. Chelex-100 was purchased
NACsTm
from BioRad. Nickel agarose affinity resin (Ni-NT
A) was purchased from Qiagen.
(Ni-NTA)
Glutathione Sepharose 4B was purchased from Amersham Biosciences. POROS
chromatography resins were from PerSeptive Biosystems. Whatman GF-B and
Whatman P81 filter disks were purchased from Fisher. Centriprep YM-30, Centricon
Centricon YM-3, and Amicon Ultra YM-10 centrifugal devices, Amicon
YM-10, Centrico_n
Ultra-MC spin filters, and HA filters were from Millipore. Dialysis was performed in

Slide-A-Lyzer cassettes or mini ·dialysis
dialysis units from Pierce. Buffers used in work
involving RNA were prepared with DEPC-treated water and filtered through Cameo
25ES nitrocellulose filters from Osmonics, Inc. Anti-RNase was from Ambion. Ultra
2’-deoxyGTP, GTP, GMP and GDP were from Ameresco or Sigma.
pure grade 2'-deoxyGTP,

Protein concentrations were based on the Bradford dye binding procedure (Bio-Rad).
Adenine, methionine, 2'-deoxyATP,
2 ’-deoxyATP, 3'-deoxyATP,
3’-deoxyATP, ATP, AMP, S-adenosyl-L15

methionine (AdoMet, SAM), neopterin, L-sepiapterin, ribose-5-phosphate,
phospho(enol)pyruvate trisodium salt (PEP), NADH, NAD, NADPH, 7-

deazaadenosine (Tubercidin), and 3-deazaadenosine were from Sigma. 7,8-dihydroD-neopterin and 7,8-dihydro-L-biopterin were from Axxora. D-neopterin-3'D-neopterin-3’monophosphate and 7,8-dihydro-D-neopterin-3'-monophosphate
7,8-dihydro-D-neopterin-3’-monophosphate were purchased from

Schircks Laboratories. Pterin was from MP Biomedicals. 8-oxo-GTP was purchased
from Jena Bioscience. 7-deazaGTP and 7-deazaA
TP.were
7-deazaATP
were purchased from Trilink
Biotechnologies. 6-Phosphogluconate dehydrogenase type V from torula yeast and
nucleoside monophosphate kinase was purchased from MP Biologics
Biologies as an

ammonium sulfate suspension. L-Glutamic dehydrogenase type I from bovine liver,
pyruvate kinase type II from rabbit muscle, glucose-6-phosphate dehydrogenase type

VII from baker's
baker’s yeast, and myokinase from rabbit muscle were from Sigma as
ammonium sulfate suspensions. Phosphoriboisomerase from torula yeast and
hexokinase type F-300 from baker’s
baker's yeast were from Sigma as lyophilized powders
and were stored in 50% glycerol and the appropriate buffer at -80°C. Proteins utilized
in gel filtration analysis were from Sigma. UltracleanTm
UltracleanTm mini plasmid and
Tm

Ultraclean Tm 15 DNA purification kits were from MolBio. Oligodeoxynucleotides
were from Integrated DNA Technologies. Linearized vector pET-30Xa/LIC PCR
cloning kit was from Novagen. DNA from E. coli K12 was a generous gift from Dr.
David Boone, Portland State University. Genomic DNA from B. subtilis JH642 (trpC2
pheAl)
pheA
l) was a generous gift from Dr. Michiko Nakano, Oregon Graduate Institute of
of
7! maritima were
Science and Engineering. Genomic DNA from N.
N gonorrhoeae and T
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from ATCC. Bromophenol blue, blue dextran 2000 and DNP-aspartic acid were from
Sigma. Econosafe scintillation counting cocktail is from RPI. Protein concentrations
were determined by Bradford dye-binding analysis (BioRad).

All chemicals used in metal analysis were of
o f high purity, analytical metal-free grade.
All buffers and solutions utilized in metal analysis were prepared with Milli-Q water
(18.2 MO.)
M£T) and treated with Chelex-100 (BioRad) to remove any contaminating
metals. Divalent metals used were a minimum of
o f 99.9% pure and prepared with
Chelex-100 treated Milli-Q water. To minimize the leaching of
o f metals into solution all
plastic and glassware were soaked in 10% nitric acid followed by 1 mM EDTA (for
glassware) and rinsed liberally with Chelex-treated Milli-Q water before use. To
reduce enzyme activation due to metals leaching form the quartz cuvettes, the cuvettes
were soaked in 1:
1:1l nitric acid:sulfuric acid for 15 min and rinsed extensively with
Chelex-treated Milli-Q water before use.

Instrumentation
PCR was carried out using a Perkin-Elmer 2400 thermocycler. Radioactivity was
quantified by liquid scintillation counting utilizing a Beckman LS6500 Liquid
Scintillation Counter. UV-vis spectrophotometry was conducted with a Varian Cary
100 Bio spectrophotometer. Fluorescence spectroscopy was carried out with either a
PTI Time-Master fluorometer or a Gemini XPS microplate spectrofluorometer from
Molecular Devices. HPLC analysis was performed on a Hitachi Model D-7000
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System
System equipped with a L-7100 pump system and an L-4500A diode array detector.
PAGE electrophoresis was conducted utilizing a Mini Protean III apparatus from
Bio
Rad. Sequence analysis was carried out
BioRad.
out using the Vector NTI software package.
Centrifugation was performed with an Avanti J-20 XP centrifuge utilizing JA-25.50
and JA-10 rotors, an LE-SOK
LE-80K ultracentrigfuge using a Ti-60 rotor, or a TJ-6 swinging
bucket centrifuge all from Beckman Coulter. A
A Molecular Dynamics Typhoon 9200
variable mode imager with ImageQuant 5.2 software was used for the fluorescence
detection of
o f ethidium bromide or SybrGreen-stained nucleic acids in PAGE and
agarose gels. Mass spectrometry was done on an LCQ Advantage ion trap mass
spectrometer (Thermo Electron, San Jose, CA) equipped with an electrospray
ionization source at the BioAnalytical Shared Resource/Pharmacokinetics Core
Facility in the Department of Physiology and Pharmacology at Oregon Health and
Science University. The metal content of
o f the proteins were analyzed by inductively
coupled plasma mass spectroscopy (ICP-MS; HP-4500 ICP-MS) performed at the
Trace Element Laboratory, Department of
o f Geology, Portland State University
(Portland, OR). DNA sequencing analysis was performed on a 3100 Avant Genetic
Analyzer from Applied Biosystems at the Portland State University-Keck Genomic

Facility (Portland, OR).

Bacterial Strains
E.coli
E.
coli strain DH5a (F-,
(F \ <D80d/acZ~l5,
®80d/acZA15, ~(lacZYA-argF)Ul69,
A(lacZYA-argF)U 169, deoR, recAJ,
recA l, endAJ,
endA l,
7(f K,m-K), phoA, supE44, )..;,
hsdRJ
h sd R l7(r'K,m'ic),phoA,
X, thi-1, gyrA96, re/Al)
relA l) was from Gibco BRL Life
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Technologies. E. coli strain BL21 (DE3) (F",
(F \ dcm, ompT, hsdS(r"
hsdSix'^,
m'e)
8 , m8 ) was from
Stratagene. The E. coli queA deletion mutant K12QueA and the pGEX-QA plasmid
were generous gifts from Helga Kersten, (Univeritat Erlangen, Erlangen, Germany).
The E. coli strains, BL21(DE3), harboring the recombinant AdoMet synthetase (MAT)
genes from Methanococcus
Methanococcusjannaschii
jannaschii in plasmid pMJ1208 and E. coli, iri
in plasmid
pK8, respectively, were generous gifts from Dr. G. Markham (Fox Chase Cancer
Center, Philadelphia, PA). Hypoxanthine-guanine phosphoribosyltransferase
(HGPRTase) from Leishmania donovani was expressed from pBAC-HGPRTaseLB/S0S6, a generous gift from Dr. Buddy Ullman (Oregon Health and Science
University, Portland, OR). The E. coli strain, B25, harboring the recombinant adenine
phosphoribosyltransferase (APRTase) gene in plasmid pQEAPTl was a generous gift

from Dr. Milton Taylor (Indiana University). The E. coli strain DH5u,
DH5a, harboring the
recombinant 5-phosphoribosyl-1-pyrophosphate
5-phosphoribosy 1-1-pyrophosphate (PRPP) synthetase gene from

Salmonella typhimurium in plasmid pBRSl
pBRS 111R
R was a generous gift from Dr. Vern
Vem L.
Schramm (Albert Einstein College of
o f Medicine, Bronx, NY).

Factor Xa Cleavage Reactions

The His
His6-affmity
6-affinity fusion tag was cleaved from recombinant fusion proteins (20 mg)
pg of
o f Factor Xa protease (Novagen) in a reaction mixture consisting of
o f 50
with 20 µg

00 mM KCl,
mM Tris-acetate (pH 8.0), I100
KC1, and 2 mM CaClz
CaCh in a final volume of 1 ml.
After incubating for 20 h at room temperature the cleavage reactions were loaded onto
a 2 ml Ni-NTA agarose column (Qiagen) equilibrated in 50 mM Tris-Acetate (pH
19

8.0), 300 mM KCl,
KC1, and 10% glycerol (Buffer A). The cleaved proteins were eluted
from the column with the addition of
o f 10 column volumes of
o f Buffer A. Uncleaved
His6·tagged
His 6 -tagged protein was eluted with the addition of
o f 10 column volumes of
o f Buffer A
containing 200 mM imidazole. Wild type protein was concentrated and dialyzed
against 50 mM Tris-Acetate (pH 8.0), 50 mM KCI,
KC1, and 10% glycerol. The proteins
were analyzed by SDS-PAGE and concentration was determined by Bradford assay
(BioRad) using bovine serum albumin as a standard.

Selenomethionione Proteins

Selenomethionine containing proteins utilized in structural crystallography were
lie [77]. Transformed E. coli BL2
l (DE) cells
expressed according to methods of
o f Doub
Doublie
BL21(DE)
except
were grown in M9 media supplemented with 50 mg of each amino acid ((except
methionine), 0.2% glucose, 2 mM MgSO4,
MgSC>4 , 0.1 mM CaCl2,
CaCh, 1.5 mg thiamine, 1.5 mg
biotin, 0.5 mg guanosine, 0.5 mg thymine, 0.5 mg uracil, 2 µl
pi Maria's
Maria’s magic
1,000,000X micronutrients, 50 mg of
o f selenomethionine and either 30 µg/ml
pg/ml
kanamycin or 100 µg/~l
pg/ml ampicillin [77]. Cultures were incubated at 37 DC
PC with
o 0.9-1.0 was attained. Protein expression was induced with the
shaking until an 0D
OD 60
600

addition of IPTG to a final concentration of
o f 0.1 mM 15 min after the addition of
o f 50
mg lysine, 50 mg phenylalanine, 50 mg threonine, 25 mg leucine, 25 mg valine and 25
mg selenomethionine. Cells were allowed to grow overnight and harvested by
centrifugation (5000 x g for 10 min). Selenomethionine proteins were purified
identically to their non-selenomethionine containing counter-parts except all buffers
20

contained 10 mM P-mercaptoethanol
(3-mercaptoethanol and were degassed prior to use. The addition of
a reductant and degassing the buffers prior to use was essential in the prevention of
o f the
oxidation of
o f selenomethionine.

In vivo Overexpression of preQ
preQi-tRNAT
yr
1-tRNATyr
An expression plasmid, pTrc99B-Tyr, was constructed previously, in which the
synthetic gene for E. coli tRNATyr(I) was ligated into a pTrc99B vector [78]. E.coli
Kl2QueA
K12QueA competent cells (100 µl)
pi) were transformed with 1 µg
pg ofpTrc99B-Tyr
o f pTrc99B-Tyr
expression plasmid and plated onto LB medium agar plates containing 100 µg/ml
pg/ml
ampicillin. A single colony was used to inoculate 3 ml of
o f LB medium containing 100
µg/ml
pg/ml ampicillin. After incubating for 12 h at 3
377 °C with shaking (250 rpm), a 1 ml
aliquot was removed from the cultures and used to inoculate 100 ml of
o f LB medium
supplemented with 100 µg/ml
pg/ml ampicillin. The culture was incubated for 12 h at 3
377 °C
with shaking (250 rpm), then 5 ml aliquots were used to inoculate 7-2500 ml flasks,
each containing 500 ml of
o f LB medium supplemented with 100 µg/ml
pg/ml ampicillin. The
OD 600
resulting cultures were incubated at 37 °C with shaking (250 rpm) until the 0D6oo

reached 0.9-1.0. Expression ofpreQ,-tRNATyr
o f preQi-tRNATyr was induced by the addition ofIPTG
o f IPTG to
a final concentration of
o f 0.5 mM. Cells were harvested by centrifugation (5000 x g for
10 min at 4 °C) 13 h post induction, flash frozen in liquid nitrogen and stored at -80 °C

.5 L of
until needed. Approximately 15 g of
o f cells were obtained from 3
3.5
o f cell culture.
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tRNATyr
preQ1 enriched tRNAT
Isolation of preQi
yr
Bulk tRNA was extracted and isolated from E. coli cells utilizing the acid guanidium
o f cells were suspended in
thiocyanate-phenol-chloroform method [79]. Twenty grams of

N-lauroylsarcosine, 100 mM
o f lysis buffer (4 M guanidine thiocyanate, 0.5% N-lauroylsareosine,
40 ml oflysis
2-mercaptoethanol and 25 mM sodium citrate (pH 7.0)) and stirred for 1 hhat
at 4 °C. A

M sodium acetate (pH 4.0) was added and the solution was stirred
4 ml solution of 2 M
o f 40 ml of water-saturated phenol.
for an additional 5 min followed by the addition of

49: 1) was added and the
After stirring for 5 min, 8 ml of
o f chloroform:isoamyl alcohol ((49:1)
solution was shaken vigorously for 10 sec. The aqueous phase was recovered after
centrifugation (800 x g for 20 min) and the RNA was precipitated from solution with
-20
the addition of an equal volume ooff cold isopropanol. After storing at -2
0 °C for 2 h,
the precipitated RNA was recovered by centrifugation (20,000 x g for 30 min) and
washed twice with 70% ethanol.

To ensure complete removal of proteins a second round of
o f extraction was conducted
lA the original volumes were used. After suspending the
as described above except ¼

RNA pellet in sterile DEPC treated water, an equal volume of 8 M lithium chloride
was added and the resulting solution was stored-20
stored -2 0 °C for 2 h, followed by
centrifugation (20,000 x g for 30 min) to remove large RNAs. The tRNA was
precipitated from the supernatant with the addition of an equal volume ooff cold
-2 0 °C for 2 h, the tRNA was recovered by
isopropanol. After storing at -20

centrifugation (20,000 x g for 30 min), washed with 70% ethanol and suspended in 3
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mM s~dium
sodium citr~te
citrate (pH 6.3). Total concentration of
o f tRNA was determined by UV-vis
spectroscopy (E260=
(e260 = 15 units/mg/ml). Tyrosine-tRNA synthetase activity assay was
used to determine the percentage ofpreQ1-tRNATyr
o f preQi-tRNATyr from total tRNA that had been
extracted from the cells [80].

Purification of preQ1
Tyr
preQi containing tRNA
tRNAT
yr

PreQ1-tRNATyr
PreQi-tRNATyr was purified further by successive chromatography using BNDcellulose [81, 82] and
NACs™ (trialkyamine ion exchange resin) [83, 84].
andNACs™
84], Crude
tRNA (20 mg) was loaded onto a 12 ml BND-cellulose column equilibrated in Buffer
B (20 mM sodium acetate (pH 4.5), 10 mM MgCb
M gC f and 0.5 M NaCl). The column was
washed with 20 ml of
o f Buffer Bat
B at a flow rate of 0.5 ml/min followed by an 80 ml salt
gradient (O.SM-1.0M
(0.5M-1.0M NaCl) in Buffer B from 20-100 ml. After washing the column
with IO
10 ml of
o f Buffer C (Buffer B containing I1 M NaCl), tyrosine specific tRNA was
eluted from the column with a 40 ml ethanol gradient (0-20% v/v) in Buffer C.
Fractions (2 ml) were collected and analyzed by UV-vis at 260 nm. Those fractions
containing preQi-tRNATyr,
preQ I-tRNA Tyr, as determined by QueA or tyrosine-tRNA synthetase
activity assays, were pooled and the tRNA was precipitated from solution with the
addition an equal volume of cold isopropanol. After storing at -20 °C for 2 h, the
precipitated preQi-tRNATyr
preQ 1-tRNATyr was collected by centrifugation (20,000 X g for 30 min),
washed twice with 70% ethanol and suspended in 3 mM sodium citrate (pH 6.3).
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After dialyzing against 4 L of
o f Buffer D (10 mM sodium acetate (pH 4.5), 10 mM

MgCh
MgCl2 and 0.2 M NaCl) at 4 °C for 4 h, the enriched tRNA sample was applied to a
column containing IO
NACsTM resin equilibrated in Buffer D. The column was
10 ml NACs™
washed with a I100
00 ml of Buffer D at a flow rate of
o f I1 ml/min and tyrosyl-tRNA was
eluted with a 400 ml salt gradient (0.2 M - IM)
1M) in Buffer D. Fractions (2.5 ml) were
preQ 1collected and analyzed by UV-vis at 260 nm. Those fractions containing preQitRNATyr, as determined by QueA or tyrosine-tRNA synthetase activity assays, were
pooled and the tRNA was precipitated from solution with the addition an equal

volume of
o f cold isopropanol. After storing at -20 °C for 2 h, the precipitated RNA was
collected by centrifugation (20,000 X g for 30 min), washed twice with 70% ethanol
and suspended in 3 mM sodium ,citrate
.citrate (pH 6.3). Removal of excess metal ions was
achieved with the addition of EDT
A to a final concentration of
EDTA
o f 5 mM followed by
dialysis against 3 mM sodium citrate (pH 6.3) for IO
10 min at 80 °C. The sample was
). The concentration
dialyzed further at 4 °C for 8 h against 2 exchanges of
o f buffer (2 L
L).
oftyrosyl-tRNA
o f tyrosyl-tRNA was determined spectrophotometrically at 260 nm (e
(s = 816,000 L
1
1
mor
m ol'1 cm"
cm '1).
).

Expression and Purification of APRTase His6•tag
His6-tag Fusion Protein

The expression and purification of
o f recombinant APRTase was conducted according to
the methods of Alfonzo [85, 86].
86], E. coli B25 competent cells (100 µl)
pi) were

transformed with I1 µg
pg of the APRTase expression plasmid, pQE-APTl, and plated on
2xYT
pg/ml ampicillin and 25 µg/ml
pg/ml kanamycin.
2x
YT medium agar plates containing 100 µg/ml
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Isolated colonies were used to inoculate 3 ml of2xYT
o f 2xYT medium containing 100 µg/ml
pg/ml
ampicillin and 25 µg/ml
pg/ml kanamycin. After incubating for 12 hat
h at 37 °C with shaking
(250 rpm), a 1 ml aliquot was removed from the culture and used to inoculate 100 ml
of 2xYT medium containing 100 µg/ml
pg/ml ampicillin and 25 µg/ml
pg/ml kanamycin. The
culture was incubated for 12 hat
h at 37 °C with shaking (250 rpm), then 5 ml aliquots
were used to inoculate 7-2500 ml flasks containing 500 ml of 2xYT medium
supplemented with 100 µg/ml
pg/ml ampicillin and 25 µg/ml
pg/ml kanamycin. The cultures were
allowed to grow at 37 °C with shaking (250 rpm) until an OD6oo
OD 600 of0.9-1.0
o f 0.9-1.0 was
attained. The expression of APRTase was induced by the addition of
o f IPTG to a final
concentration of 0.1 mM. After incubating the cultures for an additional 5 hat
h at 37 °C
with shaking (250 rpm), the cells were collected by centrifugation (5000 x g for 10
min at 4°C), flash frozen in liquid nitrogen and stored at -80 °C until needed.
.5 L of
Approximately 12 g of
o f cells were obtained from 3
3.5
o f cell culture.

Recombinant His6-tag APRTase fusion protein was purified by suspending l10
Og of
of
frozen cells in lysis buffer (50 mM Tris-HCl (pH 7.5), 300 mM NaCl, 1 mM P()mercaptaethanol, 1 mM PMSF; l10%
0% glycerol, and 1 mM MgCli)
M gCk) at a concentration of
250 mg/ml. Once the cells were completely suspended, DNase was added to a final
pg/ml and the cells were lysed by two passes through a French
concentration of 10 µg/ml

press. Cell debris was removed by centrifugation (15,000 x g for 30 min). The cell
free extract was filtered with a low protein binding, 0.45 µm,
pm, syringe filter
Ni-NT A agarose column (Qiagen) equilibrated
(Fisherbrand) and loaded onto a 10 ml Ni-NTA
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with 10 column volumes of
o f Buffer E (100 mM Tris-HCl (pH 7.5), 300 mM KCl,
KC1, 2
mM ~-mercaptoethanol,
% Triton X-100, 1 mM PMSF and 10% glycerol). The
P-mercaptoethanol, 11%
column was sequentially washed with 5 column volumes of
o f Buffer E, 5 column
volumes of
o f Buffer F (Buffer E containing 20 mM imidazole) and 5 column volumes of
Buffer G (Buffer F without Triton X-100 and PMSF). The protein was eluted from the
column with 7 column volumes of
o f Buffer H (Buffer G containing 200 mM imidazole)
and collected in 10 ml fractions. Fractions containing the protein were pooled,
concentrated using an Amicon Ultra YM-10 centrifugal filter device (Millipore) and
dialyzed against 50 mM Tris-HCl (pH 7.5), 50 mM KCl,
KC1, and 2 mM DTT at 4 °C. The
;

recombinant APRTase was greater than 90% homogeneous as determined by SDSPAGE and stored as glycerol stocks at -80°C. Protein concentration was determined
by Bradford assay (BioRad) using bovine serum albumin as a standard, and activity

was measured by methods described by Hochstadt [87].
[87],

Expression and Purification of PRPP Synthetase
E. coli DH5a competent cells (100 µl)
pi) were transformed with 1 µg
pg of
o f the PRPP

synthetase expression plasmid, pBRSl
pBRS 111R,
R, and plated onto LB medium agar plates
containing 100 µg/ml
pg/ml ampicillin. An isolated colony was used to inoculate 3 ml of
o f LB
medium containing 100 µg/ml
pg/ml ampicillin. After incubating for 12 h at 3
377 °C with
shaking (250 rpm), a l1 ml aliquot was removed from the culture and used to inoculate
pg/ml ampicillin. The culture was incubated for
100 ml of LB medium containing 100 µg/ml

12 hat
h at 37 °C with shaking (250 rpm), then 5 ml aliquots were used to inoculate 7-
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2500 ml flasks containing 500 ml of
o f LB medium supplemented with 100 µg/ml
pg/ml
ampicillin. Once th~
the OD6oo
ODeoo reached 0.9-1.0, the cultures were incubated for an
additional 4 hat
h at 37 °C with shaking (250 rpm), cells were collected by centrifugation
(5000 x g for 10 min), flash frozen in liquid nitrogen and stored at -80 °C until needed.
Approximately 10 g of
o f cells were obtained from 3.5 L of
o f cell culture.

PRPP synthase was purified by suspending 10 g of
o f frozen cells in lysis buffer (50 mM
sodium phosphate (pH 77.5),
.5), 1 mM PMSF and 2 mM DTT) at a concentration of
o f 250
mg/mL. The cells were lysed by the addition of
o f lysozyme to a final concentration of
200 µg/ml.
pg/ml. After incubating at 37 °C with rotation for 30 min, DNase was added to a
final concentration of 10 µg/ml
pg/ml and the cell solution was incubated for an additional
30 min at 37 °C with rotation. Cell debris was removed by centrifugation (15,000 x g
for 30 min) and the resulting cell free extract was filtered with a low protein binding,
pm syringe filter (Fisherbrand). PRPP synthetase was precipitated from solution
0.45 µm

upon the addition of ammonium sulfate to a final concentration of 15%. The protein
was collected by centrifugation (15,000 X g for 30 min) and suspended in minimal
o f lysis buffer containing 10% glycerol. The protein sample was dialyzed
amount of

against the lysis buffer containing 10% glycerol at 4°C and stored at -80 °Casa
°C as a

.

glycerol stock. The protein sample was approximately 60% pure as judged by SDSp AGE analysis. Protein concentration was determined by Bradford assay (BioRad)
PAGE
using bovine serum albumin as a standard, and activity was measured by methods
described by Braven [88].
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Enzyma~ic
[U-ribosyl- 14CJATP
Enzymatic synthesis of [U-n6<wy/-14C]ATP
14
14
[U-ribosylC]ATP was synthesized from [UC]-glucose in a modification of
[U-n7>o.yy/-14C]ATP
[U-14C]-glucose
o f the

multienzyme reaction described by Parkin and LoBrutto [89, 90]. The reaction was

carried out in 50 mM phosphate (pH 7.5), 50 mM gly-gly (pH 7.8), 10 mM MgCh,
M gCb, 3
mM adenine, 10 mM a-ketoglutarate, 835 µM
pM ATP, 20 mM phosphoenol pyruvate, 1
14
mM NADP+, 1.2 mM [UC]glucose, 4.8 U glucose-6-phosphate dehydrogenase, 4.8
[U-14C]glucose,

U 6-phosphogluconate dehydrogenase, 48 U myokinase, 48 U hexokinase, 48 U
phophoriboisomerase, 96 U pyruvate kinase, 0.6 mg PRPP synthease, 150 µg
pg

APRTase and 72 U glutamate dehydrogenase in a final volume of 6 ml. To minimize
the inhibitory effects of
o f excess ammonium ions all of
o f the enzymes except for
glutamate dehydrogenase were diluted to 15 ml with water and then concentrated by
centrifugation to 500 µl
pi prior to use. The reaction was incubated for 4 hat
h at 37 °C and
terminated by heating at 95 °C for 3 min. Precipitated proteins were removed by
14
centrifugation (14,000 X g for 30 min) and [U-ribosylC]ATP was purified by
[U-r/6o5y/-l4C]ATP

C l8 column (250 mm X 10 mm, 5
reverse phase HPLC on a semipreparative Luna C18
uM, Phenomenex) under isocratic conditions using a mobile phase of
o f 83.3 mM

triethylammonium acetate (pH 6.0) and 6% methanol at a flow rate of 4 ml/min.
Fractions containing ATP were pooled, lyophilized to dryness and suspended in water.
3
The concentration of
Mo f ATP was determined by UV-vis spectroscopy (e=
(s= 15.4 X 10
103
M'

1cm-1).
'em '1). Typical radiochemical yields were 65-80% after accounting for the loss of
o f C-1
C-l
from glucose.
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Expression and Purification of E. coli AdoMet Synthetase (EcMAT) Protein
E. coli DH5a competent cells (100 µl)
pi) were transformed with 1 µg
pg of
o f the E. coli
AdoMet synthetase expression plasmid, pk8, and plated onto LB medium agar plates
containing 50 µg/ml
pg/ml tetracycline. An isolated colony was used to inoculate 3 ml of
of
LB medium containing 50 µg/ml
pg/ml tetracycline. After incubating for 12 hat
h at 37 °C with
shaking (250 rpm), a 1 ml aliquot was removed from the cultures and used to inoculate
100 ml of
o f LB medium supplemented with 50 µg/ml
pg/ml tetracycline. The culture was
incubated for 12 h at 3377 °C with shaking (250 rpm), then 5 ml aliquots were used to
inoculate 7-2500 ml flasks containing 500 ml of LB medium supplemented with 50
µg/ml
pg/ml tetracycline. The cultures were allowed to grow at 37 °C with shaking (250
rpm) until an OD6oo
OD 600 of0.9-1.0
of 0.9-1.0 was attained. The expression ofEcMAT
o f EcMAT was induced
by the addition of
o f IPTG to a final concentration of
o f 0.1 mM. After incubating the
cultures for an additional 5 hat
h at 37 °C with shaking (250 rpm) the cells were collected
by centrifugation (5000 x g for 10 min), flash frozen in liquid nitrogen and stored at o f cells were obtained from 3.5 L of
o f cell
80 °C until needed. Approximately 12 g of

culture.

E. coli AdoMet synthetase was purified by suspending 10 g of
o f frozen cells in Buffer I
(50 mM Tris-HCI
Tris-HCl (pH 8.0), 1 mM PMSF, 1 mM DTT and 0.5 mM EDTA) at a
concentration of 250 mg/ml. The cells were lysed by the addition of
o f lysozyme to a
o f 200 µg/ml.
pg/ml. After incubating at 37 °C with rotation for 30 min,
final concentration of

DNase was added to final concentration of 10 µg/ml
pg/ml and the cell solution was
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incubated for an additional 30 min at 37 °C. Cell debris was removed by
centrifugation (15,000 x g for 30 min) and the resulting cell free extract was filtered
with a low protein binding, 0.45 µm
pm syringe filter (Fisherbrand). A fresh solution of
streptomycin sulfate was added to a final concentration of
% and the solution was
o f 11%
centrifuged at 15,000 X g for 30 min. AdoMet synthetase was partially purified by the
addition of
o f ammonium sulfate to a final concentration of
o f 65%. The precipitated
protein was collected by centrifugation (15,000 X g for 30 min}and
min)*and suspended in
minimal amount of Buffer J (Buffer I containing 10% glycerol). The protein sample
was dialyzed against the Buffer J at 4°C and stored -80°C as a glycerol stock. The
protein sample was judged to be ~70% pure as judged by SDS-PAGE. Protein
concentration was determined by Bradford assay (BioRad) using bovine serum
albumin as a standard, and activity was measured by methods described by Markham

[91].
(MjMAT)
HiscExpression and Purification of M. jannaschii AdoMet Synthetase (MjMA
T) His6tag Fusion Protein

E.coli
E.
coli BL21(DE) competent cells (100 µl)
pi) were transformed with 1 µg
pg of the MjMAT
expression plasmid, pMJ
1208, and plated onto LB medium agar plates containing 100
pMJ1208,
pg/ml ampicillin. An isolated colony was used to inoculate 3 ml of
o f LB medium
µg/ml

containing 100 µg/ml
pg/ml ampicillin. After incubating for 12 h at 3
377 °C with shaking (250
rpm), a 1 ml aliquot was removed from the culture and used to inoculate 100 ml of
o f LB

medium containing 100 µg/ml
pg/ml ampicillin. The culture was incubated for 12 h at 3
377 °C
with shaking (250 rpm), then 5 ml aliquots were used to inoculate 7-2500 ml flasks
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containing 500 ml of LB medium supplemented with I100
00 µg/ml
pg/ml ampicillin. The
cultures were incubated at 37 °C with shaking (250 rpm) until an OD
ODeoo
o f 0.9-1.0 was
600 of
attained. The expression of
o f MjMAT was induced by the addition of
o f IPTG to a final
concentration of 0.1 mM. After incubating the cultures for an additional 5 hat
h at 37 °C
with shaking (250 rpm), the cells were collected by centrifugation (5000 x g for 10

min), flash frozen in liquid nitrogen and stored at -80 °C until needed. Approximately

12 g of
o f cells were obtained from 3.5 L of
o f cell culture.

Recombinant His6-tag MjMA
T fusion protein was purified by suspending 10 g of
MjMAT
of
frozen cells in lysis buffer (50 mM Tris-HCI
Tris-HCl (pH 7.5), 300 mM NaCl, 1 mM P(3mercaptaethanol, 1 mM PMSF; 10% glycerol and 1 mM MgCh)
MgCL) at a concentration of

250 mg/ml. Once the cells were completely suspended, DNase was added to a final
concentration of 10 µg/ml
pg/ml and lysed by two passes through a French press. Cell debris
was removed by centrifugation (15,000 x g for 30 min) and the cell free extract was
filtered with a low protein binding, 0.45 µm
pm syringe filter (Fisherbrand). The protein

sample was loaded onto a 10 ml Ni-NTA
Ni-NT A agarose column (Qiagen) equilibrated with
10 column volumes of Buffer E (100 mM Tris-HCl (pH 7.5), 300 mM KCl,
KC1, 2 mM Ppmercaptoethanol, 1% Triton X-100, 1 mM PMSF and 10% glycerol). The column was
o f Buffer
sequentially washed with 5 column volumes of Buffer E, 5 column volumes of

F (Buffer E containing 20 mM imidazole) and 5 column volumes of
o f Buffer G (Buffer
F without Triton X-100 and PMSF). The protein was eluted from the column with 7

column volumes of Buffer H (Buffer G containing 200 mM imidazole) and collected
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in 10 ml fractions. Fractions containing protein were pooled, concentrated using an
Amicon Ultra YM-10 centrifugal filter devices (Millipore) and dialyzed against 50
mM Tris-HCI
Tris-HCl (pH 7.5), 50 mM KCI,
KC1, and 2 mM DTT at 4 °C. The recombinant
MjAdoMet synthetase was greater than 90% homogeneous as determined by SDSP
AGE and stored at -80°C as glycerol stocks. Protein concentration was determined
PAGE
by Bradford assay (BioRad) using bovine serum albumin as a standard and activity
was measured by methods described by Markham et.al. [92].

Enzymatic Synthesis of AdoMet and AdoMet Analogs
14

The enzymatic synthesis of [U-ribosyl[U-ribosyl-u C]AdoMet and AdoMet analogs (SeAdoMet,
3'-deoxyAdoMet
3 ’-deoxyAdoMet and 7-deazaAdoMet) was achieved according to modified methods
described by Park [93, 94]. Reactions involving the synthesis of
o f [U-ribosyl14C]AdoMet
l4C]AdoMet wer.e
were carried out at 25°C in the presence of
o f 100 mM Tris-HCl (pH 8.0),
50 mM KCl,
KC1, 26 mM MgCh,
MgCE, 5 mM DTT, 20% acetonitrile, 0.2 mg/ml E.coli MAT
14
(EcMAT),l mM [U-ribosylC]ATP and 5 mM L-methionine. After 2 h the reaction
[U-ribosyl-]4C]AT?

o f 8% and
was terminated with the addition of cold 50% TCA to a final concentration of

the precipitated proteins were removed by centrifugation (15,000 x g for 30 min). The
14
o f [U-ribosyl[U-r//?05_y/-l4C]
SeAdoMet and SeAdoMet was achieved in a similar
synthesis of
C]SeAdoMet

o f methionine. Due
manner except with the substitution of selenomethionine in place of

to the decreased stability of SeAdoMet, reactions were carried out for 1 h at 25 °C
using 0.6 mg/ml ofEcMAT.
of EcMAT. The synthesis of
o f 3'-deoxyAdoMet
3’-deoxyAdoMet and 7-deazaAdoMet
14
[U-n'&o.yy/-14C]AdoMet
was conducted according to the procedure described for [U-ribosylC]AdoMet
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except the reactions were carried out in the presence of 1 mM 3'-deoxyATP
3 ’-deoxyATP or 714
deazaATP (Tubercidin), and 0.5 mM [1CC]-methionine (55 mCi/mmol) or 5 mM
[lC -14C]-methionine

methionine using 0.6 mg/ml EcMAT. The enzymatic synthesis of2'-deoxyAdoMet
o f 2’-deoxyAdoMet
was conducted according to methods described by Graham [95, 96]. Reactions were
carried out at 55 °C for 1 h in 25 mM HEPES (pH 8.0), 50 mM KCl,
K C1,10
MgCl2, 5
10 mM MgCh,
14
mM DTT, 20% acetonitrile, 0.5 mM of
C]-methionine (55 mCi/mmol) or 5 mM
o f [1C[lC -14C]-methionine

methionine,, 1 mM 2'-deoxyATP,
Mjannaschii
methionine,-1
2’-deoxyATP, and 0.6 mg/ml M.
jannaschii AdoMet synthetase
(MjMAT). AdoMet analogs were purified from unreacted substrate and
decomposition products by HPLC on a semi
preparative Luna C l188 column (250 mm X
semipreparative
10 mm, 5 uM, Phenomenex) under isocratic conditions using a mobile phase of
o f 20
mM ammonium acetate (pH 6.0) and 2% methanol at a flow rate of
o f 3 ml/min.
Fractions containing AdoMet analogs were pooled, lyophilized to dryness and
dissolved in 10 mM H
H2SO4.
o f the compounds were determined by
2 SO 4 • The concentration of
1
1
1
3
1
UV-vis spectroscopy (s = 14.9 x 10
Mcmors=
103
M '1
cm '1
or e = 9500 MM '1
cm '1
cmfor 7-

deazaAdoMet).

Expression and Purification of Escherichia coli QueA-GST Recombinant protein

E. coli DH5a competent cells (100 µl)
pi) were transformed with 1 µg
pg of
o f the QueA-GST
expression plasmid, pGEX-QueA, and plated on LB medium agar plates containing
I100
00 µg/ml
pg/ml ampicillin. A single colony used to inoculate 3 ml of
o f LB medium

, containing 100 µg/ml
pg/ml ampicillin. After incubating for 12 h at 3
377 °C with shaking (250
rpm), a 1 ml aliquot was removed from the cultures and used to inoculate 100 ml of
of
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LB medium containing 100 µg/ml
pg/ml ampicillin. The culture was incubated for 12 h at
37 °C with shaking (250 rpm), then 5 ml aliquots were used to inoculate 7-2500 ml
flasks containing 500 ml of LB medium supplemented with 100 µg/ml
pg/ml ampicillin.
The cultures were incubated at 37 °C with shaking (250 rpm) until an OD6oo
OD 600 of
o f 0.9-1.0
was attained. The expression of
o f QueA-GST was induced by the addition of isopropyl1-thio-B-D-galactopyranoside (IPTG) to a final concentration of
o f 0.1 mM. Cells were
were
harvested 4 h post induction by centrifugation (5000 x g for 10 min), flash frozen in
. liquid nitrogen and stored at -80 °C until needed. Approximately 10 g of
o f cells were
obtained from 3.5 L of
o f cell culture.

Recombinant QueA-GST protein was purified by suspending 10 g of
o f frozen cells in
lysis buffer (50 mM Tris-HCl (pH 8.0), 10 mM EDTA and 50 mM KCl)
KC1) at a
concentration of 250 mg/ml and lysed by the addition of lysozyme to a final
concentration of 250 µg/ml.
pg/ml. After incubating at 37 °C with rotation for 30 min, DNase
o f 10 µg/ml
pg/ml and the solution was incubated for an
was added to final concentration of

additional 30 min at 37 °C. Cell debris was removed by centrifugation (15,000 x g for
30 min) and the resulting cell free extract was filtered with a low protein binding, 0.45
pm, syringe filter (Fisherbrand). An equal volume of Buffer K (50 mM Tris-HCl (pH
µm,
KC1, 10 mM MgCh,
MgCl2, 2 mM OTT,
DTT, I1 mM PMSF, 10% glycerol) was
78.0), 100 mM KCl,

added and the cell free extract was centrifuged in a Beckman 50 Ti rotor at 33,000 rpm
% and the
for 4 hours at 4 °C. Triton X-100 was added to a final concentration of 11%
resultant solution was filtered with a low protein binding, 0.45 µm,
pm, syringe filter
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(Fisherbrand). The cell free extract was loaded on to 10 ml of
o f Glutathione-sepharose
4B (Pharmacia) equilibrated with 10 column volumes of
o f Buffer L (Buffer K,
containing 1 % Triton X-100, 2 mM PMSF). The column was sequentially washed
with 10 column volumes of Buffer Land
L and 10 column volumes of
o f Buffer M (Buffer K
containing 2 mM PMSF). The protein was eluted from the column with 5 column
volumes of
o f Buffer N (Buffer K containing 2 mM PMSF and 20 mM reduced
glutathione) at 4 °C. Fractions containing QueA-GST were pooled and the pH adjusted
to 8.6 with the addition of 1 M NaOH. The protein sample was concentrated using a
Amicon Centriprep YM-30 ultracentrifugation device (Millipore) and dialyzed at 4 °C
against Buffer K without PMSF.

QueA-GST was purified further by HPLC by loading 1 mg of
ROS
o f protein onto a PO
POROS
HQ column (4.6 mm X 100 mm; PerSeptive Biosystems) equilibrated with Buffer 0
O

(20 mM Tris-HCl (pH 8.0), 10 mM MgCb,
MgCl2, 2 mM DTT, and 10 % glycerol). The
protein was eluted from the column with a linear salt gradient (0-lM
(0-1M NaCl) in Buffer
O at a flow rate of
o f 4 ml/min. The eluant was monitored at 280 nm and fractions
0

containing QueA-GST were pooled and concentrated using an Amicon Ultra YM-30
centrifugation device (Millipore). The protein solution was dialyzed at 4 °C against
Buffer K without PMSF. The recombinant QueA-GST was purified to near
homogeneity as determined by SDS-PAGE and stored at -80 °C as a glycerol stock.

Protein concentration was determined by Bradford assay (BioRad) using bovine serum
albumin as a standard.
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Expression and Purification of recombinant His6-QueA from E. coli
The expression plasmid, pET30-EcHis6-QueA,
pET30-EcHis6•QueA, was transformed into E.coli BL2l(DE)
BL21(DE)
competent cells ((100
100 µI)
pi) with 1 µg
pg of
o f expression plasmid and plated on LB medium
agar plates containing 50 µg/ml
pg/ml kanamycin. An isolated colony was used to inoculate
3 ml of LB medium containing 50 µg/ml
pg/ml kanamycin. After incubating for 12 hat
h at 37
°C with shaking (250 rpm), a 1 ml aliquots was used to inoculate 100 ml of
o f LB
medium supplemented with 50 µg/ml
pg/ml kanamycin. The culture were incubated for 12 h
at 37°C with shaking (250 rpm), then 5 ml aliquots were used to inoculate 7-2500 ml
flasks containing 500 ml of
o f LB medium supplemented with 50 µg/ml
pg/ml kanamycin. The
cultures were incubated at 37 °C with shaking (250 rpm) until an OD
ODeoo
o f 0.9-1.0 was
600 of0.9-1.0
attained. Protein expression was induced by the addition of
o f isopropyl-1-thio-B-Disopropyl- 1-thio-B-Dgalactopyranoside (IPTG) to a final concentration of
o f 0.1 mM. Cells were harvested 4
h post induction by centrifugation (5000 x g for 10 min), flash frozen in liquid
nitrogen and stored at -8 0°C until needed. Approximately 12 g of
o f cells were obtained
o f cell culture.
from 3.5 L of

of
The recombinant His6-tag QueA fusion protein was purified by suspending 10 g of
KC1, 1 mM ~(3frozen cells in lysis buffer (50 mM Tris-Acetate (pH 8.0), 50 mM KCl,
MgCE) at a concentration of
mercaptaethanol, 1 mM PMSF; 10% glycerol, and 1 mM MgClz)

250 mg/ml. The cells were lysed by the addition of
o f lysozyme to a final concentration
of
o f 250 µg/ml.
pg/ml. After incubating at 37 °C with rotation for 30 min, DNase was added to
o f 10 µg/ml
pg/ml and the cell solution was incubated for an additional
final concentration of
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30 min at 37 °C. The solution was placed on ice for 10 min after the addition of
o f 10 ml
of
o f Buffer P (200 mM Tris-acetate (pH 8.0), 1.2 M KCl,
KC1, 8 mM P-mercaptaethanol, 4
mM PMSF and 40% glycerol) and clarified by centrifugation (15,000 x g for 30 min).
The resulting cell free extract was filtered with a low protein binding, 0.45 µm,
pm,
syringe filter (Fisherbrand) and loaded onto 10 ml Ni-NTA
Ni-NT A agarose column (Qiagen),
equilibrated with 10 column volumes of Buffer Q (100 mM Tris-Acetate (pH 8.0), 300
1 mM PMSF and 10%
mM KCl,
% Triton X-100,
KC1, 2 mM P-mercaptoethanol, 11%
X -1 0 0 ,1

glycerol). The column was sequentially washed with 5 column volumes of
o f Buffer Q,

5 column volumes of
o f Buffer R (Buffer Q containing 20 mM imidazole) and 5 column
volumes of
o f Buffer S (Buffer R without Triton X-100 and PMSF). The protein was
eluted from the column with 7 column volumes of
o f Buffer T (Buffer S containing 250
mM imidazole). Fractions containing the protein were pooled, concentrated with
Amicon Ultra YM-10 centrifugal filtration device (Millipore) and dialyzed against 50
mM Tris-Acetate (pH 8.0), 50 mM KCl,
KC1, and 2 mM DTT at 4 °C. The recombinant
QueA-His proteins were purified to homogeneity as determined by SDS-PAGE and
stored as a glycerol stock at -80 °C. The protein concentration was determined by
Bradford assay (BioRad) using bovine serum albumin as a standard.

QueA Activity Assays
QueA activity was determined by following the radiochemical incorporation of
o f the
4
14
C]AdoMet or [U-ribosy/-1
C]SeAdoMet into
ribosyl moiety from either [U-ribosyl[U-ri&asy/-14C]AdoMet
[U-n'6o5y/-14C]SeAdoMet

preQ 1-tRNATyr according to established procedures described by Van Lanen et. al.
preQi-tRNATyr
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[78]. Assays were performed in 100 mM gly-gly (pH 8.7), 100 mM EDTA (pH 8.7),
100 mM KCl,
0.5 mM DTT, 0.2 µM
KC1,0.5
pM QueA, 20 µM
pM ofpreQ
of preQi-tRNATyr,
1-tRNATyr, and varying
14
14
concentration of either [U-ribosy/C]SeAdoMet or [U-ribosylC]AdoMet in a final
[U-ribosyl-l4C\SeAdoMet
\\J-ribosyl-^C\AdoMet

volume of
o f 50 µI.
pi. The reaction mixtures were incubated at 37 °C under initial velocity
conditions. Due to the instability of
o f substrate under alkaline conditions, reactions
were initiated upon the addition of
o f AdoMet or SeAdoMet. Reactions were terminated
with the addition of
o f 3 volumes of
o f cold 10% TCA to precipitate the tRNA
tRNA' and protein
from solution. The precipitant was recovered on Whatman GF/B filters by vacuum
filtration and washed with cold 5% TCA followed by 95% ethanol and dried.
Radioactivity was determined by liquid scintillation counting.

The catalytic activity of QueA in the presence of
o f AdoMet analogs in which the isotope
is located in the methionine or adenine moiety, was measured using a chromatographic
protocol to separate substrates and products [97]. Reactions were carried out as
14
described above in the presence of
C]3 ' o f varying concentrations of
o f [1-methionine[l-methionine-14C]3’14
1-methionineC]7deoxy
Ado Met, [[l-methionine-14C]2’-deoxyAdoMet,
1-methionine- 14C]2' -deoxy Ado Met, or [[l-m
deoxyAdoMet,
ethionine-14C]7-

deazaAdoMet. The reactions were terminated by decreasing the pH to 6.5 with the
pi of
of
addition of acetic acid and the samples were subsequently loaded onto 250 µl
Dowex 50WX4 (cation exchange resin) equilibrated in 0.1 N H2SO
H2SO4,
4 , respectively.

Methionine, adenine and AdoMet were sequentially washed from the column with the
addition of
o f 10 ml of IN, 2N and 8N H
H2SO4.
2SO4 • Fractions (1 ml) were collected and
quantified by liquid scintillation counting. When applicable, kinetic parameters were
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calculated from the average of minimally 4 duplicates with the
the'Michaelis-Menten
Michaelis-Menten
equation using the curve fitting software Kaleidagraph 4.0 (Synergy Software,
Reading, PA).

QueA Inhibition Analysis
Inhibition analysis of
o f QueA was conducted with varying concentration of
o f [U-ribosyl14C]AdoMet and various fixed concentrations of SeAdoMet, 33’dAdoMet,
'dAdoMet, 2 'dAdoMet
’dAdoMet
and 7-deazaAdoMet. Reactions were carried out as described above and terminated
with the addition of TCA. QueA activity was quantified by liquid scintillation
counting. The data (average of
o f minimally 4 duplicates) were fitted to the equation for
competitive inhibition ((eq.
eq. I).
1).

v = VS / (Km(l+ 1/Kj) + S)

( 1)

Where S is the varied substrate concentration, I is the inhibitor concentration and Ki
Kj
the inhibition constant.

Time Dependent Inhibition Analysis
Time dependent inactivation studies were conducted in which 2 µM
pM QueA was
preQ1-tRNATyr in
preincubated in the presence of
o f 300 µM
pM SeAdoMet and 50 µM
pM preQi-tRNATyr
reaction Buffer U (100 mM gly-gly (pH 8.7), 100 mM EDTA (pH 8.7), 100 mM KCl,
KC1,
and 0.5 mM DTT) or reaction Buffer V (50 mM Tris-HCl (pH 8.0), 100 mM EDTA
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(pH 8.0), 100 mM KCl,
KC1, and 0.5 mM DTT). Aliquots of
o f the preincubation mixture
were taken at various times into standard QueA assay conditions containing 100 µM
pM
14
[U-ribosylC]AdoMet and 20 µM
preQ1-tRNATyr. The reaction assays were carried
[U-n6£M>7-14C]AdoMet
pM preQi-tRNATyr.

out as described above and terminated with the addition of 3 volumes of
o f cold 10%
TCA and worked up as described above.

QueA Activity Assay using Ni-NT
A
Ni-NTA
Potential formation of
o f an enzyme-substrate covalent adduct was analyzed by nickel
affinity chromatography. Assays were performed in 100 mM gly-gly (pH 8.7), 25
mM sodium phosphate (pH 8.0), 100 mM KCl,
KC1, 0.5 mM ~-mercaptoethanol,
J3-mercaptoethanol, 25-50 µM
pM
14
C]SeAdoMet or [V-ribosylpreQ1-tRNA1Y\ and 200 µM
QueA, 50 µM
pM preQi-tRNATyr,
pM [U-ribosyl[U-ribosyl-1
4C]SeAdoMet
[U-ribosyl-

14C]AdoMet
l4C]AdoMet in a final volume of 50 µl.
pi. The reaction mixtures were incubated at 37 °C
for 30 min and loaded onto 500 µl
Ni-NT A agarose equilibrated in Buffer W (100 mM
pi Ni-NTA
Tris-HCl (pH 8.0) and 300 mM KCl).
KC1). The column was washed with 25 ml of
o f Buffer
A followed by 6 ml of Buffer X (Buffer W containing 250 mM imidazole). One
milliliter fractions were collected and quantified by liquid scintillation counting.

Expression and Purification of HGPRTase
The expression system, pBAC-HGPRTase-LD/SOS6, for the recombinant HGPRTase
from Leishmania donovani was grown in a low phosphate media supplemented with
%
0.2% glucose, 1.5 µM
pM thiamine, 20 µg/ml
pg/ml adenine, 75 µg/ml
pg/ml ampicillin and 0.1
0.1%
vitamin free casamino acids [98-101]. The cultures were allowed to grow until an
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OD6oo
OD 600 of
o f 1.4 was attained. Cells were collected by centrifugation (5000 x g for 10
min), washed two times with phosphate buffered saline solution, flash frozen in liquid
nitrogen and stored at -80 °C until needed. Approximately 9 g of
o f cells were obtained

from 3.5 L of cell culture.

HGPRTase was purified by suspending 9 g of
o f frozen cells in lysis buffer (20 mM TrisHCI
HCl (pH 7.5), 5 mM MgCh,
MgCl2, 1 mM PMSF, and 1 mM DTT) at a concentration of250
o f 250
mg/mL. The cells were lysed by the addition of
o f lysozyme to a final concentration of
of
200 µg/ml
pg/ml and incubating at 37 °C with rotation for 30 min, DNase was added to a
final concentration of
o f 10 µg/ml
pg/ml and the cell solution was incubated for an additional
30 min at 37 °C. Cell debris was removed by centrifugation (15,000 x g for 30 min)
and the resulting cell free extract was filtered with a low protein binding, 0.45 µm,
pm,
syringe filter (Fisherbrand). HGPRTase was precipitated out of
o f the solution upon the
addition of
o f ammonium sulfate to 40% saturation. The solution was clarified by
centrifugation (15,000 x g for 30 min) and HGPRTase from precipitated from solution
with the addition of
o f ammonium sulfate to 80% saturation. The protein was collected
by centrifugation (15,000 X g for 30 min) and suspended in minimal amount of
o f lysis
buffer containing 10% glycerol. The protein sample was dialyzed against the lysis
buffer containing 10% glycerol at 4°C and stored at -80 °C as a glycerol stock. The
purity of
o f the protein sample was analyzed by SOS-PAGE
SDS-PAGE analysis and found to be
-60% pure. Protein concentration was determined by Bradford assay (BioRad) using
~60%
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bovine serum albumin as a standard, and activity was measured by methods described
by Jardim and Ullman [101]

14
Enzymatic Synthesis of [8C]-GTP
[8-,4C]-GTP
14
14
The enzymatic synthesis of [8C]GTP from [8C] guanine was achieved in a
[8-l4C]GTP
[8-14C]
14
similar fashion to that of
C]ATP. The synthesis reaction was carried out
o f [U- ribosyl- 14C]ATP.

at 37°C in 50 mM gly-gly (pH 7.8), 50 mM potassium phosphate (pH 7.5), 10 mM
14
MgCh,
C]guanine, 8 U/ml
MgCl2, 20 mM PEP, 0.25 mM ATP, 0.4 mM PRPP, 0.1 mM [8[8-l4C]guanine,

myokinase, 16 U/ml pyruvate kinase, 0.5 mg/ml nucleoside monophosphate kinase,
and 0.5 mg/ml hypoxanthine-guanine phosphoribosyltransferase (HGPRTase) in a
final volume of 0.5 ml. After 2 h the reaction was terminated by heating at 95 °C for 2
min followed by centrifugation (14,000 X g for 30 min). ATP was removed from the
mixture with the addition of EcMAT. The reaction was carried out in 20%

acetonitrile, 10 mM MgCb,
MgCh, 5 mM methionine, 0.2 mg/ml EcMAT to a final volume of
0.7 ml. After incubating for l1 hr at room temperature the reaction was terminated with
the addition cold 50% TCA to a final concentration of 8%. Precipitated proteins were
14
removed by centrifugation (14,000 x g for 10 min), and [8C]GTP was purified by
[8-l4C]GTP

HPLC on a semipreparative LUNA C18
C l 8 column (250 X 10 mm, 5 um, Phenomenex).
Radiolabeled GTP eluted from the column under isocratic conditions using a mobile
o f 83.3 mM triethylammonium acetate (pH 6.0), and 5% methanol at a flow rate
phase of

of
o f 4 ml/min. Fractions containing GTP were pooled, lyophilized to dryness and
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dissolved in water. Concentration was determined by UV-vis spectroscopy ((se =
= 12.5 x
1
I103
03 M"
M '1cm·1).
cm '1). Typical radiochemical yields were 50-60%.

Cloning and Construction of an Expression System for COG1469 proteins from
Thermotoga maritima, Neisseria gonorrhoeae and Bacillus subtilis
The COG1469 genes from Thermotoga maritima (tm0039;
(tm0039; GenBank accession
number gil15642814),
g ill5642814), Neisseria gonorrhoeae (ngo0387; GenBank accession number
gil59800831)
giI59800831) and Bacillus subtilis (yciA;
iyciA-, GenBank accession number gi12632620)
giI2632620)
were amplified by PCR from genomic DNA. The following primers corresponding to
the 55’' - and 33’' - regions of
o f the gene were used for PCR amplification: T. maritima sense
primer (5'-GGTATTGAGGGTCGCTTGAAGGATGTTCAGAAC-3
(5 ’-GGTATTGAGGGTCGCTTGAAGGATGTTCAGAAC-3 '),
’k T
T. maritima
antisense primer (5'-AGAGGAGAGTTAGAGCCTCATCCCTCCAGAACG-3'),
N
(5 ’-AGAGGAGAGTTAGAGCCTCATCCCTCCAGAACG-3 ’), N.
gonorrhoeae sense primer (5'-GGTATTGAGGGTCGCATGAACGCCATTGCAG(5’- GGT ATT G AGGGTCGC AT GA ACGCC ATT GC AG-

3')
3’) and N. gonorrhoeae antisense primer (5'(5’AGAGCCCTACGGGT
’), B. subtilis sense
AGAGGAGAGTT AGAGCCCT
ACGGGT AGGCGATAT AG-3 '),

'-GOTATTGAGGGTCGCATGAATCAACATACGCTGCTCCCG-3 ') and
primer (5
(5’-GGTATTGAGGGTCGCATGAATCAACATACGCTGCTCCCG-3’)
B. subtilis antisense primer (5'-AGAGGAGAGTTAGAGCCTCATATTTTATCCAC(5’-AGAGGAGAGTTAGAGCCTCATATTTTATCCAC-

33’).
'). The start codons are represented in boldface type and the Factor Xa cleavage site
is underlined in the sense primer.

The PCR reaction contained 500 ng genomic DNA, 200 µM
|iM dNTPs, 50 pmol of
o f the
sense and antisense primers, lx Pfu Ultra buffer (supplied by the manufacturer), and
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2.5 units of
o f Pfu Ultra DNA polymerase (Stratagene) in a final volume of 50 µ1.
pi. A
three step PCR thermocycling protocol was utilized; (1) 94 °C for 1 min; (2) 30 cycles

of
o f denaturation at 94 °C for 1 min, annealing at 50 °C for 2 min, and extension at 72 °C
for 1 min; (3) 72 °C for 4 min. The PCR product was purified from a 11%
% agarose gel
containing ethidium bromide and cloned into a linearized pET-3
pET-300 Xa/LIC expression
vector according to manufacturer (Novagen). The primary structures of
o f the cloned
genes were confirmed by sequencing.

Expression and Purification of recombinant T. maritima, N. gonorrhoeae and B.
subtilis COG1469 proteins

E. coli BL21
(DE) competent cells (100 µl)
BL21(DE)
pi) were transformed with 1 µg
pg of plasmid
DNA harboring the COG 1469 gene and plated on LB medium agar plates containing
50 µg/ml
pg/ml kanamycin. An isolated colony was used to inoculate 3 ml of LB medium
containing 50 µg/ml
pg/ml kanamycin. After incubating for 12 hat
h at 37 °C with shaking (250
rpm), a 1 ml aliquot was used to inoculate 100 ml of
o f LB medium supplemented with
pg/ml kanamycin. The culture was incubated for 12 hat
h at 37 °C with shaking (250
50 µg/ml

rpm), then 5 ml aliquots were used to inoculate 7-2500 ml flasks containing 500 ml of
LB medium supplemented with 50 µg/ml
pg/ml kanamycin. The cultures were allowed to
grow at 37 °C until an OD60
600o of0.9-1.0
o f 0.9-1.0 was attained. Expression of the recombinant
proteins was induced by the addition of
o f IPTG to a final concentration of
o f 0.1 mM.
Cells were harvested 4 h post induction by centrifugation (5000 x g for 10 min), flash
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frozen in liquid nitrogen and stored at -80 °C until needed. Approximately 10-15 g of
cells was obtained from 3.5 L of
o f cell culture.

The recombinant His6-tag fusion proteins from T
N
T. maritima, B. subtilis and N.
gonorrhoeae were purified by suspending 10 g of
o f frozen cells in lysis buffer (50 mM

Tris-Acetate (pH 8.0), 50 mM KCl,
1 mM P-mercaptaethanol,
K C1,1
p-mercaptaethanol, 1 mM PMSF and 10%
glycerol) at a concentration of 250 mg/ml. The cells were lysed by the addition of
of
lysozyme to a final concentration of
o f 250 µg/ml
pg/ml and incubating at 3
377 °C with rotation
for 30 min, DNase was then added to final concentration of
o f 10 µg/ml
pg/ml and the cell
solution was incubated for an additional 30 min at 37 °C. The solution was incubated
on ice for 10 min after the addition of 10 ml of Buffer P (200 mM Tris-acetate (pH
8.0), 1.2 M KCl,
KC1, 8 mM P-mercaptaethanol, 4 mM PMSF and 40% glycerol). Cell
debris was removed by centrifugation (15,000 x g for 30 min) and the resulting cell
free extract was filtered with a low protein binding, 0.45 µm
pm syringe filter
(Fisherbrand). The cell free extract was loaded onto a 10 ml Ni-NTA
Ni-NTA agarose column
(Qiagen), equilibrated with 10 column volumes of Buffer Q (100 mM Tris-Acetate
(pH 8.0), 300 mM KCl,
% Triton X-100, 1 mM PMSF and
KC1, 2 mM P-mercaptoethanol, 11%
l10%
0% glycerol). The column was sequentially washed with 5 column volumes of
of
Buffer 1, 5 column volumes of
o f Buffer R (Buffer Q containing 20 mM imidazole) and
5 column volumes of
o f Buffer S (Buffer R without Triton X-100 and PMSF). The
protein was eluted from the column with 7 column volumes of
o f Buffer T (Buffer S

containing 250 mM imidazole). Fractions containing the protein were pooled,
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concentrated with Amicon Ultra YM-10 centrifugal filtration device (Millipore) and
dialyzed against 50 mM Tris-Acetate (pH 8.0), 50 mM KCl,
KC1, and 2 mM OTT
DTT at 4 °C.
The recombinant proteins were greater than 90% homogeneous as determined by
SDS-PAGE and stored as glycerol stocks at -80 °C. The protein concentration was
determined either by Bradford assay (BioRad) using bovine serum albumin as a
standard or spectrophotometrically using the extinction coefficient calculated by the
amino acid sequence of
o f the denatured protein (6 M guanidine hydrochloride) [102].

Radiochemical Based Assay for GCYH-1
GCYH-I and GTPCH-11
GTPCH-II Activity
COG 1469 proteins were analyzed for type I and II GTP cyclohydrolase activity by
14

14

monitoring the release of
C] formate from [8C]-GTP [51, 103]. Assays were
o f [[14C]
[8-14C]-GTP
14
carried out in 100 mM Tris-HCl (pH 8.0), 100 mM KCl,
2_mM
C]KC1,2
mM MgCh,
MgCl2, 1 mM [8[8-l4C]-

GTP and 5 µM
pM of
o f enzyme in a total volume of
o f 250 µl.
pi. Aliquots of
o f 50 µl
pi were taken at
specific time points and terminated by the addition of 6_2.5
62.5 µl
pi 0.5 M
M formic acid. After
pi of
of
chilling on ice for 5 min the samples were loaded onto a column containing 250 µl

charcoal equilibrated in 50 mM Tris-HCl (pH 7.5). Radiolabeled formate was washed
from the column with the addition of
o f 50 mM Tris-HCl (pH 7.5). Five 2 ml fractions
were collected and quantified by liquid scintillation counting.

Spectrophotometric Based Assay for GCYH-1
GCYH-I Activity
GCYH-1
GCYH-I activity of the COG 1469 proteins were assayed spectrophotometrically by
1
1
)) due to the
monitoring the increase in absorbance at 330 nm (e
cm"'1
(s = 6300 M"
M"lcm
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formation of
104]. Assays were performed in
o f a dihydroneopterin chromophore [60,
[60,104].
100 mM Tris-HCl (pH 8.0), 100 mM KCI,
KC1, 2 mM MgCh,
M gCb, and either 20 µME.
pM E. coli
FolE or 40 µM
pM COG1469 proteins in a total volume of
o f 100 µl.
pi. Reactions were
· · initiated upon the addition of GTP to a final concentration of
o f 0.1 mM and incubated at
37 °C. The reactions were allowed to proceed for 60 min while monitoring the
absorbance from 200-400 nm.

Fluorescence Based Assay for GTPCH-1
GTPCH-I Activity
GCYH-I activity of
o f the COG1469
COG 1469 proteins were assessed by fluorescence according to
methods ofNar
o f Nar [52]. Assays were performed in 100 mM Tris-HCl (pH 8.0), 100 mM

KCI,
µME.coli
KC1, 2 mM MgCh,
MgClz, and either 10 pM
E.coli FolE or 40 µM
pM COG1469 proteins in a
total volume of 100 µl.
pi. Reactions were initiated upon the addition of
o f GTP to a final
concentration of 1 mM and incubated at 37 °C (E. coli FolE, N. gonorrhoeae and B.
COG1469)
(T, maritima COG
COG1469).
o f the
subtilis COG
1469) or 75 °C (T.
1469). Dephosphorylation of

reaction product was achieved upon the addition of
o f 5 units of alkaline phosphatase
followed by a 30 min incubation at 37 °C. The suspected product, 7,8pi 11%
H (w/v) and
dihydroneopterin, was oxidized to neopterin with the addition of 12 µl
% 1z
HC1 followed by incubating in the dark at room temperature for
2% KI (w/v) in 1 M HCl

15 min. Excess iodine was reduced by the addition of
o f 6 µl
pi of2%
o f 2% ascorbic acid (w/v)
and the samples were analyzed by fluorescence (excitation 365 nm and emission at
o f 4 nm) after centrifuging at high speed for 5 min. Fluorescence
446 nm; slit width of
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based activity assays were also carried out in which the dephosphorylation of
o f the
reaction product, was eliminated.

HPLC Based Assay for GCYH-1
GCYH-I Activity
Product formation was monitored by HPLC in reactions containing 100 mM Tris-HCI
Tris-HCl
(pH 8.0), 100 mM KCI,
KC1, 2 mM MgCh,
MgCL, 1 mM OTP
GTP and either 60 µME.
pM E. coli FoIE
FolE or
1469 protein. Reactions were incubated at 3377 °C for 60 min
100 µM
pM B. subtilis COG
COG1469
in the dark followed by the addition of 5 units of
o f alkaline phosphatase incubated for an
additional 60 min at 37 °C. The proteins were removed from the solution using an
YM-10 micron centrifugal device and the samples were analyzed by reversed phase
HPLC on a Gemini C18
C l 8 (Phenomenx; 250 X 3.90, 5 um) column equilibrated in 25
mM ammonium acetate (pH 6.0), at a flow rate of
o f 1 ml/min. The following solvent

gradient was used to elute neopterin from the column: (time,%
(time, % acetonitrile): 0
0 min,
0%, 10 min 0%, 30 min 4%, 35 min, 50% and 40 min, 0%. Assays were also
performed by analyzing the products without dephosphorylation by alkaline
phosphatase.

LC-MS Analysis of COG1469 Reaction Product
The preparation of dihydroneopterin triphosphate for LC-MS analysis was achieved in
reaction mixtures containing 100 mM Tris-HCl (pH 8.0), 100 mM KCl,
KC1, 2 mM MgCli,
MgCL,

1 mM OTP
GTP and either 20 µME.
pM E. coli FolE or 40 µMN.
pM N. gonorrhoeae COG1469 protein
pi. The reactions were carried out at 37°C for 3 h in the dark
in a final volume of 500 µl.
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and treated with activated charcoal according to modified methods of
o f Yim [105].
After incubating in the presence of
o f charcoal at 4°C for 30 min in the dark, the mixtures
were filtered through a Millipore type HA (0.45 uM) filter. The filter which contains
the charcoal was successively washed with 10 ml water, 10 ml 5% ethanol, 10 ml 50%
ethanol containing 3.1
% ammonium hydroxide (pH 8.0) and 5 ml 50% ethanol
3.1%
containing 33.1%
.1 % ammonium hydroxide (pH 12) after which the filtrate from the final
wash was quickly neutralized with acetic acid.

The fractions were immediately frozen in liquid nitrogen and lyophilized to dryness.
The samples containing neopterin triphosphate were suspended in 20 mM ammonium
acetate (pH 8.0), and 50% methanol and filtered through a Millipore Amicon ultrafreeMC spin filter. Samples were analyzed by an LCQ Advantage ion-trap mass
spectrometer (Thermo Electron, San Jose, CA) equipped with an electrospray
ionization (ESI) source. The ion interface was operated in the negative mode using
o f 4.5kV; sheath and auxiliary gas flow rates of
the following settings; needle voltage of

25 and 3.0 p.s.i., respectively; tube lens voltage of 50 V;
Y; capillary voltage of
o f 3.0 V;
and capillary temperature of 275 °C. An instrument method was created to scan the
range mlz
m/z 50-1100. An isocratic LC mobile phase system consisted of
o f methanol and
.0) (1:
water (pH 9
9.0)
(1:11 v/v) at a flow rate of 0.4 ml/min. The injection volume was 2050µ1
50pl in aqueous 20mM ammonium acetate (pH 8.0).
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Temperature and pH optima
The detennination
determination of optimal temperature for enzymatic activity of
o f B. subtilis, N.
gonorrhoeae, and T. maritima COG1469 proteins, was determined in reaction

mixtures containing 100 mM phosphate (pH 7.5), 0.5 mM MnCii,
MnCL, 0.5 mM GTP and 2
µM
pM protein in a final volume of 100 µl.
pi. After incubating at various temperatures in
the dark for 30 min, the reactions were tenninated
terminated and analyzed by fluorescence as
described above.

The optimal pH of B. subtilis and N. gonorrhoeae COG 1469 proteins were determined
in a 3 component buffer system composed of
o f Tris-MES-acetic acid (100-50-50 mM)
over a pH range of
o f 4.0-9.0. Buffers also contained 100 KCl,
KC1, 0.5 mM MnC}z,
MnCL, 2 mM
OTT,
DTT, 50 µM
pM GTP and 1 µM
pM protein in a final volume of
o f 100 µl.
pi. After incubating at
37 °C in the dark for 30 min, the reactions were tenninated
terminated and analyzed by
fluorescence as described above.

Molecular Mass Determination
o f native wild-type B. subtilis and N. gonorrhoeae COGI469
COG 1469
The molecular mass of
determined by HPLC on a BioSep-SEC-S4000 (300 mm X 7.8 mm,
proteins were detennined

Phenomenex Inc.) gel filtration column. The proteins (100 µg)
pg) were eluted with 20
o f 0.5 ml/min.
mM sodium phosphate (pH 7.2) and 100 mM NaCl at a flow rate of

Ferritin (443 kDa), pyruvate kinase (237 kDa), alcohol dehydrogena·se
dehydrogenase (150 kDa),
BSA (65.4 kDa), ovalbumin (48.9 kDa), and carbonic anhydrase (30 kDa) were used
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as molecular weight standards. The void and total column volume were determined
from the elution volume of
o f blue dextran and DNP-aspartate (299 Da). Elution of
o f the
proteins from the column was monitored by the absorbance at 280 nm. Tp.e
The analysis

was also repeated with an elution buffer containing GTP and MnCh.
MnCl2.

Buffer and Buffer Strength
The effect of buffer on activity was examined for B. subtilis and N gonorrhoeae
COG 1469 proteins in reactions carried out at 3377 °C for 20 min in 100 mM buffer
(Tris-HCl, HEP
ES, Tricine and MOPS; pH 8.0), 100 mM KCl,
HEPES,
KC1, 0.5 mM MnCh,
MnCl2, 1 mM
DTT, 50 µM
pM GTP, and 0.5 µM
pM protein in a final volume of
o f 100 µl.
pi. Reactions were
terminated and analyzed as described above for fluorescence based activity assays.
Follow up studies were conducted with varying concentration ofHEPES
o f HEPES (pH 8.0)
under conditions described above.

Apoenzyme Preparation
o f metal ions from COG 1469 proteins was achieved by incubating the
Removal of

A for 1 h at room
purified wild-type enzyme in the presence of
o f 5 mM EDT
EDTA
temperature followed by dialysis against of 50 mM Tris-HCI
Tris-HCl (pH 8.0), 50 mM KCI,
KC1, 5
mM EDTA, and a few grams of
o f Chelex-100 for 4 hat
h at room temperature. The protein
h at 4 °C with 3 exchanges of
o f buffer (4 L
sample was dialyzed for an additional 12 hat

each). EDTA was removed by dialyzing the resulting apoenzyme solution against 50
mM Tris-HCI
Tris-HCl (pH 8.0), 50 mM KCl
KC1 and Chelex-100 for 16 hat
h at 4 °C with three
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exchanges of
o f buffer (3 Leach).
L each). Protein samples were then passed through Chelex-100
resin (5 ml protein solution per 3 ml resin) prior to activity assays or ICP-MS analysis.
Protein concentrations were determined spectrophotometrically using the extinction
coefficient calculated by the amino acid sequence of
o f the denatured protein (( 66 M
guanidine hydrochloride) [102].
[ 1 0 2 ].

Metal Activation Studies
The effects of
o f metal ions on enzyme activity was examined by incubating the
apoenzyme (2 µM)
pM) in the presence of
o f varying concentration (0.1 µM-4
pM-4 mM) of
o f metal
chlorides (MnCh,
NiCh, CaCh,
(MnCl2, ZnCh,
ZnCl2, MgCh,
MgCl2, NiCl2,
CaCl2, CdCh,
CdCl2, CoCh,
CoCl2, CuC}z,
CuCl2) CoCb,
CoCl3, FeCb)
FeCl3) in
100 mM HEPES (pH 8.0) and 100 mM KCl
KC1 for 10 min at 37 °C. Since iron(II) readily
oxidizes in the presence of oxygen, all assays involving iron were conducted with
Fe(SO4)2
Fe(SC>4 ) 2 under anaerobic conditions with buffers that had been degassed and sparged
with nitrogen prior to use. Assays were initiated upon the addition of
o f OTP
GTP to a final
concentration of
o f 0.1 mM and the reactions were allowed to proceed at 37 °C for 30
min in the dark. Reactions were terminated and analyzed as described above for
fluorescence based activity assays.
fluor~scence

Determination of Iron Content

The iron content of apo-forms of
1469 was
o f N. gonorrhoeae and B. subtilis COG
COG1469
determined by methods described by Fish [106]and Percival [107]. The proteins (0.5
mg) were precipitated from solution upon the addition of
o f 30% trichloroacetic acid

52

solution to a final concentration of 5% and volume of
o f 100 µI.
pi. The samples were
centrifuged for 5 min at high speed and the resulting supernatant was transferred to a
clean 1.5 ml centrifuge tube. The following components were added to the samples in
the following order: 0.04 ml of
o f saturated ammonium acetate solution; 0.025 ml 0.12 M
ascorbic acid; 0.025 ml 0.25 M FerroZine and milliQ water to C1.3
0’.3 ml. The resultant
mixture was incubated for 30 minutes at room temperature, centrifuged at a high

speed, and the absorbance monitored at 562 nm in a 0.5 ml quartz cuvette. An
external calibration curve generated from an iron atomic absorption standard solution
was used to determine the iron concentration of
o f the protein samples.

Reconstitution of Enzyme with Divalent Metals
Reconstitution of
o f the enzymes was carried out by incubating the purified apoenzyme
in the presence of 2-7 molar equivalents ofMnCh
o f M nC^ or ZnCh
ZnC^ in 100 mM HEPES (pH
KC1, and 2 mM DTT for 60 min at 25 °C with gentle shaking. Prior to
8.0), 100 mM KCl,

excess metal removal, the proteins were analyzed for activity as described above for
the fluorescence based activity assay. The reconstituted protein was isolated from
unbound metal either by: (1) dialyzing against 2 L Buffer Y (50 mM Tris-HCl, (pH
8.0), 50 mM KCl,
KC1, and 1 mM DTT) for 4 hr at 4 °C (2 exchanges of
o f buffer); (2)
passing the protein solution over a Sephadex G-25 column; or (3) extensive dilution

and concentration with Buffer Y using the Amicon YM-10 ultra-centrifugal device.
The reconstituted proteins were assayed for activity by fluorescence and the metal
content was analyzed by ICP-MS.
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Metal Analyses by ICP-MS
The metal content of various protein samples was analyzed by ICP-MS. Protein
samples (2 mg/ml) were prepared in metal free solutions and acidified below pH 2.0
with the addition of high purity nitric acid to release any protein bound metal ions into
2
2
solution. The samples were analyzed for the following metal ions; Ni2+, Ca
+, Co
+,
Ca2+,
Co2+,

Mn2+,, Zn2+ by ICP-MS. An external calibration curve was generated from the
multielement calibration standard 2 (Spex CertiPrep). Each sample was prepared in
triplicate.

The Effects ofDTT
of DTT upon COG1469 Activity.
Activity
The effect of DTT on enzyme activity of COG
1469 proteins from B. subtilis and N.N.
COG1469
gonorrhoeae was examined in UV-vis based assays by monitoring the increase in
1
1
absorbance at 330 nm (e= 6300 M"
M ' 1cm"
cm '1)) [60, 104]. Assays were carried out at 37 °C

in 100 mM HEPES (pH 8.0), 100 mM KCl,
KC1, 0.5 mM MnCh,
MnCl2, 10 µM
pM protein, 0.1 mM
o f 110 µl.
pi.
GTP and varying concentration of DTT (0-12 mM) in a final volume of
o f DTT
Absorbance readings from 200-400 nm were recorded for 30 min. The effect of
COG 1469 proteins from B. subtilis and N.
on COG1469
N gonorrhoeae activity was also

monitored using fluorescence based assays performed in 100 mM HEPES (pH 8.0),
KC1, 0.5 mM MnCl2, 0.5 µM
pM protein, 50 µM
pM GTP and varying concentration
100 mM KCl,

of DTT (0-12 mM) in a final volume of 100 µI.
pi. Reactions were incubated at 3
377 °C for
30 min in the dark and terminated as described above. Follow-up studies examined
the effects of
o f DTT on as-isolated and apoenzymes with and without 0.5 mM MnCl2.
M nCl2.
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COG1469 Activity as a Function of Time and Enzyme Concentration
A time course analysis of
o f B. subtilis and N. gonorrhoeae COG1469 activity was
performed at 37 °C in 100 mM HEPES (pH 8.0), 100 mM KCl,
KC1, 0.5 mM MnCh,
MnCl2, 2 mM

DTT, 30 µM
pM GTP and 0.1 µM
pM protein in a final volume of
o f 100 µl.
pi. Reactions were
terminated at specific time points and analyzed by fluorescence as described above.
above,
enzyme activity was also investigated as a function of
o f enzyme concentration.
Reactions were performed as described above except in the presence of
o f varying
concentration of
o f enzyme (0.1-2 µM).
pM). Reactions were terminated after 15 min and
analyzed by fluorescence.

Substrate Specificity Analysis of N. gonorrhoeae COG1469 Protein
Substrate specificity of
o f N. gonorrhoeae COG1469 was determined with various
nucleosides in the presence of
o f 100 mM HEPES, 100 mM KCl,
KC1, and 0.5 mM MnCh.
MnCl2.

Reactions were incubated at 3377 °C for 60 min. Substrate activity with 2'
-dGTP, GMP,
2’-dGTP,
GTP and guanosine were monitored by fluorescence whereas 8-oxoGTP,
8 -oxoGTP, 7-deazaGTP,
2'dGTP,
2’dGTP, GTP and ATP were analyzed by HPLC.

Kinetic Studies of and B. subtilis and N. gonorrhoeae COG
1469 Proteins
COG1469
Steady-state kinetic measurements were conducted for B. subtilis and N. gonorrhoeae
COG 1469 proteins under initial velocity conditions with varying OTP
GTP (3-50 µM)
pM) or
pM) as substrate. Initial assays were carried out in 100 mM HEPES
GDP (50-2000 µM)

(pH 8.0),
·100 mM KCI,
8.0),100
KC1, 0.5 mM MnCh
MnCl2 and 2 µM
pM of
o f protein in a final volume of
o f 100
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µlat
pi at 37°C. Subsequent steady state studies were conducted under conditions
described above except in the presence of
o f 1 mM DTT and 0.5 µM
pM protein. Time
course assays, up to 80 min, were conducted in order to determine initial velocity
conditions. Reactions were terminated at various time points and analyzed by
fluorescence. Kinetic parameters were calculated from the average of
o f minimally 4
triplicates with the Michaelis-Menten equation using the curve fitting software
Kaleidagraph 4.0 (Synergy Software, Reading, PA).

Inhibition Analysis of N. gonorrhoeae COG1469 Protein
Inhibition analysis for N. gonorrhoeae COG
1469 protein was conducted with variable
COG1469
GTP (3-50 µM)
pM) and various fixed concentration of
o f 7-deazaGTP (15-60 µM),
pM), 8-oxo8 -oxoGTP (0.1-0.5 µM)
pM) and 2'd-GTP(0-200
2’d-GTP(0-200 µM).
pM). Reactions were carried out as described
above in the presence of 1 mM DTT and 0.5 µM
pM protein. The data (average of
minimally 4 triplicates) were fitted to the equation for competitive inhibition (eq. 1)

v = VS / (Km(l+ I/Kj) + S)

(1)

where S is the varied substrate concentration, I is the inhibitor concentration, Ki
Kj is the
inhibition constant.
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Mutagenesis of N. gonorrhoeae COG1469 Protein
The His 245 mutants of N. gonorrhoeae COG
1469 protein were constructed using the
COG1469
TM site-directed mutagenesis protocol from Stratagene. Primers were
QuikChange
QuikChange™

designed to mutate His 245 to Asp (CAC-GAC),
(CAC—>GAC), Lys (CAC-AAG),
(CAC—>AAG), Asn
(CAC-AAC),
(CAC—>AAC), Gin (CAC-CAG),
(CAC-^CAG), Gly (CAC-GGC),
(C A C ^G G C ), Ala (CAC-GCC).
(CAC-»GCC). The PCR
reaction contained 500 ng plasmid DNA encoding the wild-type COG1469 protein
from N. gonorrhoeae, 200 µM
pM dNTPs, 50 pmol of the sense and antisense primers, lx
lx
Pfu Ultra buffer (supplied by the manufacturer), and 2.5 units of
o f Pfu Ultra DNf\
DNA
polymerase in a final volume of
o f 50 µI.
pi. A three step PCR thermocycling protocol was
utilized; (1) 95 °C for 1 min; (2) 12 cycles of denaturation at 95 ~C
°C for 30 s, annealing

at 55 °C for 1 min, and extension at 68
6 8 °C for 10 min; (3) 68
6 8 °C for 15 min. The PCR
reaction mixture was incubated with Dpnl at 3377 °C for 1 h to digest the methylated
wild-type DNA template. The mutant plasmids were transformed into E. coli
NovaBlue competent cells (Novagen) and plated. An isolated colony was used to
pg/ml kanamycin. After growing the
inoculate 3 ml LB media supplemented with 30 µg/ml

cultures for 12 h at 3377 °C with shaking and the mutant plasmids were extracted from
o f the cloned genes were confirmed by sequencing.
the cells. The primary structures of

The expression plasmid (1 µg)
pg) for each of
o f the mutants were transformed into E. coli
BL21(DE)
pi) competent cells and protein expression and purification was
BL21
(DE) ((100
100 µl)

carried out according to procedures described for the wild-type protein.
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Radiochemical Based Assay for GCYH-1
GCYH-I and GTPCH-11
GTPCH-II Activity
Type I and II GTP cyclohydrolase activity for each of
o f the mutants, with the wild-type

N gonorrhoeae COG 1469 and E.
N.
E, coli RibA functioning as positive controls, were
14
14
assessed by the release of
C formate from [8o f 14C
[8 - 14C]-GTP according to methods

described by Burg [108] and Ferre [103]. Assays were carried out in 100 mM HEPES
14

(pH 8.0), 100 mM KCl,
KC1, 0.5 mM MnCh,
MnCl2, 50 µM
pM [8[8 - 14C]-GTP and SO
50 µM
pM of enzyme in
a total volume of 50 µl.
pi. Reactions were allowed to proceed at 3
377 °C for 60 min and
terminated by the addition of
o f 62.5 µl
pi of
o f 0.5 M formic acid. After chilling on ice for 5
min the reaction mixtures were loaded onto a column containing 250 µl
pi of
o f charcoal
equilibrated in 50 mM Tris-HCI
Tris-HCl (pH 7.5). Radiolabeled formate was washed from the
column with the addition of
o f 50 mM Tris-HCl (pH 7.5). Five 2 ml fractions were
collected and quantified by liquid scintillation counting.

Spectrophotometric Based Assay for Mutant Activity
Each of
o f the mutants were assayed spectrophotometrically, with wild-type N.
gonorrhoeae COG 1469 as a positive control, by monitoring the increase in absorbance
1
) due to the formation of a dihydroneopterin chromophore
at 330 nM (e= 6300 MM"11cmcrrf1)

[60, 104]. Assays were performed in 100 mM HEPES (pH 8.0), 100 mM KCl,
KC1, 0.5
(60,

mM MnClz,
MnCl2, and 50 µM
pM mutant N. gonorrhoeae COG1469 protein in a total volume of
150 µL
pi. Reactions were initiated upon the addition of
o f GTP to a final concentration of
of
0.1 mM and incubated at 37 °C. The reactions were allowed to proceed for 2 h while
recording the absorbance from 200-400 nm.
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Fluorescence Based Assay for Type II and III GTPCH Activity
Reactions catalyzed by N. gonorrhoeae COG 1469 mutants were analyzed for the
APy or APy according to procedures described by Bracher
potential formation of F
FAPy
[59]. Wild-type N. gonorrhoeae COG 1469 and E. coli RibA were utilized as controls
Assays were carried out at 37 °C for 1 h in 100 mM HEPES (pH 8.0), 100 mM KCl,
KC1,
0.5 mM MnClz,
MnCE, 1 mM DTT 0.1 mM GTP and 2 µM
pM enzyme. Reactions were
terminated upon the addition of
o f 100 µl
pi of
o f I1 M HCl
HC1 followed by incubation at 90 °C for
5 min. After adjusting the pH to 8.5 with the addition of
o f 1 M NaOH, butanedione in 1
M Tris-HCI
Tris-HCl (pH 8.5) was added to each of the assays to a final concentration of
o f 0.5%.
The reactions were incubated for I1 hat
h at 90 °C and the formation of
o f 6,7-dimethylpterin
was analyzed by fluorescence (excitation 365 nm, emissions 460 nm).
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Results
QueA
PreQ1-tRN.A
Tyr
PreQi-tRNAT
yr
The expression plasmid, pTrc-Tyr, was expressed in E. coli K12QueA, a queA
deletion mutant strain that produces preQi
preQ 1 containing tRNA instead of queuosine
modified tRNA [33]. Total tRNA was extracted from the cells using the acid
guanidinium thiocyanate/phenol/chloroform protocol [109], of
o f which~
which - 20-25% was
determined to be preQi-tRNATyrby
preQ1-tRNATyrby tyrosine-tRNA synthetase activity assay.
Enrichment ofpreQ
of preQi-tRNATyr
1-tRNATyr was achieved by mixed-mode chromatography using
benzoylated-napthoylated DEAE-cellulose (BND-cellulose) as described in Material

and Methods [81, 82].
82], PreQ
PreQi-tRNATyr
o f IM
1M
1-tRNATyr eluted from the column in the presence of
NaCl and ~
10% ethanol (Figure 15). PreQ,-tRNA
Tyr was enriched further by
-10%
PreQi-tRNATyr
chromatography on a NACS™ (trialkylmethylammonium chloride anion exchange)
column, with preQi-tRNATyreluting
preQ 1-tRNATyr eluting at ~750
-7 5 0 mM NaCl (Figure 16) [83, 84]. PreQ
P re Q1rtRNA was then precipitated from solution, suspended in 3 mM citrate (pH 6.3) and
dialyzed against EDT
A to remove any metals. The preQi-tRNATyrcontent
preQ 1-tRNATyr content was 80EDTA
90% based on tyrosine-tRNA synthetase activity assay.

[V-ribosyl- 14 C]ATP Synthesis
[U-n6usy/-14C]ATP
14
A multienzymatic synthesis reaction was used to produce [U-ribosyl\\J-ribosyl-X
AC]ATP
C\AT'? from

[U-14
14C]glucose (Figure 17) [89, 110].
110], Seven of
o f the enzymes (hexokinase, myokinase,
[U-

glutamate dehydrogenase, glucose-6glucose-6 - phosphate dehydrogenase,
phosphoriboisomerase and pyruvate kinase) were commercially available, 5 of
o f which
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were obtained as sulfate suspensions. Recombinant His6-tag
His6 -tag APRTase was purified in
a single step to homogeneity by nickel metal affinity chromatography and appeared as
a 25 kDa band on SDS-PAGE gel (Figure 18). PRPP was partially purified by
ammonium sulfate precipitation, and appeared as a 34 kDa band on SDS-P
AGE gel
SDS-PAGE
(Figure 18).

All of the necessary enzymes, excluding glutamate dehydrogenase, were pooled,

diluted with Milli-Q water and concentrated by ultrafiltration prior to use. [U-ribosyl14C]ATP
14C]ATP was purified by C 18
l 8 reverse phase HPLC under isocratic conditions using a
mobile phase composed of 83.3 mM triethylammonium acetate (pH 6.0) and 6%
6%
14
methanol. Under these conditions [U-ribosyl\U-ribosyl-u C]ATP
C \A lY eluted at 24 min (Figure 19).

14
Fractions containing [U-ribosyl[U-r/ho,sy/-14C]ATP were pooled, lyophilized to dryness and
dissolved in Milli-Q water. Typical radiochemical yields were approximately 70-80%
14 C 0 2 from C-1
after accounting for the loss of
o f 14CO2
C-l of
o f glucose.

Enzymatic Synthesis of AdoMet and AdoMet Analogs

AdoMet and AdoMet analogs were prepared enzymatically from their respective NTP
and methionine or selenomethionine in an AdoMet synthase (MAT) catalyzed reaction
(EcMAT)
(Figure 20). AdoMet synthase from E. coli (EcMA
T) was overproduced in E. coli and

purified to 70-80% homogeneity by streptomycin sulfate and ammonium sulfate
fractionation (Figure 18). Approximately 100 mg of
o f protein was purified from 10 g of
of
Hisg-tag
cells. AdoMet synthase from M.
M jannaschii (MjMAT) was expressed as a His6-tag
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fusion protein and purified in a single step by nickel metal affinity chromatography.
Approximately 53 mg of
o f MjMAT from 10 g of cells was purified to homogeneity as
determined by SDS-PAGE(Figure
SDS-PAGE (Figure 18).

14
EcMA
T was utilized in the synthesis of
C]AdoMet and [U-ribosylEcMAT
o f [U-ribosyl[U-n7>oyy/-l4C]AdoMet

14C]SeAdoMet as well in.
C-methionine- 14C]3 '-dAdoMet and [1
Cin the synthesis of
o f [l
[lC-methionine-14C]3’-dAdoMet
[1Cmethionine-14C]7-deazaAdoMet. Since 2'dATP
2’dATP does not function as a substrate for
C-methionine- 14C]2' -dAdoMet was carried out in the
EcMAT the synthesis of
o f [l
[lC-methionine-14C]2’-dAdoMet

M jannaschii (MjMAT). Due to the high temperature
presence of
o f MAT from M.
optimum of MjMAT, the synthesis of2'-dAdoMet
of 2 ’-dAdoMet was needed to be carried out at
55°C. Unfortunately, the higher reaction temperatures promoted the decomposition of
2'
-dAdoMet. Therefore, to maximize product formation and minimize the
2 ’-dAdoMet.
decomposition of
o f the newly formed 2'-dAdoMet,
2’-dAdoMet, reactions were allowed to proceed
o f 2 in the presence of 0.6 mg/ml of
o f MjMAT as opposed to 0.2 mg/ml.
for 1 h instead of

AdoMet analogs were purified from their respective nucleoside triphosphates and
decomposition products by reverse-phase HPLC under isocratic conditions, with a
mobile phase composed of 20 mM ammonium acetate (pH 6.0) and 2% methanol.
14
14
Under these conditions both [U-ribosylC]-AdoMet and [U-ribosylC]SeAdoMet
[U-r/6o.?y/-,4C]-AdoMet
[U-r/6osy/-14C]SeAdoMet
14
14C]7eluted~
C]3'-dAdoMet and [1-methionineeluted ~ 10 min (Figure 21), [1-methionine[ 1-methionine-14C]3’-dAdoMet
[l-m ethionine-14C]7-

at —11.5 and 17 min, respectively (Figure 22). The HPLC
deazaAdoMet eluted at~

chromatogram from the enzymatic synthesis of
o f 2'-deoxyAdoMet
2’-deoxyAdoMet displayed three
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peaks eluting at 8,
8 ,112
2 and 26 min (Figure 23). Unreacted 2'-dATP
2 ’-dATP eluted at 8
8 min
14
while [1-methionine[l-methionine- 14C]2'-dAdoMet
C]2’-dAdoMet eluted at 12 min, as determined from the

amount of
o f radioactivity associated with the peak. The peak at 26 min is probably due
to the formation of
o f 2'dMTA
2 ’dMTA as a result of
o f higher reaction temperatures. Typical
14
14
radiochemical yields of
o f [U-ribosyl[U-n'6 osy/- 14C]AdoMet and [U-ribosyl[lJ-n'6 oyy/-14C]SeAdoMet were

14
80 and 65%, respectively. The radiochemical yield for [IC-methionine[lC-methionine- 14C]-3'C]-3’-

dAdoMet, [[lC-methionine1C-methionine- 14
C-methionine- 14
-dAdoMet
14C]7-deazaAdoMet and [1
[lC-methionine14C]2'
C]2’-dAdoMet
were approximately 70,
45 and 40%, respectively. Each of
70,45
o f the samples were
lyophilized to dryness and resuspended in 10 mM H22 SO44 •.

QueA Expression and Purification
QueA from E. coli was expressed as an amino-terminal His 66-tag fusion protein and
purified in a single step by nickel metal affinity chromatography. Approximately 120
mg of protein from 10 g of cells was purified to homogeneity as determined by SDSP
AGE (Figure 24). E.
E.coli
PAGE
coli QueA was also expressed as an amino-terminal
glutathione-S-transferase fusion protein that was partially purified by affinity
chromatography utilizing Glutathione Sepharose 4B (Figure 25A). The protein was
purified to 90% homogeneity after HPLC (Figure 25B). It has been demonstrated
previously that the OST
GST or the His-tag does not compromised QueA activity, therefore

all substrate and inhibition analysis was conducted with the fusion proteins.
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Assay Development for the Quantification of Methionine and Adenine
The development of
o f a QueA assay which allows for the quantification of
o f the reaction
by methionine or adenine elimination was based on chromatographic procedures used

to analyze the decomposition products of
o f AdoMet [111).
[111]. To confirm the
chromatographic resolution of
o f substrate and products, isotopically labeled AdoMet,
methionine and adenine were each analyzed. A QueA reaction with [1C-methionine[lC-methionine14C]AdoMet
I4 C]AdoMet was also analyzed. Samples were loaded onto a column containing
Dowex-50WX4 equilibrated with 0.1 N H22 SO4
SO 4 and the columns were washed with the
successive addition of 0.1,
2, and 4 N H2SO4 and the eluant was quantified by liquid
0.1,2,
scintillation counting. Methionine and adenine eluted from the column with the
addition of
o f 1 and 2 N H
H2SO4,
2SO4, respectively, whereas AdoMet eluted from the column
with the addition of
o f 4 N H2SO4 (Figure 26A). Analysis of
o f the QueA catalyzed
reaction on Dowex-50WX4 resulted in the resolution of
o f methionine and unreacted
AdoMet (Figure 26B). The chromatographic method using Dowex was used in all
QueA assays using AdoMet analogs in which methionine or adenine were isotopically
labeled.

Substrate Analysis of QueA
SeAdoMet, 3'-dAdoMet,
3’-dAdoMet, 2'-dAdoMet,
2 ’-dAdoMet, and 7-deazaAdoMet were all tested as
substrates of
o f QueA under initial velocity .conditions.
conditions. Table 1 summarizes the results
obtained from the substrate analysis. No activity was observed for QueA in the
-dAdoMet, 3'
-dAdoMet and 7-deazaAdoMet regardless of
presence of
o f 2'
2’-dAdoMet,
3’-dAdoMet
o f substrate
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analog and enzyme concentration. These results suggest that 3'-dAdoMet,
3’-dAdoMet, 2'2 ’dAdoMet and 7-deazaAdoMet do not function as substrates for QueA.

Very little QueA activity was observed when assayed in the presence of
o f varying

concentration of
A). However, activity was observed when
o f SeAdoMet (Figure 27
27A).
QueA concentration was varied (0.2-50 µM)
pM) while SeAdoMet was fixed at a 100 µM
pM
(Figure 27B). Steady state activity assays conducted in the presence of
o f higher enzyme
1
concentrations gave a Km
Km of 111 ± 3 µM
pM for SeAdoMet and kcat
kcat of
o f 0.0838 min·
min "1 to

1
nM"' 11 (Figure 28).
give a kcat!Km
kcat/Kmof 0.75 min"
m n f’nM

Inhibition Analysis of QueA
2'-deoxyAdoMet,
2 ’-deoxyAdoMet, 3'-deoxyAdoMet,
3’-deoxyAdoMet, 7-deazaAdoMet and SeAdoMet were tested as
14
C]AdoMet as substrate. Table 1 summarizes the results
inhibitors using [U-ribosyl[U-ribosyl-l4C]AdoMet

obtained from the inhibition analysis. All AdoMet analogs gave competitive
inhibition patterns with respect to AdoMet (Figure 29). Inhibition constants, derived
by fitting the data to the competitive inhibition equation, are 217.l
217.1 ± 7.3,
7.3,224.4
.1 ,
224.4 ± 55.1,

99.2 ± 2.9 and 138.4 ± 3.5 µM
pM for 2'-deoxyAdoMet,
2’-deoxyAdoMet, 3'-deoxyAdoMet,
3’-deoxyAdoMet, SeAdoMet
and 7-deazaAdoMet, respectively.

Analysis of the Formation of a Covalent Adduct
Time dependent inactivation studies were conducted in which QueA was preincubated
in the presence of
o f SeAdoMet. Aliquots of
o f the preincubation mixture were taken into
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14

[V-ribosyl- C]AdoMet at various times.
standard QueA assay conditions containing \}J-ribosyl-l*C\AdoMet
Upon analysis, time-dependent inactivation was not observed, suggesting that the
o f a covalent adduct between QueA and SeAdoMet did not occur (Figure
formation of
follow up studies exploiting the presence of the N30). To confirm these findings, follpw

His6-tag
terminal His
6 -tag on QueA was conducted. The analysis entailed incubating 20-50

[U-ribosy/pM ooff QueA in the presence oof20-50
f 20-50 µM
pM tRNA and 100-300 µM
pM ooff [U-ribosylµM
14C]SeAdoMet
14C]SeAdoMet for 20 min. Samples were directly loaded onto 250 µl
pi of
o f nickel metal
affinity resin and unreacted SeAdoMet and tRNA were washed from the column.
QueA was then eluted and the eluant was analyzed by scintillation counting. No
radioactivity was associated with the fractions containing QueA, demonstrating that
QueA did not form a covalent adduct with SeAdoMet.

COG 1469
COG1469
14
[8-14C]GTP
C]GTP Synthesis
[8-

14
The enzymatic synthesis of [8[8 - 14
14C]GTP from [8[8 - 14C]-guanine
C]·guanine was based on procedures
14
used in the synthesis of
o f [U-ribosyl\\J-ribosyl-{4C
\K YY, as illustrated in Figure 31. Of
O f the three
C]ATP,

enzymes two were commercially available; pyruvate kinase and nucleoside
monophosphate kinase. Hypoxanthine-guanine phosphoribosyltransferase
(HGPRTase) from L. donovani was expressed in a low phosphate media supplemented
with the necessary growth factors [98-100] and was partially purified by ammonium
14
o f the [8[8 - 14C]GTP synthesis reaction
sulfate precipitation (Figure 32). The progress of

was monitored by TLC over a 24 h period and showed that maximal product
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formation was observed at 2 h, with further incubation resulting in a decrease in OTP
GTP
yield. Therefore, all OTP
GTP synthesis reactions were terminated at two hours by the
14
addition ofEcMAT
o f EcMAT and methionine to remove ATP, and [8[8 - 14C]GTP was then

purified by HPLC under isocratic conditions using a mobile phase composed of
o f 83.3

mM triethylammonium acetate (pH 6.0), and 5% methanol. Under these conditions
14

14
[8[8 - 14C]GTP eluted around 7 min (Figure 33). Fractions containing [8[8 - 14C]GTP were

pooled, lyophilized to dryness and dissolved in water. Typical radiochemical yields

were 50-60%.

Cloning and Expression, and Purification of T. maritima, N. gonorrhoeae and B.
subtilis COG1469 proteins
The genes encoding COG 1469 proteins from A.
N gonorrhoeae (ngo03
87), T.
(ngo03S7),
T. maritima
(tm0039)
(,tm0039) and B. subtilis (yciA)
(yciA) were amplified by PCR from genomic DNA and

cloned into a linearized pET-30 Xa/LIC expression vector (Novagen) containing an inin
frame His66 cassette allowing for nickel metal affinity purification. The expression
constructs also contained a Factor Xa cleavage site immediately adjacent to the start
Met to generate wild-type proteins. Each of
o f the proteins were successfully
overproduced in E. coli BL2
l (DE) as soluble N-terminal His6-tag
BL21(DE)
His 6 -tag fusion proteins that
were purified to homogeneity in a single step by nickel metal affinity chromatography.
Recombinant proteins containing fractions from each of the purifications had a
yellowish brown tint that disappeared after dialysis. Purified N. ggonorrhoeae,
o n o rrh o e a e, T.

COG1469
Hisg-tag proteins showed a major band on a
maritima, and B. subtilis COG
1469 His6-tag

coomassie stained SDS-PAGE gel (Figure 34) with a apparent molecular weights of
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33.6, 35.2 and 39.7 kDa, respectively, which were consistent with the molecular
masses calculated by the amino acid sequences plus the mass of
o f the N-terminal fusion
.(Figure 34
). Typical yields rariged
34).
ranged from 70-110 mg protein per 10 g of
o f cells.

Though the activities of the His6-tag
His 6 -tag fusion proteins were comparable to that of
o f the
wild-type, all analysis was conducted with wild-type protein, which was obtained by
incubating the His6-tag
His 6 -tag fusion protein in the presence of
o f Factor Xa followed by nickel
metal affinity chromatography. Purified wild-type N gonorrhoeae, T. maritima and
B. subtilis COG1469 proteins showed a major band on a coomassie stained SOSSDS-

PAGE gel with apparent molecular masses of 28.7, 30.3 and 34.7 kDa consistent with
the molecular masses calculated by the amino acid sequences (Figure 34).

Radiochemical Based Assay for GCYH-1
GCYH-I and GCYH-11
GCYH-II Activity
o f radiolabeled GTP at C-8
C - 8 allows the detection and quantification of
o f enzyme
The use of

activity by monitoring the elimination of
o f C-8
C - 8 as formate. Radiochemical analysis
14
utilizing [8[8 - 14C]GTP with each of the COG1469 proteins along with E. coli FoIE
FolE
14
o f [[l4 C]functioning as a positive control demonstrated the time dependent formation of

formate (Figure 35). The calculated specific activities for COG1469 proteins under
FolE were 4-10 fold lower than that of the E. coli FoIE.
FolE.
conditions optimal for E. coli FoIE
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Spectrophotometric Based Assay for GCYH-1
GCYH-I Activity
To determine if the release of
o f formate was the result of GCYH-1
GCYH-I activity, and not
GCYH-II activity, enzyme assays were monitored directly by UV-vis spectroscopy to
determine if dihydroneopterin was formed. The reactions catalyzed by COG 1469

gonorrhoeae,, resulted in a time dependent decrease of
proteins from B. subtilis and N. gonorrhoeae
the GTP peak at 252 nm with the concomitant increase of
o f a new broad peak at 330 nm
1
(e
), which is consiste~t
(s = 6300 M"
M '11cm"
cm 'i),
consistent with the formation of
o f a dihydroneopterin

chromophore (Figure 36) [60, 104] The calculated specific activities for the formation
of
o f the dihydroneopterin compound were 4-6 fold lower than that measured in parallel
for E. coli FoIE.
FolE.

Fluorescence Based Assay for GCYH-1
GCYH-I Activity
A highly sensitive fluorescence assay was also employed to monitor enzyme activity
with the B. subtilis, T. maritima and N. gonorrhoeae COG 1469 proteins and E. coli
o f the
FolE. The analysis entailed the dephosphorylation with alkaline phosphatase of
presumed reaction product, dihydroneopterin triphosphate, followed by oxidation to

neopterin with an acidic iodine solution (Figure 37) [52]. Prior to oxidation none of
of
the assay solutions exhibited any fluorescence, but upon oxidation all of the COG 1469
catalyzed reaction products exhibited a fluorescence profile identical to that of the E.

coli FolE reaction and authentic neopterin (Figure 38).
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HPLC Based Assay for GCYH-1
GCYH-I Adivity
Activity
To further aid with identification of
1469 reaction product, the
o f the COG
COG1469

B.subtilis
E.coli
dephosphorylated reaction products from B.
subtilis COG1469
COG 1469 and E.
coli FolE were
analyzed by HPLC according to methods ofNar
o f Nar [52]. The HPLC chromatogram of
of
the B. subtilis COG1469 reaction was identical to that of E.coli
E. coli FolE (Figure 39A),
with a new peak at~
at ~ 9 min that co-eluted with authentic neopterin and which
possessed an identical UV-visible spectrum to that of neopterin (Figure 39B).

When the reaction products from E. coli FolE, N. gonorrhoeae and B. subtilis
COG1469
COG 1469 were directly analyzed by HPLC without alkaline phosphatase or acid
treatment a new peak appeared at ~4 min that had a UV-vis spectrum that was
identical to that of
o f dihydroneopterin (Figure 40). Upon the addition of
o f alkaline
phosphatase, the peak eluting at ~ 4 min disappeared and a new peak emerging at ~ 9
o f authentic
min, which co-eluted with and had an identical UV-vis spectrum to that of
neopterin, as seen in Figure 40C. Under the work-up and HPLC conditions employed

the reaction products were oxidized to neopterin.

LC-MS Analysis of COG1469
COG 1469 Reaction Products

E.
coli FolE and N. gonorrhoeae COG1469 reaction products were isolated according
E.coli
to Yim utilizing activated charcoal which binds both GTP and dihydroneopterin
triphosphate [105]. The reaction mixtures containing charcoal were filtered through a
type HA Millipore filter (0.45 uM) that was subsequently washed with water. OTP
GTP
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and neopterin triphosphate were eluted from the charcoal with the successive addition
of
% NH 4OH,
o f solutions of 5% ethanol and 50% ethanol solution containing 3.1
3.1%
respectively. It has been documented by Yim that dihydroneopterin triphosphate is
oxidized to neopterin triphosphate under these conditions. MS analysis confirmed that

N gonorrhoeae COG1469 reactions generated the same products
the E. coli FoIE
FolE and N.
with ions corresponding to unreacted OTP
GTP (m/z 522 M-ff;
M-H'; m/z 544, M-2ff
M-2H" + Na+;

mlz
m/z 566, M-3ff
M-3H' + 2Na+), and neopterin triphosphate (m/z 492, M-ff;
M-H';
dihydroneopterin is oxidized to neopterin under these conditions). The reactions also
contained neopterin cyclic monophosphate (m/z 314, M-ff),
M-H'), but it has been previously
documented that under the alkaline conditions used during the work up neopterin
triphosphate is converted to the cyclic monophosphate [112-114].

Temperature and pH Optima

T. maritima COG1469
COG 1469
The optimal temperature for N. gonorrhoeae, B. subtilis and T.
proteins were determined at pH 7.5 in a 100 mM phosphate buffer. T.
T. maritima

COG1469
COG 1469 protein was active over a broad range of
o f temperatures (68-83 °C), with a
maximal activity observed at 78 °C (Figure 41 A). These results are consistent with the

N gonorrhoeae and B. subtilis
organism's
organism’s optimum growth temperature of 80 °C. N.
COG1469 proteins were active over a broad range of temperatures (30-50 °C) with
maximal activity observed at 37 °C (Figure 41 Band
B and C). Subsequent studies were
performed at 37 °C for B. subtilis and N. gonorrhoeae COG
COG1469,
1469, and 78 °C for T.
COG1469.
maritima COG
1469. Although the natural habitat of B. subtilis, a non-pathogenic soil
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bacterium, varies considerably with respect to nutrient, temperature, pH and oxygen
content, the temperature profile for N.
N gonorrhoeae COG 1469 is consistent with the

N gonorrhoeae is a pathogenic bacterium
organism's
organism’s optimum growth temperature. N.
that resides in the mucous membranes of
o f the genital-urinary system of
o f humans.

The effect of
N gonorrhoeae and B. subtilis COG 1469 activity was conducted
o f pH on N.
at a constant ionic strength using a 3 component buffer system comprised of
o f TrisMES-acetic acid over a pH range of 7-9. The pH profile for both B. subtilis and N.
N
1469 proteins displayed a bell shaped curve with activity observed
gonorrhoeae COG
COG1469
over a pH range of7.8
o f 7.8 to 8.6
8 . 6 (Figure 42), with both proteins displaying maximal
activity at a pH of
o f 8.0. Based on these findings all subsequent studies were performed
at a pH of
o f 8.0.

COG1469
Effects of Buffers upon COG
1469 Activity
To determine the optimal buffer for activity assays, B. subtilis and N. gonorrhoeae
COG1469 were assayed in various buffers (Figure 43). Maximum activity was
observed in HEPES for both proteins. Approximately 15-25% relative activity was
observed for both proteins in the presence of
o f MOPS or Tricine.

o f HEPES concentration at pH 8.0 upon B. subtilis and N.
The effect of
N gonorrhoeae
COG 1469 activity are summarized in Figure 44. Maximum activity was observed at a
COG1469
buffer concentration of
o f 100 mM for both proteins. Less than 5% relative activity was
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observed at concentrations below 50 mM. Subsequent studies were performed in 100
mM HEPES (pH 8.0).

Metal Analysis
To investigate the importance of
o f metals upon COG1469 activity, the purified proteins
were depleted of
A for 1 h at room
o f all metals by treatment with 5 mM EDT
EDTA
temperature followed by extensive dialysis against a metal free buffer containing 5
mM EDT
A and Chelex-100. The protein samples were dialyzed further against an
EDTA
EDTA free buffer and then passed over Chelex-100 column prior to analysis. When
the resulting apoenzymes were analyzed for enzyme activity by fluorescence, no
activity was observed, suggesting that the enzymes are metal dependent.

The effect of various metals upon N. gonorrhoeae and B. subtilis COG 1469 activity
are summarized in Table 2 and Table 3, respectively. The enzymes were assayed for
activity over a range of metal concentrations, and the concentrations supporting
maximal activity is listed in Table 2. To circumvent any potential time dependence of
1 0 min in the presence of the metal
metal binding, the apoenzymes were incubated for 10

o f GTP. B. subtilis and N.
ions before the assays were initiated with the addition of
2
2
+, Fe
+, Zn
+,
gonorrhoeae COG1469
COG 1469 activity was observed in the presence ofMn
o f Mn2+,
Fe2+,
Zn2+,
2

*Ay

Mg2+,, Ni 2+ and Co2+,, whereas no activity was observed in the presence of
o f Ca2+,, Cd2\ ,
Ai

A|

At

A|

Ai

A I

At

A |

Cu2+,, Co 3+ and
Fe3+.. Both enzymes were maximally activated in the presence of
andFe
o f Mn 2+
2
at a concentration of 0.5 mM. The further addition ofMn
+beyond 0.5 mM resulted
of Mn2+beyond
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in a gradual decrease in enzyme activity (Figure 45). When assayed in the presence of
of
i

Fe2+ under anaerobic conditions, B. subtilis and N. gonorrhoeae exhibited 75% and
2
+.
50% relative activity, respectively, to that observed in the presence of 0.5 mM Mn
Mn2+.

Interestingly, the activity of B,
B. subtilis and N. gonorrhoeae COG 1469 in the presence
2
2
of an optimal concentration of Zn
+was only ~15% to that observed with Mn
+.
Zn2+was
Mn2+.
2
COG 1469 activity decreased at Zn
+ concentrations above 50 µM,
Zn2+concentrations
pM, and no activity was

observed at concentration above 0.5 mM (Figure 45). When the apoenzymes were
2
+ and varying Zn22+
concentration, an inhibitory
assayed in the presence of
o f 0.6 mM Mn
Mn2+
+concentration,

affect was observed (Figure 46).

Various reconstitution procedures were explored with the N. gonorrhoeae and B.

subtilis apoenzymes. The demetallated proteins were incubated in the presence of
of
2
2
varying concentrations of
+ or Zn
+ (2, 4 or 7 molar equivalents) at various
o f Mn
Mn2+
Zn2+

temperatures (4, 25 and 37 °C) and times (1-2 h). Aliquots (10 µl)
pi) were taken into the
appropriate reaction conditions lacking additional metals. The final protein
concentration was 0.5 µM,
pM, and the final metal concentrations upon dilution were 1, 2
or 3.5 µM.
pM. No activity was detected except for control samples that included 0.5 mM
M nCb or 50 µM
pM ZnCh
ZnC h (Table 4). When 30 µl
pi aliquots of
o f the reconstitution protein
MnCh

samples were taken into the appropriate reaction conditions lacking metals, activity
was observed in those samples in which the final metal concentration upon dilution
was 10.5 µM
pM (Table 4). These findings suggest that the metal may not be tightly

bound within the active site. Removal of excess metal ion (not bound) was achieved
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by passing the protein solution over a Sephadex G-25 or Chelex column, or by
extensive dialysis against a metal free buffer, or by buffer exchange with a metal free
buffer using an Amicon Ultra centrifugal device. No activity was detected after the
removal of
o f excess metal, regardless of
o f method used.

ICP-MS
The metal content of
o f as-isolated (not treated with EDTA) and apoenzyme N.
gonorrhoeae andB.
and B. subtilis COG1469 proteins were analyzed by ICP-MS,
ICP-MS. All

protein samples, including the as-isolated were prepared in metal free solutions and
acidified with the addition of high purity nitric acid to release the metal into solution.
2
2
2
2
+, Co
+, Ni2+,
Ni 2+, Cu
+, Zn
+
The digested samples were analyzed for the presence of
o f Mn
Mn2+,
Co2+,
Cu2+,
Zn2+

2
and Cd
+. Due to argon gas interference the F
e2+ content was not examined.
Cd2+.
Fe2+

However, iron was not detected in the apoforms of
o f N. gonorrhoeae and B. subtilis
COG 1469 proteins when analyzed by the ferrozine assay. Analysis revealed the
2
2
+, Ni2+
Ni 2+ and Zn
+ in all protein samples,
presence of
o f substoichiometric amounts of Mn
Mn2+,
Zn2+

2
+ being the predominant metal. The results,
including apoenzyme samples, with Zn
Zn2+

o f metal-to-protein (monomeric subunit).
summarized in Table 5A, represent the ratio of
o f the
Treatment with EDTA resulted in a 3-9 fold decrease in the metal content of
proteins (Table 5A)
5A) compared with the protein as isolated, but did not completely
2
remove metal ions from the protein. The presence ofNi
+ is likely due to leaching
of Ni2+

o f the proteins. Based
from the nickel metal affinity resin utilized in the purification of

on these results, the demetallation protocol failed to completely demetallate the
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proteins, so a follow up analysis incorporated longer incubation and dialysis times in

the presence of
A.
o f a higher concentration of
o f EDT
EDTA.

In the follow-up analysis of N. gonorrhoeae and B. subtilis COG1469
COG 1469 proteins, the as
2
2
+ or Zn
+ forms were analyzed by ICPisolated, apo-form and the reconstituted Mn
Mn2+
Zn2+
2
+ being the
MS. Again, substoichiometric amounts of metals were detected, with Zn
Zn2+

predominant species. The results, summarized in Table 5B, again represent the ratio
of metal-to-protein (monomeric subunit). Demetallation resulted in a 5.5 fold
decrease in the Zn2+ content and complete removal of Mn2+.. After reconstituting N.
2
+ and removing excess metal, approximately
gonorrhoeae COG 1469 with Mn
Mn2+

3
2
1.45x10·
1.45x10' ± 5x10·5
5x10'5 mol of manganese per mol of protein was detected, l.71xl0·
1.71x10' ±

2x
10 4"4 mol of
1469 from N.
2X10
o f zinc per mol of protein. After reconstituting the apo-COG
apo-COG1469
2
+ was detected per
10·’22 ± 8x
gonorrhoeae with zinc approximately l.34x
1.34xl0
8 x10·
l0 ' 44 mol of Zn
Zn2+

o f protein, 9 and 1.
1.7
o f the as-isolated and apoenzyme,
mol of
7 fold lower than that of

respectively. Manganese was not detected in samples reconstituted with zinc.

Molecular Mass Determination
o f the wild-type B. subtilis and N. gonorrhoeae COG 1469
The native molecular mass of
proteins were estimated by size-exclusion chromatography on a BioSep-SEC-S4000

column. The column was calibrated using the following standards: Ferritin (443 kDa),
pyruvate kinase (237 kDa), alcohol dehydrogenase (150 kDa), BSA (65.4 kDa),
ovalbumin (48.9 kDa) and carbonic anhydrase (30 kDa) (Figure 47). B. subtilis and N.
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gonorrhoeae COG 1469 proteins eluted with an apparent molecular mass of
o f 102250 ±

2577 and 91872 ±1982
± 1982 Da, respectively (Figure 4477 and 48). These findings indicate
that both enzymes are homotrimers. Incubating the proteins in the presence of
o f GTP (0,
1, 2 mM) and 0.5 mM MnCh
M nCb at various temperatures and time and using an elution
solvent containing 0.5 mM OTP,
GTP, 0.5 mM MnCh
M n C f and varying concentration of
phosphate buffer did not alter the apparent native molecular mass of
o f either protein.

OTT
DTT analysis

The effect of
o f a thiol reductant, DTT, upon N. gonorrhoeae and B. subtilis COG 1469
-vis spectroscopy and fluorescence based assays. When
activity was examined by UV
UV-vis
analyzed by UV-vis spectroscopy, enzyme activity increased with increasing DTT
concentration with maximal activity observed at 2 mM (Table 6).
6 ). Higher
concentrations of
o f DTT up to 12 mM did not result in further stimulation of
o f B. subtilis
COG 1469 activity, however, a gradual decrease in activity was observed for N.
gonorrhoeae COG 1469, with only. 78% relative activity observed at 12 mM. When

analyzed by fluorescence, fluorescent intensity increased with increasing DTT
concentration with maximal fluorescence observed at 1 mM (Table 6).
6 ). However,
greater sensitivity is obtained when analyzing enzyme activity by fluorescence,
therefore all subsequent analysis were conducted in the presence of
o f 1 mM DTT and

analyzed by fluorescence.
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Substrate Analysis
The effects of
o f various nucleosides were explored as potential substrates for the N.
N,

gonorrhoeae COG1469
COG 1469 enzyme. When OTP
GTP was replaced with GDP, GMP, 2'dGTP
2 ’dGTP
or guanosine, only GDP was observed by fluorescence, to function as a substrate. The
compounds 8-oxoGTP,
8 -oxoGTP, 7-deazaGTP and ATP were also investigated as alternate
substrates, and their behavior was probed by HPLC, in each case only a single peak
corresponding to the starting nucleotide was observed in assays with each of
o f these
compounds, indicating that they were not turned over by the enzyme.

Steady State Kinetic Analysis of N. gonorrhoeae and B. subtilis COG
1469
COG1469
Proteins
N. gonorrhoeae and B. subtilis COG1469 activity were both time (Figure 49A)and
49A) and
enzyme concentration (Figure 49B) dependent. Steady-state kinetic parameters,
summarized in Table 7, were obtained for N. gonorrhoeae and B.
B. subtilis COG1469
COG 1469
proteins under initial velocity conditions with varying substrate concentrations. Both
proteins exhibited classical hyperbolic Michaelis-Menten behavior in all cases (Figure

50and51).
50 and 51).

Inhibition Analysis of N. gonorrhoeae COG 1469 Protein
o f substrate analogs as potential inhibitors of
o f N.
The effects of
N gonorrhoeae COG 1469
2 ’-deoxyGTP gave
protein are summarized in Table 8. 8-oxo-GTP, 7-deaza-GTP and 2'-deoxyGTP

competitive inhibition patterns with respect to GTP with a calculated K/sof
Kj’sof 0.149 ± 5
µM,
pM, 46 ± 1.5 µM,
pM, and 164 ± 3 µM,
pM, respectively (Figure 52).
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Mutagenesis of N. gonorrhoeae COG1469 H245
The H245K, H245N, H245Q, H245D mutants of
N. gonorrhoeae COG169 were
of N.
generated to investigate the catalytic role of
o f His 245. Each of
o f the mutant proteins
were successfully overproduced in E. coli BL21(DE) cells as soluble N-terminal His6His 6 tag fusion proteins and were purified to homogeneity in a single step by nickel metal
affinity chromatography. Purified mutant proteins showed a major band on a
coomassie stained SDS-PAGE gel with an apparent molecular weight of
o f 33.6 kDa
which was consistent with the molecular mass calculated by the amino acid sequence
plus the mass of the His-tag (Figure 53). Typical yield of
o f the purified proteins ranged
from 40-80 mg protein per 10 g of cells. The His6-tag
His 6 -tag was cleaved by incubating the
fusion protein in the presence of
o f Factor Xa followed by nickel metal affinity
chromatography. Purified proteins lacking a His-tag showed a major band on a
coomassie stained SDS-PAGE gel with an apparent molecular mass of28.7
o f 28.7 consistent

with the molecular mass calculated from the amino acid sequence (Figure 53).

[8 - 14
l4 C]GTP for each of the N. gonorrhoeae COG
COG1469
Radiochemical assays utilizing [81469

mutants with wild-type N. gonorrhoeae COG 1469 and£.
and E. coli RibA as positive
controls demonstrated that all of the mutants were capable of
o f catalyzing the
14C]-formate. The calculated specific activities for each of
o f the proteins
elimination of [14

are summarized in Table 9. Replacing the His residue located at position 245 with
either an Asp or a Gln
Gin resulted in only a modest 1.5 fold decrease in activity compared
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to wild-type, while replacing the His residue with either an Asn or a Lys resulted in an
approximate 4 and 19 fold decrease in activity, respectively.

When the reactions catalyzed by the H245D and H245Q mutants were analyzed
spectrophotometrically, there was a time dependent decrease in the OTP
GTP absorbance at
252 nm and a concomitant increase of
o f a hew broad peak centered at 330 nm (E
(e =
= 6300
1
1
Mcm-'1
), consistent with the formation of
IVr’cm
o f a dihydroneopterin chromophore (Figure.

54A and B) [60, 104].
104], The specific activities for the formation of
o f dihydroneopterin
1
1
triphosphate were 4.3 and 3.4 nmol minm in'Vµmor
m ol ' 1 for H245D and H245Q, respectively,

which are 33 to 41 fold lower than that of
o f the wild type (Table 10). Spectroscopic

assays of
o f the H245N and H245K did not result in the formation of
o f dihydroneopterin as
indicated by the lack of
o f absorbance at 330 nm (Figure 54C and D).

In a type I OTP
GTP cyclohydrolase fluorescent assay, the H245D and H245Q mutants
catalyzed reactions resulted in a product that displays a fluorescent spectra identical to
that of
o f wild-type, consistent with the formation of
o f dihydroneopteim (Figure 55).

H245N and H245K mutants did not generate products capable of
o f fluorescence in this
assay, indicating that dihydroneopterin was not generated. When analyzed as a
function of substrate concentration, H245D and H245Q activity increased with
increasing OTP
GTP up to 500 µM,
pM, whereas wild-type activity decreased at OTP
GTP
pM (Table 11). The relative activities ofH245D
o f H245D and
concentrations above 200 µM
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H245Q, as determined by fluorescence, were 19 anq
and 48 fold lower then that of
o f the
wild-type.

In a type II and III GTP cyclohydrolase activity assay, the reaction assays were boiled
in HCl, neutralized with NaOH and incubated with butanedione (Figure 56) [59]. The
reaction was then analyzed by fluorescence with an excitation of
o f 365 nm and an

emission of
o f 460 nm. Fluorescence was observed in all cases except for reactions
catalyzed by H245K (Figure 57). Replacing the His residue with either an Asp or a
Gln
Gin resulted in a 12 fold decrease in the relative activity compared to that of wild-type
whereas replacing with an Asn resulted·in
resulted in a 33 fold decrease in activity.
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Discussion
QueA Analysis
QueA catalyzes the penultimate step in the biosynthesis of
o f queuosine; the
unprecedented transfer and isomerization of
Met to
o f the ribosyl moiety from Ado
AdoMet
preQ 1-tRNA to give epoxyqueuosine
preQ]-tRNA
epoxy queuosine modified tRNA (oQ-tRNA) as illustrated in
Figure 3. The reaction is accompanied by the rearrangement of
o f the ribosyl moiety to
form an epoxy-carbocycle and the elimination of
o f methionine and adenine from
AdoMet [32, 33].
33], A chemical mechanism has been proposed for QueA and is
consistent with the kinetic mechanism and biochemical studies carried out to date
(Figure 5) [44]. The first step of the QueA catalyzed reaction is proposed to be the
deprotonation of
o f AdoMet at C-5'
C-5’ to give the sulfonium ylide I.

To investigate the timing of proton abstraction of
o f C-5',
C-5’, the sulfur atom of AdoMet was
replaced with a selenium atom. SeAdoMet is both isosteric and isoelectric with
o f the
AdoMet, but the replacement of sulfur with selenium increases the apparent pKa
pKa of
C -5’ hydrogen from 11.5 to 14.1 [94, 115].
115], It has been calculated that a pKa
C-5'
pKa

difference of
o f 2.6 units would result in a ~400
-400 fold decrease in the deprotonation rate
constant [94, 115]. If deprotonation is at least partially rate limiting SeAdoMet will
react slower than AdoMet.

Sn2 attack by the ppreQ1re Q r
An alternative to the proposed mechanism involves the direct SN2
4’carbon of
o f AdoMet followed by deprotonation to give the
tRNA aminomethyl at the 4'carbon

82

sulfonium ylide III (Figure 58). Although the SN2
S^2 route is mechanistically simpler
than the proposed mechanism, it is not favorable at a 2°
2 ° carbon, and nucleophilic
substitution reactions in biology are dominated by elimination and addition
mechanistically and not SN2
Sn2 [116]. Nevertheless, none of
o f the results from previous
mechanistic studies explicitly ruled out this mechanism, and thus remains a viable
alternate to the existing proposal.

If the SN2
Sn2 mechanism is occurring then SeAdoMet should not act significantly
different than AdoMet with respect to radioactive quantification because the ribosyl
moiety would be attached to the tRNA that is precipitated upon the addition of TCA

and quantified (Figure 59B).

QueA exhibited very low activity with [I]-ribosyl]-SeAdoMet
[U-ribosyl]-SeAdoMet even when present at
high concentrations. Replacing AdoMet with SeAdoMet had little effect upon
kcat. When analyzed as a potential
substrate binding but exhibited 30-fold reduction in kcat•
Kj of
o f 99.2 ± 0.9 µM
pM for SeAdoMet was obtained, which is comparable to
inhibitor, a Ki

the Km
K m of AdoMet. These results demonstrate that SeAdoMet binds to QueA with an
affinity comparable to that of
Met and that the replacement of
o f Ado
AdoMet
o f the sulfur atom with
o f the catalytic steps, presumably deprotonation,
selenium decreased the rate of

following substrate binding. These results are most consistent with a mechanism in
which deprotonation at C-5'
C-5’ precedes nucleophilic attack at C-4'.
C -4 \

83

While the substitution of
o f selenium for sulfur in AdoMet decreases the reactivity of
o f the

55’-hydrogen
'-hydrogen to deprotonation the electrophilicity of
o f the 5'
5’ carbon of
o f SeAdoMet is
roughly ten times greater than in Ado
Met [94]; this creates the potential for
AdoMet
nucleophilic attack instead of
o f deprotonation exist leading to the formation of
of a

covalent adduct (Figure 59C).

However, we observe no time dependent inhibition of
o f QueA when incubated with
SeAdoMet, nor did we observe the transfer of
C from [U-ribosyl- 14
o f 14
14C
14C]-SeAdoMet to
enzyme, demonstrating that a covalent adduct between QueA and SeAdoMet did not
occur. These results demonstrate the transfer of
o f the ribosyl moiety from SeAdoMet to
the modified tRNA, and not with the formation of
o f a covalent adduct between protein
and substrate.

QueA catalysis entails the transfer of
o f the ribosyl moiety from AdoMet onto tRNA with
the elimination of adenine and methionine. When the radiolabel is located in the
ribosyl moiety of AdoMet, QueA activity can be assessed by measuring the amount of
radioactivity incorporated into tRNA via TCA precipitation. When the isotopic label

is located in methionine or adenine moiety of
o f AdoMet, QueA activity can not be
monitored by TCA precipitation because neither of the groups are transferred to the
tRNA during catalysis. The development of
o f an assay that allowed for the direct
measurement of
o f either methionine or adenine was crucial for the analysis of
methionine and adenine labeled AdoMet analogs. Utilizing Dowex as a means to
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quantify QueA activity proved successful with greater accuracy and resolution than
other cation exchange methods involving P-11,
P-l 1, P-81, and activated charcoal.
Furthermore, using Dowex gave flexibility in terms of quantifying methionine,
14
adenine and/or AdoMet and was therefore used to evaluate [1-methionine[l-methionine- 14C]-714
14
dAdoMet, and [1-methionine'dAdoMet as
deazaAdoMet, [1-methionine[l-methionine-l4 C]-2'
C]-2’dAdoMet,
[l-methionine- 14C]-3
C]-3’dAdoMet

potential substrates for QueA.

The second step of
o f the proposed chemical mechanism involves the opening of
o f the
ribose ring with concomitant elimination of
o f adenine (Figure 5). The cleavage of
o f the
N-glycosidic bond of
o f AdoMet and the subsequent release of
o f adenine must occur in

concert with the protonation of
o f adenine to activate it for elimination. In principle this
can occur at N-7, N-3 and/or N-1.
N - l, Nucleoside hydrolases, which play an important
role in the purine salvage pathways, are example of
o f enzymes involved in the
hydrolysis of
o f the N-glycosidic bond of ribonucleosides to give free base and ribose.
The catalytic mechanism of nucleoside hydrolase entails leaving group activation via
o f the purine ring, a process that is also observed in many
protonation at the N-7 atom of

other N-glycosidic bond cleaving enzymes [117]. Replacing the natural substrate of
nucleoside hydrolase or S-adenosylhomocysteine hydrolase (AdoHcy hydrolase) with

a 7-deaza analog, in which the nitrogen at position 7 is replaced with a carbon atom,
prevents the activation and elimination of
o f the leaving group [90, 118-121].
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7-deazaAdoMet failed to function as a substrate for QueA which is consistent with
leaving group activation via protonation at N-7 is essential for QueA activity. The 7deaza analog of AdoMet exhibited a Ki
Kj that was only slightly higher than the Km
K m for
AdoMet, indicating that N-7 is critical for catalysis and not substrate binding.

Although not directly involved in catalysis or outlined in the proposed mechanism, the
presence of
o f the two ribose hydroxyl groups on the ribosyl moiety may collectively add
to the binding energy by means of hydrogen bond formation. Disruption of
o f the
hydrogen bonding opportunities between nucleoside hydrolase and substrate by
replacing the 2'
2 ’ or the 3'
3’ hydroxyl groups with a hydrogen atom resulted in little or no
activity [117, 120].
120], Furthermore, deoxynucleoside analogs of
o f nucleoside hydrolase
functioned as poor inhibitors, thus demonstrating the necessity of
o f the hydroxyls in
substrate recognition and catalysis [120]. Neither the 2'
2 ’ nor 3'
3’ deoxyanalog
functioned as a substrate for QueA, but unlike the results observed with nucleoside
hydrolase the binding was only moderately compromised, with both compounds
Kj values only 2 fold above the Km
Km of
o f AdoMet.
exhibiting Ki

The results obtained from these studies are consistent with the proposed mechanism as
outlined for QueA, where the first step involves the enzyme catalyzed deprotonation
of
Met at C-5
', and the cleavage of the C-N bond and the release of adenine
o f Ado
AdoMet
C-5’,
o f adenine at N-7. Although not shown, the
occurs in concert with the protonation of

presence of
o f the ribosyl hydroxyl groups is needed for catalysis.
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COG1469 Analysis
Early biosynthesis studies had shown that GTP was the metabolic precursor to
queuosine, in a transformation involving the loss of
o f C-8
C- 8 from guanine, suggesting
GTP cyclohydrolase like chemistry [122]. Comparative genomics analysis was
conducted to determine if the participation of GCYH-I in the biosynthesis of
queuosine was a viable hypothesis. Analysis of
o f all sequenced bacterial genomes
revealed thatfo!E,
that folE, the gene encoding GCYH-1,
GCYH-I, clustered with known queuosine
biosynthesis genes in a number of organisms. These findings support the potential
involvement of GCYH-1
However,fo!E
GCYH-I in queuosine biosynthesis. However,
fo lE was absent in a
large number of
o f bacterial genomes that contain queuosine biosynthetic genes, and
more importantly other folate biosynthesis genes. It was therefore presumed that
another unidentified protein family was responsible for conversion of
o f GTP to H
H2NTP
2NTP
in those organisms lacking/a/£.
lacking/o/E. Utilization of
o f the newly developed SEED database
resulted in the identification of
o f a protein family, COG 1469, which was of
o f unknown

function and clustered with folate and/or queuosine biosynthesis genes in a number of
organisms.

COG1469
1469 are type I GTP cyclohydrolases, an
To test the hypothesis that members of COG

LlfolE: :KanR
E. coli 4/b/£::K
anR mutant strain was constructed and utilized in complementation
studies. The mutant proved to be lethal but partially rescued when grown in a rich
medium supplemented with thymidine (LB/dT) (Figure 60) [123]. However, when
transformed with COG1469 gene from B. subtilis (yciA),
iyciA), T
T. maritima (tm0039) or
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Acinetobacter baylyi, complementation was observed even in the absence of

thymidine. These observations are consistent with the COG
1469 proteins exhibiting
COG1469
OCYH-1
GCYH-I activity and, was therefore proposed to catalyze the conversion of OTP
GTP to
H
2 NTP.
H2NTP.

Potential OTP
GTP cyclohydrolase activity was investigated by four different methods;
14

radiochemical based release of
o f [ 14C]-formate [103], UV-vis spectroscopy [104, 124],

fluorescence [52, 58], and HPLC analysis. All assays were run in parallel with GTP
cyclohydrolase I (FolE) from E. coli as a positive control, under standard OCYH-1
GCYH-I
14
conditions. Although [8[8 - 14C]GTP was commercially available, it was more

economical to synthesize it enzymatically according to methods similar to those
utilized in the synthesis of ribosyl-labeled ATP. In a radiochemical analysis, each of
14

the proteins along with E. coli FolE catalyzed the elimination of
o f [ 14C]-formate when
[8 - 14
14C]GTP, consistent with the hydrolytic ring-opening
incubated in the presence of [8-

and deformylation of OTP
GTP at C-8.
C- 8 . When analyzed by UV-vis spectroscopy and
o f a dihydroneopterin compound was observed in
fluorescence the catalytic formation of

all cases. To confirm that fluorescence was due to the formation of
o f dihydroneopterin
triphosphate, the dephosphorylated and oxidized reaction products from B. subtilis
C001469
E.coli
COG1469 and E.
coli FolE catalyzed reactions were analyzed by HPLC. Each of
o f the
reactions contained a new peak that had the same retention time and UV-vis spectrum
to that of neopterin. Furthermore, this new peak co-eluted with authentic neopterin,
suggesting the formation of dihydroneopterin.
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GCYH-1
GCYH-I is known to convert GTP to H22NTP and formate, however, recent studies
conducted on COG 1469 homolog from M,
M jannaschii had demonstrated the catalytic
formation of 7,8-dihydro-D-neopterin 2,3-cyclic phosphate and formate from GTP .
(Figure 61) [125]. The cyclic monophosphorylated form of
o f dihydrorieopterin
dihydroneopterin is not
susceptible to dephosphorylation by alkaline phosphatase unless it is first subjected to
1469 catalyzed
acid hydrolysis [126]. When N. gonorrhoeae and B. subtilis COG
COG1469
reactions, along with E. coli FolE as a positive control, were analyzed by HPLC, each
of
o f the reaction products were dephosphorylated in the presence of alkaline
phosphatase. These findings demonstrate the formation of
o f a phosphorylated

dihydroneopterin compound that is not cyclic in nature.

Finally, through MS analysis it was shown that like E. coli FolE, the N. gonorrhoeae
COG 1469 reaction produced a product whose molecular weight was identical to that
o f neopterin triphosphate. Notably, both reactions also contained neopterin cyclic
of

monophosphate, but it has been previously documented that under the alkaline
conditions used during the work up neopterin triphosphate is converted to the cyclic
monophosphate [112-114].

These studies provided direct biochemical evidence that COG 1469 catalyzes the
conversion of
o f GTP to dihydroneopterin triphosphate and formate. Collectively, the
results obtained from biochemical and genomic analysis clearly demonstrate that
COG1469 exhibit type I GTP cyclohydrolase activity, and therefore the gene and
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proteins were renamed/o/E-2
renamed folE-2 and GCYH-IB, respectively, and the canonical GCYH-1
GCYH-I

and the corresponding gene were renamed GCYH-IA andfo/El,
and fo lE l, respectively. For the
remainder of
o f the discussion COG 1469 proteins will be referred as GCYH-1B.
GCYH-IB.

Primary sequence alignment ofGCYH-IB
o f GCYH-IB (denoted as COG1469)
COG 1469) and GCYH-IA
proteins (Figure 62), demonstrates the apparent lack of homology between the two
protein families. Notably, conserved residues involved in catalysis in GCYH-IA

olE) and metal binding
(His
152, and His
179, numbering based on E. coli F
(Hisl113,
13, Glu
Glul52,
H isl79,
FolE)
(Cysl 10, Hisl
H isl 12 and Cysl81; numbering based on E.coli
E. coli FolE) are absent in GCYHIB proteins [61]. GCYH-IB proteins also do not exhibit sequence homology to any
other known protein family. However, when the primary and the predicted tertiary
structure of
o f the C-terminal region of GCYH-IB was aligned with GCYH-IA enzymes,
a~16%
a -16% sequence similarity was observed (Figure 63) [123].

Based on the predicted 30
3D structure, GCYH-IB proteins are members of
o f the tunneltunnel
fold (T-fold) structural family [123], a superfamily of enzymes that include urate
oxidase (UOX), 6-pyruvol tetrahydropterin synthase (PTPS), dihydroneopterin
aldolase (DHNA), GTP cyclohydrolase I (GCYH-1)
(GCYH-I) and QueF. Despite the low
sequence identity ((-10%
~ 10%), observed among family members, there is high tertiary
structural homology among T-fold proteins. All members have identical topologies
containing a T-fold domain which is composed of four antiparallel ~-sheet
[3-sheet and two
p2 ndn barrel
antiparallel a-helices between the second and third strand, forming a ~2nUn
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(Figure 64) [127],
[127]. All are large multimeric structures composed of
o f smaller
130 residues. The oligomerization of
monomeric subunits of~
o f -130
o f the functional enzymes
entails the association of
o f two multimeric barrels in a "head-to-head"
“head-to-head” fashion resulting
in the formation of
o f a tunnel-like center running through the multimer (Figure 65).
Although members differ with respect to function and catalytic mechanism they all
bind to planar substrates such as purine or pterin like compounds at the interface
between monomers in which a conserved glutamate or a glutamine residue anchors the

substrate at the bottom of
o f the active site (Figure 66) [127]. Importantly, the conserved
Glu residue (Glu 152 of
E. coli FolE numbering) involved in substrate binding in
o f E,
GCYH-1
GCYH-I enzymes was conserved in a comparable position in GCYH-1B
GCYH-IB proteins.

GCYH-IA enzymes can be categorized into two structural subfamilies;
homodecameric enzymes consisting of unimodular 26 kDa T-fold domains as

observed in the bacterial and mammalian GTPCH-IA, and bimodular 50 kDa proteins
consisting of two tandem T-fold domains as observed in plant GCYH-IA [58, 112,
128].
128], The predicted tertiary structure of
o f the N-terminal region of
o f COG1469 proteins
is most similar to 77,8-dihydroneopterin
,8-dihydroneopterin triphosphate epimerase, whereas the predicted
tertiary structure of
o f the C-terminal region is most similar to 7~8-dihydroneopterin
7,8-dihydroneopterin
o f the GCYH-IB proteins (~250-300
(-250-300
aldolase (DHNA) (Figure 67). Based on the size of

residues) and the presence of two predicted T-fold domains suggest the GCYH-1B
GCYH-IB
proteins are members of
o f the bi-modular subfamily of the T-fold superfamily (Figure
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67). In addition to plant GCYH-IA, other bi-modular T-fold proteins include urate
oxidase [127]and the type II QueF proteins exemplified by the E. coli homolog [129].

By size-exclusion chromatography both the B. subtilis and the N. gonorrhoeae
GCYH-1B
GCYH-IB were determined to be hornotrimers.
homotrimers. E. coli FolE is reported to be a 247
kDa decamer that consist of
o f a tightly associated dimer of
o f pentamers that dissociates

into smaller molecular weight subunits under high salt conditions [52, 58,
130].
58,130].
However, in the presence of
o f OTP
GTP the ionic dissociation ofFolE
o f FolE is prevented. This
phenomenon was not observed with OCYH-IB
GCYH-IB from B. subtilis or N. gonorrhoeae; the
trimeric nature of
o f the proteins were not altered under high ionic strength or in the
presence of
o f OTP
GTP and MnCh
M nCh suggesting that the monomeric units are tightly
associated. In contrast to the gel filtration analysis, the crystal structure revealed that
the OCYH-IB
GCYH-IB from N. gonorrhoeae was a homotetramer. The results obtained from
X-ray crystallography are consistent with the oligomerization pattern of
o f T-fold
proteins and therefore maybe a more accurate representation of
o f the oligomeric nature
of N. gonorrhoeae GCYH-IB.

GCYH-IA contains an essential zinc metal ion that has been shown to function as a
OCYH-IA

Lewis acid in the activation of the water molecule that subsequently undergoes a
nucleophilic attack at C-8 of OTP
GTP (Figure 9). The zinc ion has also been proposed to
assists in the nucleophilic attack of
o f a second water molecule by polarizing the
resulting amide carbonyl. In E. coli FolE the zinc atom is coordinated by Cys-110,
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His-113
H is-113 and Cys-181. These residues are strictly conserved in all GCYH-IA [58, 61].
Furthermore, the zinc coordinating residues are located in two conserved motifs,
CEHH and HXC, which are separated by ~70
-7 0 residues. In GCYH-IB enzymes, these
two conserved motifs are missing and replaced with CP-C/H/S-A/S and ESXHXH,
that are separated by ~
100 residues [[123],
123]. Also, the zinc coordinating residues His-100
113 and Cys-181 found in GCYH-IA are replaced with Ser/Ala and His residues,
respectively (Figure 63), suggesting that metal binding maybe substantially different.

The N.
N gonorrhoeae and B. subtilis GCYH-IB were treated with metal chelating
reagents, EDTA and Chelex-100, to remove all metals from the proteins. As a result
the proteins were rendered inactive. Although, it has been reported that E. coli FolE is
not dependent upon any coenzymes or metals besides zinc for activity, GCYH-IB
2
+, whereas only 15% activity
proteins were maximally activated in the presence of Mn
Mn2+,
2
was restored by the addition of
+. GCYH-IB homolog from M.
M jannaschii was
o f Zn
Zn2+.
2
shown to be maximally activated in the presence of
o f Fe + [125]. However, for the
2

2
+ restored 50-75% activity compared to that ofMn
+.
bacterial enzymes, Fe
Fe2+
of Mn2+.

2
2
By ICP-MS analysis only substoichiometric amounts of
+ and Zn
+ were detected
o f Mn
Mn2+
Zn2+

in all protein samples, even after reconstitution. These findings suggest that
manganese is not tightly associated to the proteins and readily dissociate from the
protein upon purification and dilution, consistent with the intrinsic properties of
manganese.
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Manganese is a characteristically labile metal that readily dissociates from proteins
upon purification. The !ability
lability of
o f manganese is reflected in the thermodynamic

instability of
o f its complexes with the side chains of
o f amino acids and its affinity for
water [[131,
131, 132]. Furthermore, the manganese ions found in manganese dependent '
enzymes are in dynamic equilibrium with the metal ions of
o f the surrounding
environment, and binding is dependent upon the environmental concentrations and the
2
protein affinity towards Mn
+ [132]. Restoration of
Mn2+
o f manganese dependent enzyme

activity can be achieved upon the addition of
o f manganese to the assay mixture.

2
2
+ and Zn
+ by ICP-MS and knowing that GCYH-IA is a zinc
The detection of Mn
Mn2+
Zn2+

dependent enzyme, 'lead
lead us to examine the effects of
o f both metals on activity. An
'l-i

antagonistic effect was observed, where Mn2+ stimulated activity decreased with
increasing zinc concentration. These findings are consistent with loosely associated
manganese that is readily replaced with a zinc ion.

2
2
+ (0.74 A) and Mn
+ (0.75 A) are almost the same size, the metals differ
Although Zn
Zn2+
Mn2+

with respect to ligand preference [133]. Manganese has been characterized as a hard
metal ion that favors oxygen over nitrogen or sulfur donating ligands. Some common
oxygen donating ligands are; H2O,
H 2 O, Off,
OH', OK,
OR', Glu, Asp, Tyr, Ser, and Tor
Thr [134]. Zinc
has been described as borderline in hardness which favors nitrogen, oxygen and sulfur
donating ligands such as His, Glu and Cys residues [134]. Although GCYH-IB
proteins from B. subtilis and N. gonorrhoeae are less active in the presence of
o f zinc, the
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or an Ala) and a His, may favor the
proposed m~tal
metal binding site made up of
o f Cys, Ser ((or
binding of zinc and not manganese, however a detailed examination is needed to

confirm the binding affinity of
o f each metal in GCYH-IB proteins. However, these

N gonorrhoeae and B.
results clearly demonstrate that GCHY-IB homologs found in N.
subtilis are manganese dependent enzymes. Since divalent manganese can also

function as a Lewis acid with properties comparable to that of zinc, it is believed that
manganese maybe functioning analogous to that of
o f zinc found in GCYH-IA by
134,
activating a nucleophilic water molecule needed in the deformylation of
o f GTP [[134,
135].

Although the Km
Km values for OTP
GTP were not substantially affected, the addition of
o f DTT

N gonorrhoeae and B. subtilis GCYH-IB,
resulted in a 7 and 3 fold increase in kcat for N.
respectively. Though the effects of OTT
DTT upon B. subtilis GCYH-IB activity were not
as substantial as those observed for GCYH-IB from N. gonorrhoeae, this could be
rationalized by the use of freshly purified B. subtilis protein that had been extensively
dialyzed against a buffer containing DTT. The effects of DTT upon catalytic
efficiency occur at the chemical steps following substrate binding, as reflected in the
increase in kcat,
kcat- Thiol reagents, such as DTT, are known to prevent the oxidation of
of
thiol containing residues and the formation of
o f disulfide bonds. Although there are 3
cysteine residues, only two are conserved (Cys-146 and Cys-148, numbering based on
N. gonorrhoeae enzyme) in GCYH-IB proteins. The two conserved Cys residues are
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in close proximity to one another and are believed participate in catalysis by
coordinating the metal ion, consistent with the mechanism proposed for GCYH-IA.

Although GTP was the preferred substrate, it was demonstrated that GDP also reacted
with G~YH-IB.
GCYH-IB. GDP exhibited a 20-25 fold increase in Km
K mand a 1.5-3 fold decrease
in kcat•
kcat. These findings indicate that the removal of the y phosphate group has little
effect upon the catalytic steps occurring after substrate binding. Although GDP
functions as an inhibitor of E. coli FolE with a Ki
Kj of
o f 1.5 µM,
pM, the kinetic constants
obtained for GDP were comparable to those reported for T
T. thermophilus GCYH-I
[105, 136]. When GMP and guanosine were analyzed as substrates no activity was
observed. These results clearly demonstrate that the phosphate groups are necessary
for substrate binding and therefore catalytic efficiency.

In addition to substrate analysis, inhibition studies using 8-oxoGTP, 7-deazaGTP and
2'
-dGTP were also conducted with GCYH-IB from N.
N gonorrhoeae in hopes of
2 ’-dGTP
gaining insight into the catalytic mechanism. While all three functioned as
competitive inhibitors with respect to GTP only 8-oxo-GTP functioned as a potent
GCYH-IB with a K/Km
K j/K mof
o f 0.022, which is 300 and 1000 fold lower than
inhibitor of GCYH-1B
K j/K m for 7-deazaGTP and 2'-dGTP,
2’-dGTP, respectively.
the K/Km

The higher affinity to the enzyme exhibited by 8-oxoGTP and its structural
resemblance to the putative reaction intermediate, suggest that 8-oxoGTP maybe
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functioning as a transition state inhibitor of
o f GCYH~IB,
GCYH-IB, consistent with what has been
reported for GCYH-IA from T. thermophilis [136]. Although 8-oxoGTP can undergo
keto-enol tautermerization, it has been reported that at neutral pH the keto form
predominates (Figure 68) [137]. When 8-oxoGTP was analyzed as a potential
substrate, no activity was detected. These results are consistent with the proposed
GCYH-IA chemical mechanism in which replacing GTP with 8-oxoGTP, where N-7
is protonated and C-8 is oxidized to the carbonyl state (keto
(keto form), would prevent the
hydrolysis and deformylation of
o f GTP (Figure 9).

The 7-deazaGTP analog exhibited a Ki
Kj value that was 7 fold lower than the Km
Km of
of
GTP, suggesting that binding was moderately affected. However, 7-deazaGTP did not
function as a substrate for GCYH-IB. These results are consistent with the proposed

chemical mechanism of
o f GCYH-IA, in which replacing the nitrogen at position 7 with
o f GTP (Figure 9).
a carbon, would prevent the hydrolysis and deformylation of

o f substrate binding and catalysis.
Hydrogen bond formation is an integral part of

Studies with crystal structure of
o f GCYH-IA from T. thermophilis had reported the
formation of 4 hydrogen bonds between the enzyme and the ribosyl moiety of GTP
and replacing the hydroxyl group would results in the loss of 3 hydrogen bonds [136].
2’-deoxy
o f GTP exhibited a Ki
Kj value that was 24 fold higher than the Km
Km
The 2'
-deoxy analog of

of
o f GTP, suggesting binding was compromised with the removal of
o f the 2'-hydroxyl
2 ’-hydroxyl
2 ’dGTP, the formation of
o f dihydroneopterin
group. When GTP was replaced with 2'dGTP,
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triphosphate was not observed, as determined by fluorescence. Although these results
-hydroxyl group is needed in the formation of
indicate that the 2'
2’-hydroxyl
o f dihydroneopterin
triphosphate, consistent with the proposed mechanism of GCYH-IA (Figure 9), they
fail to determine if 2'dGTP
2’dGTP undergoes the initial deformylation when assayed with
GCYH-IB proteins. Utilizing [8- 14
C]-2'dGTP or employing a type III GTP
14C]-2’dGTP
cyclohydrolase fluorescence based assay will determine if GCYH-IB catalyzes the
deformylation of
o f 2'dGTP.
2’dGTP.

Despite the structural differences between the type IA and IB cyclohydrolase families,
we believe that the chemical mechanism of GCYH-IB is similar to that of
o f GCYH-IA,

which catalyzes the conversion of
o f GTP to dihydroneopterin triphosphate and formate
through a mechanistically complex ring expansion reaction (Figure 9). A chemical
mechanism has been proposed for GCYH-IA and is consistent with crystallography
and biochemical studies, including mutagenesis, NMR analysis and transient state
o f GTP at
kinetics [[52,
52, 58-61]. The reaction is initiated with the reversible hydrolysis of

C8-N9 via a nucleophilic attack of a zinc activated water molecule to form an Nnd
hydrolysis reaction resulting
formyl intermediate, which subsequently undergoes a 22nd

in the elimination of C-8 as formate. The ribosyl moiety undergoes ring opening and
an Amadori rearrangement followed by cyclization and dehydration to give the pterin
ring.
rmg.
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In the primary and predicted
N gonorrhoeae OCYH-IB
predieted tertiary alignment, His 245 of
o f N.
GCYH-IB
was conserved in a comparable position to His 179 of E. coli FolE (Figure 63). Based
on these findings it was believed that H245 may function analogously to Hl
HI 79 by
facilitating the elimination of
o f C-8 as formate either by donating a proton to N-7 of
OTP
GTP directly [59] or by coordinating a second water molecule needed for hydrolysis
(Figure 9) [136]. To test the necessity of
o f H245 in the elimination of
o f formate the His
residue at position 245 was mutated to Asp, Oln,
Gin, Lys and Asn and the resulting
14

C]OTP, each of
mutants were analyzed for activity. Upon analysis utilizing [8[8-14C]GTP,
o f the
4
C]-formate which is consistent with the
mutants demonstrated the release of
o f [1
[14C]-formate

hydrolytic ring opening and deformylation of OTP
GTP at C-8. Furthermore, these results
F olE, therefore H245 may have a
are not consistent with those of
of H
HI179
79 of E. coli FolE,
different role in catalysis other than in the deformylation of
o f OTP.
GTP.

When analyzed by UV-vis and fluorescence, dihydroneopterin triphosphate formation
was observed for H245D and H245Q mutants. In contrast, the H245N and H245K
mutants failed to generate dihydroneopterin triphosphate. It has been reported that the
replacement HI 79 of
o f E. coli OCYH-IA
GCYH-IA results in the accumulation of
o f the N-formyl
reaction intermediate, which can be analyzed in a type III OTP
GTP cyclohydrolase
fluorescence based assay. The assay entails the derivatization of
o f the reaction product
to 6,
7-dimethylpterin. However the same assay can be used to analyzed type II OTP
6,7-dimethylpterin.
GTP
cyclohydrolase activity which catalyzes the formation of the deformylated reaction
product. Fluorescence was observed in those reactions catalyzed by H245D, H245Q,
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and H245N mutants, and not for H245K mutant. By radiochemical analysis, we were
able to demonstrate that each of the mutants catalyzes the release of
o f formate, therefore
the formation of
o f 6,7-dimethylpterin could be due to the catalytic generation of the
deformylated product.

The results obtained from the biochemical analysis are consistent with H245
functioning different to that of
o f Hl
H I 79 of£.
of E. coli GCYH-IA. Insight into the probable
role ofH245
of H245 came with the realignment of
o f GCYH-IB and GCYH-IA primary
N gonorrhoeae GCYH-IB. Due to a
structures based on the X-ray crystal structure of
o f N.
N
pending patent the new alignment and the recently solved crystal structure of N.
gonorrhoeae GCYH-IB will not be presented nor discussed in detail. The realignment
revealed that H245 was not located in a comparable position to that of
o f Hl
HI 79 of E. coli

FolE, and instead it is involved in the coordination of a second metal ion. Though the
rates of deformylation were lower to that of
o f the wild-type, mutating His 245 could
have disrupted the second metal site that is needed in the steps following the

elimination of C-8.

COG1469
COG 1469 proteins represent a new prokaryotic type I GTP cyclohydrolase that
2
+ ion for maximal activity. We are currently conducting further
requires a Mn
Mn2+

biochemical analysis that will help elucidate the chemical mechanism of
o f this new
family of
o f enzymes. Further analysis will entail, but not limited to site directed
mutagenesis of the conserved residues believed to be involved in metal ion
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coordination and acid/base chemistry; transient state kinetics which allows for a detail
characterization of
o f the events taking place during catalysis and in the identification of
of
stable reaction intermediates, and the examination of the metal binding affinity.
Future work will also entail the development of
o f a high throughput assay allowing for
the screening of
of potential inhibitors of
o f GCYr.I-IB
GCYH-IB which is present in a number of
of

N gonorrhoeae and S. aureus. Knowledge of the
pathogenetic bacteria such as; N.
crystal structure will aid in the structure base design of
o f potential inhibitors that are
selective towards this new family of
o f enzymes.

The phylogenetic distribution offolE-1 andfolE-2
and folE-2 genes among sequenced organisms
revealedfo/E2
revealed
folE 2 is present in most archaea and ~20%
-20% of
o f bacteria (Table 13). However,
homologs offolE2
o ffolE2 are absent in eukaryotes including humans [123]. The distribution

offolE
offo lE andfolE2
and folE 2 varies among bacteria and can be divided into 4 groups. In group
lE homo
homolog
one which includes E. coli, only one fo
fo!E
log was observed whereas the second

group that includes S. aureus and N.
N gonorrhoeae, contain only the folE2 homolog. A
third group which includes B. subtilis and A. baylyi, contains afolE
a fo lE and afolE2
a folE2
homolog whereas the fourth group that includes P. aeruginosa contains multiple

copies of
o f each genes. It is unclear as to why both or multiple copies of
o f each gene are
present in a number of
o f organisms, but it may be attributed to the affects of

environmental conditions upon organism growth and/or the potential involvement of
of
these genes in other pathways besides folate biosynthesis. Comparative genomic
analysis revealed thatfo!E-2
that folE-2 genes clustered with genes encoding putative metal
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chaperones, suggesting thatfolE-2
that folE -2 genes may be up-regulated under zinc starved
conditions, which is consistent with the differences in metal specificity to that of
of
GCYH-IA and observed inhibitory effects of
o f zinc upon manganese stimulate GCYH1B
IB activity. We are currently examining the putative function and role of these metal
chaperones upon GCYH-IB activity. The necessity offolE-1
offo lE - 1 andfolE-2
and folE~2 in the
biosynthesis of queuosine has been examined in gene knockout studies. The 6.folE
t\folE
and 6.folE-2
EfolE-2 mutations resulted in the absence of
o f queuosine modified tRNA suggesting
that both folE-1 andfolE-2
and folE-2 are essential in the biosynthesis of
o f queuosine (de CrecyLagard, unpublished work).
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Table 1. Michaelis and inhibition constants for QueA

kcai/Km
I'au/Km

Substrate/
Inhibitor

Km (uM )d

Kat (m in'V

1
1
(µM·
min·
(u M 'm
in 1))

AdoMet•
A
doM ef

104.4 ± 8.6

2.3 ±
0.1
±0.1

45.4

SeAdoMet

111.5 ± 33.2
.2

0.0838 ±
0.003
±0.003

04
7.50x10·
7.50x1 O'04

Inhibition
Patternb
Patternb

Ks
(nM )c/d

C

99.2 ± 22.9
.9
138.4±
138.4 ±
3.5
217.1 ±
7.3
224.4 ±
5.1
5,1

7-deazaAdoMet

C

2'-dAdoMet

C
c

3'-dAdoMet

C
c

11

Ki/Km

0.95
1.32
2.07
2.15

Met were obtained from Van Lanen, et. al. [78].
a Kinetic parameters for Ado
AdoMet
[78],
be
bC =
= competitive inhibition.
alues for the inhibition constants were obtained from data fitted to equation I1 for
°Values
competitive inhibition against adomet.
alues are also expressed with respect to their standard deviation
dValues

cv

ctv
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Table 2. Effect of metal ions upon N. gonorrhoeae apoenzyme COG1469
COG 1469 Activity
Relative
[Metal]
[Metal] a3
R elative Activity
A ctivity
(MM)
Metal
(µM)
(%)
(%)
As-isolatedb
O
0.3
As-isolatedb
0
No Metalc
O
0
0
Metal6
Mn(II)
500
100
M n(II)cc
F
e(Il) c,d
2000
51
Fe(II)c,d
Mg(Il)
100
29
M g(II)cc
Co(II)
50
27
C o(II)cc
0
50
15
Zn(II)
Z n(II)0
Ni(II)
50
5
N i(II)cc
Ca(II)
NAe
0
NAe
C a(II)cc
c
NAe
0
Cd(II)
NAe
C d(II)c
NAe
0
Cu(II)
NAe
C u(II)cc
NAe
0
Co(III)
C o(III)cc
NAe
Fe(III)
c
NAe
0
Fe(III)0
NAe
a The metal concentration for optimal activity. Each metal was surveyed over a
concentration range of
o f 0-2 mM.
bbAs-isolated
As-isolated refers to protein that had not been treated to EDT
A and Chelex prior to
EDTA
analysis.
cCAll
A and Chelex prior
A11 proteins utilized in the metal analysis were treated with EDT
EDTA
to analysis.
d
d Assays were conducted under anaerobic conditions in the presence of
o f 100 mM
HEPES (pH 8.0), 100 mM KCl,
KC1, 0.1 mM GTP, 2 µM
pM protein, and varying
o f Fe(S 0 4 )2 .
concentrations ofFe(SO4)2.
®NA refers to no activity detected regardless of
o f metal concentration
~A
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Table 3. Effect of metal ions upon B. subtilis apoenzyme COG 1469 Activity

Metal
As-isolatedb
As-isolated
No Metalc
Metal0
Mn(Il)c
Mn(II)°
Fe(II)
c,d
Fe(II)c,d
Mg(II)c
M g(II)0
Co(II)
C o(II)cc
Zn(II)
c
Zn(II)0
Ni(II)
C
N
i(II)0
Ca(II)
C a(II)cc
Cd(II)
C
C d(II)0
Cu(II)
c
C u(II)0
c
Co(III)
C o(III)0
Fe(III)
c
Fe(III)0

[Metal]
a
[M etal]a
(UM)
{~M)

Relative
R elative Activity

0
0
500
1000
100
100
50
100

1.7

NAe
NAe
NAe
NAe
NAe
NAe
NAe
NAe
NAe
NAe

{%}
(%)
0
100
75
43
24
14
9.8
0
0
0
0
0

a The metal concentration for optimal activity. Each metal was surveyed over a

concentration range of 0-2 mM.
bbAs-isoloated
As-isoloated refers to protein that had not been treated to EDT
A and Chelex prior to
EDTA
analysis;
analysis.
cCAll
A and Che
lex prior
A11 proteins utilized in the metal analysis were treated with EDT
EDTA
Chelex
to analysis.
d
d Assays were conducted under anaerobic conditions in the presence of
o f 100 mM
HEPES (pH 8.0), 100 mM KCl,
KC1, 0.1 mM GTP, 2 µM
pM protein, and varying
concentrations of Fe(SO4)2.
Fe(S 0 4 )2 eNA refers to no activity detected regardless of
o f metal concentration
~A
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Table 4. COG 1469 activity prior to excess metal removal
Specific Activities (µmol/min/µmol)
(pmol/min/pmol)

Metal Concentrationa
Concentration3
0.5 mM

2
Mn
+ Control
Mn2+

2
+
1 µMMn
pM Mn2+
2
2 µM
+
pM Mn
Mn2+
2
3.5 µM
+
pM Mn
Mn2+
2+
3 µM
Mn
pM Mn2+
2
6 µM
+
pM Mn
Mn2+
2
10.5 µM
+
pM Mn
Mn2+

N. gonorrhoeae0
gonorrhoeaeb_______ B. subtilii
subtilisb
0.28
0.068
ND
ND
ND
ND
ND
ND
ND
05
9. lxl0lx l O'05

ND
ND
ND
1.8xlO·OS
1.8x1 O'05

2
50 µM
+ Control
0.022
0.011
pM Zn
Zn2+
2+
,
1 µM
Zn
ND
ND
pM Zn2+
2
2 µM
+
ND
ND
pM Zn
Zn2+
2
3.5 µM
+
ND
ND
pM Zn
Zn2+
2
3 µM
+
ND
pM Zn
Zn2+
ND
2+
6 µM
ND
pM Zn
Zn2+
ND
2
05
05
10.5 µM
+
4.5x10·
2.8x10·
pM Zn
Zn2+
4.5xlO"05
2.8x1 O’05
aa Final metal concentration when an aliquot of the reconstitution mixture is taken into
standard reaction conditions containing 100 mM HEPES (pH 8.0), 100 mM KCl,
KC1, 1
mM DTT and 0.1 mM GTP.
b
bND denotes no activity detected
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Table SA.
5A. Initial ICP-MS analysis of GCYH-IB metal ion content

Metal
M etal / Protein Ratio
R atio (mol/mol)
(mol/moD
N. gonorrhoeae as-isolated

N. gonorrhoeae apoenzyme
B. subtilis as-isolated
B. subtilis
subti/is apoenzyme

Mn(II)
4
1.60x10·
1.60x1 O'4
5
3.!0x10·
3.1 Ox 10*5
4
4.20xl0"
4.20x1 O'4
5
5.00xl0"
5.00xlO"5

Ni(II)
3
2.80xl0·
2.80x10"3
4
8.20xl0"
8.20x1 O’4
3
3.48x10·
3.48x10'3
4.74
xl0-4
4.74x1
O'4

Zn(II)
1
3.47
3.47 X.10"
xlO"1
2
3.70
x10·
3.70x1
O’2
1
2.56 xl0"
xlO'1
2
9.54
9 .5 4 xx10·
1 0'2

Table 5B. Follow-up ICP-MS analysis of GCYH-1B
GCYH-IB metal ion content

Metal/
M etal / Protein Ratio (mol/mol)
(mol/moD
Mn(II)

Zn(II)

N. gonorrhoeae as-isolated

2
4
1.16 xl0"
± 4X
x l0 '2±
x 10"
10'4

3
1.20
1.20 xlO•l
xlO'1± 4
4 xX 10"
10"3

N. gonorrhoeae apoenzyme

NDa
NDa

4
2.24 X
10" 1 ± 8 Xx 10"
xlO'1
10'4

2
+ Reconstituted
N. gonorrhoeae Mn
Mn2+

3
5
1.45 xl0"
± 5X
x l0 '3±
x 10"
10‘5

4
2
1.71 xl0"
± 2X
xl0'2±
x 10"
10'4

2
N. gonorrhoeae Zn
+ Reconstituted
Zn2+

ND"
ND“

4
2
1.34 X
10"‘2±
± 8X
x l0
x 10·
10'4

B. subtilis as-isolated

5
2.06 X
10"3 ± 7 X
xlO'3
x 10"
10'5

2
3
4.84 xl0"
± 3x
X 10"
x l0 '2±
10‘3

B. subtilis apoenzyme
B,

6
7
2.00 x}0"
± 1X
xl0"6±
x 10"
10'7

2
4
4.59 X
10"'2±
± 5X
x l0
x 10"
10'4

3

5
4.34 Xxl0'2±
10"2 ± 6 Xx 10"
10’5

2

+ Reconstituted
B. subtilis Mn
Mn2+

B. subtilis zn2+
Zn2+ Reconstituted

5
1.53 Xx l0
10"'3±± 6 Xx 10·
10‘s
5
6
6.00 X
10·'5±± I1 X
x l0
x 10"
10'6

aNo activity detected
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4
2
5.29 xJ0·
±4X
xl0'2±
x 10"
10'4

Table 6A. Effects of DTT upon N.
N gonorrhoeae COG 1469 activity

[DTT]
(mM)

0
0.5
' 1
2
4
8
12

UV-vis
Relative
Activity
(%}
(% )
31
86
88
100
89
87
78

Fluorescence
Relative
Activity {%}
(% )

18
90
100
77
76
0
0

Table 6B. Effects ofDTT
1469 activity
o f DTT upon B. subtilis COG
COG1469
UV-vis
Relative
Activity {%}
(% )

Fluorescence
Relative·
Relative
Activity {%}
(% )

0.5
I1
2
4
8

49
82
91
100
97
98

14
80
100
71
62
0

12

99

0

[DTT]
(mM)
{mM}
0
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Table 7 A. Michaelis constants for N. gonorrhoeae COG 1469

Substrate
OTP
GTP

GDP

Km(uM)“

kcat(min'1)a

hea/Km
(uM 'min1)

without OTT
DTT

9.15 ± 0.67
0.67

0.0159 ±
0.0013
±0.0013

0.0017

with OTT
DTT

6.76 ± 0.62

0.1160 ± 0.0050
0.0050

0.0171

without DTT

172.8 ± 10.1

0.00321 ±
0.00027
±0.00027

5
1.86 X 10·
10'5

with OTT
DTT

146.7 ± 66.8
.8

0.0793 ±
0,0081
±0.0081

0.00054

ay
alues are also presented with respect to their standard deviation.
aValues

Table 7 B. Michaelis constants for B. subtilis COG
1469
COG1469
Km(uM)a

kcat (min_1)a

hca/K,n
(aJVr’inin"1)

without DTT

8.12±0.48
8.12 ± 0.48

0.0212 ±0.0016
0.0016

0.0026

with OTT
DTT

9.87 ±0.82
0.82

0.0655 ±0.0014
0.0014

0.0066

without DTT

248.2 ± 113.0
3.0

0.00627 ± 0.00029

5
2.42 X 10"
10'5

with OTT
DTT

238.3 ± 55.7
.7

0.0224 ±0.0016
0.0016

9.42 X lO
10·'55

Substrate
OTP
GTP

GDP

ay
alues are presented with respect to their standard deviation.
aValues
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Table 8. Inhibition constants and patterns for
N gonorrhoeae COG
1469 with
for N.
COG1469
substrate analogs

Inhibitor

Inhibition
Patterna
Pattern8

K j(u M )b
Ki{f!Ml

7-deazaGTP
45.7 ± 11.5
.5
C
C
2'-deoxyGTP
164.2 ±
3.1
±3.1
C
c
8-oxoGTP
0.149 ± 0.0049
0.0049
C
c
ac
.
aC denotes competitive inhibition pattern
by
alues are presented with respect to their standard deviation.
bValues
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Kj/Km
Ki/Km

6.8
24.3
0.022

Table 9. Radiochemical analysis of N.
N gonorrhoeae His 245 mutants

Protein

Relative
Activity
(%)
(°A

Wild-type

100

E.coli
E.
coli RibA
H245D

80

H245Q
H245N
H245K

72
67
24
5

111
111

Table 10. UV-vis analysis of N. gonorrhoeae His 245 mutants

Protein

Wild-type
H245D
H245Q
H245K
H245N

Relative
Activity
(%}
(% )
100
3.0
2.4
0
0
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Table 11. GCYH-I Fluorescence analysis of N.
N gonorrhoeae His 245 mutants

Relative Activity (%)

H245D
0.0
0.0
0.4
3.0
o
©

IGTPHuM)
[GTP]
(l!M)
24
50
200
500

H245Q

H245K

H245N

Wild-type
Wild-tyee

0.6

0.0
0.0
0.0
0.0

0.0
0.0
0.0
0.0

68
81
100
93

1.2

0.8
2.1
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Table 12. GCYH-II and III fluorescence analysis on N. gonorrhoeae His 245 mutants

Wild-type
E.coli
E.
coli RibA
H245D
H245Q
H245N

H246K

Relative Activity
(%)
(% )
100
8.2
8.0
8.1
3.0

0.0
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Table 13. Distribution ofFolE,
o f FolE, FolE2 (denoted as COG1469), FolKP and YkvLKJ
homologs in a subset of
o f sequenced genomes.
Organism
M. jannaschii
jannasch ii
M. burtonii
P. abyssi
P. torridus
8.
B. bronchiseptica
S. aureus
T. maritima
N. europaea
N. gonorrhoeae
N. meningitidis
8.
B. subtilis
A. baylyi ·
M. capsulatus
X. fastidiosa
X,
E. coli
C. jejuni
Y. pestis
Z. mobilis

Domain
A
A
A
A
B

FolE

+
+
+
+
+

B
B
B
B

+
+
+
+
+
+
+
+
+
+
+
+
+

B

B
B
B
B
B

B
B
B
B
B
B
B

COG1469
+

+
+
+
+
+
+
+
+
+
+
+
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FolKP
+
+
+

+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+

YkvLKJ
+

+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+

+
+
+
+
+

+
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Figure 1. The chemical structure of archaeosine (G*) and queuosine (Q) and their
location in tRNA. Image taken from published work of Iwata-Reuyl [138].
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Figure 19. HPLC purification of
C]ATP. Purification was carried out by
o f [U-ribosyl[U-ribosyl-14C]ATP.
reverse phase HPLC utilizing
utili 4ing a semipreparative Luna C18
C l 8 column. The radio-labeled
ATP eluted from the column under isocratic conditions using 83.3 mM
triethylammonium acetate (pH 6.0) and 6 % methanol at 4 ml/min. Under these
conditions adenine eluted ~11
[U-ribosyl- 14C]ATP at 23
~ 11 min, NADPH at 13 min and [U-ribosyl-l4C]AT?
min. Absorbance at 260 is represented by a solid line and radioactivity is represented
by a dashed line.
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Figure 21. [V-ribosylC]AdoMet
C]SeAdoMet HPLC Purification.
[U-r/&o.ry/-14C]
AdoMet and [U-ribosyl[U-n7?o.?y/-14C]SeAdoMet
AdoMet and SeAdoMet were purified by reverse phase HPLC on a Luna C 18 column
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eluted ~6 min, AdoMet (A) at 10 min and SeAdoMet (B) at 10.5 min. Absorbance at
260 is represented by a solid line and total radioactivity is represented by a dashed
line.
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Figure 22. 3'dAdoMet
3’dAdoMet and 7-deazaAdoMet HPLC Purification. AdoMet analogs
C l 8 column with 20 mM ammonium
were purified by reverse phase HPLC on a Luna C18
acetate (pH 6.0) and 20% methanol mobile phase. (A) 33’dATP
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-117
7 min. Absorbance at 260 is represented by a solid line and total
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Figure 23. 2'dAdoMet
C]-2'dAdoMet was
2 ’dAdoMet HPLC Purification. [1C-methionine[lC-methionine-14C]-2’dAdoMet
purified by reverse phase HPLC on a Luna C 18 column with a mobile phase of
o f 20
mM ammonium acetate (pH 6.0) and 20% methanol. 2'dATP
2’dATP eluted ~6 min,
2'dAdoMet
2 ’dAdoMet eluted at 11.5 min and 2'dMTA
2’dMTA eluted at 26 min. Absorbance at 260 is
represented by a solid line and total radioactivity is represented by a dashed line.
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Figure 24. SDS-P
AGE of
~44 kDa). Lane I,
SDS-PAGE
o f purified QueA His6-tag fusion protein ((~44
1,
MW markers; lane 2, crude lysate; lane 3, CFE; lane 4, Buffer I1 wash; lane 5, Buffer 2
wash;
wash ; lane 6, Buffer 3 wash; lane 7, nickel agarose purified protein; lane 8,
concentrated protein.
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Figure 25: SDS-PAGE analysis of
o f (A) Glutathione sepharose 4B affinity purification
of
o f QueA-GST (65 kDa). Lane 1 MW; lane 2 CFE; lane 3 Buffer L wash; lane 4 Buffer
M wash; lane 5 Elution of protein with Buffer N, lane 6 filtrate from concentration;
lane 7 concentrated QueA-GST. (B) SDS-PAGE analysis ofHPLC
of HPLC purification of
of
QueA-GST. Lane 1 MW; lane 2 Sepharose purified protein; lane 3-7 HPLC purified
QueA-GST.
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Analysis. (A) the elution profile of
o f [[lC
Figure 26. Dowex-50WX4 Analr,sis.
1C--14C]-methionine,
C]-methionine,
14
C]-adenine and [U-ribosyl- 44C]-AdoMet
C]-AdoMet on Dowex with increasing H2SO4
[U[U-14C]-adenine
H 2 SO 4
concentration. (B) Product formation in the presence of QueA was quantified by
fractionation on Dowex. The arrows in the upper region of each plot indicate the
o f H2SO
H 2 SO44 utilized in the elution.
concentration of
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Figure 31. Enzymatic synthesis of
C]GTP. In a multienzyme reaction, [8Co f [8C[8C-14C]GTP.
14C]GTP was synthesized from phosphoribosyl pyrophosphate (PRPP) and [8C14C]guanine. Enzymes involved in the synthesis are as follows; Hypoxanthine
phosphoribosyltransferase (HGPRTase), nucleoside monophosphate kinase (NMK),
and pyruvate kinase (PK).
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Figure 32. SDS-PAGE Analysis of HGPRTase (24 kDa) purification. Lane 1 and 2,
MW markers; lane 3, supernatant after 40% ammonium sulfate fractionation; lane 4,
resuspended pellet after 80% ammonium sulfate fractionation; lane 5, resuspended
pellet from 40% ammonium sulfate fractionation; lane 6, empty; lane 7, supernatant
after 80% fractionation.
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Figure 34. SDS-PAGE analysis of
o f purified recombinant and wild-type COG1469
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proteins.. Lane 1, MW markers; lane 2, B. subtilis COG1469 His6-tag (39.7 kDa);
proteins
lane 3, B. subtilis COG1469 wild-type (34.7 kDa); lane 4, N. gonorrhoeae COG1469
1469 wild-type (28.7 kDa); lane 6,
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T
T. maritima COG1469 His6-tag (35.2 kDa); lane 7, T
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GCYH-I and GTPCH-11
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14
[8[8-14C]GTP.
C]GTP. T. maritima COGl469
COG1469 (□),
(□), N. gonorrhoeae COG1469 ((■),
■), B. subtilis
COG1469
E.coli
COG 1469 (o)
( o ) and E.
coli FolE (•).
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Figure 36. Spectrophotometric based assay for GCYH-1
GCYH-I activity. Assays were
00 mM KCl,
performed in 100 mM Tris-HCl (pH 8.0), I100
KC1, 2 mM MgC1
MgCl22 and either 20
µME.
pM
E. coli FolE or 40 µM
pM COG 1469 proteins in a total volume of
o f 100 µl.
pi. Reactions
o f GTP to a final concentration of
o f 0.1 mM and incubated at
initiated upon the addition of
37 °C. Reactions were allowed to proceed for 60 min while monitoring the
E.coli
absorbance from 200-400 nm. (a) E,
coli FolE; (b) N. gonorrhoeae COG1469;
COG 1469; (c) B.
subtilis COGI469;
COG1469; (d) no enzyme.
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Figure 38. Fluorescence based assay for GCYH-I activity. Fluorescence was
measured with excitation at 365 nm. (a) T
71 maritima COG
COG1469;
1469; (b) B. subtilis
coli FolE; (d) authentic neopterin; and (e) N.
COG1469; (c) E.
E.coli
N gonorrhoeae
COG1469.
Tris-HCl (pH 8.0), 100 mM KCI,
KC1, 2
COG
1469. Reactions were performed in I100
00 mM Tris-HCI
M gCb, 1 mM GTP and either 10 µME.
pM E, coli FoIE
FolE or 40 µM
pM COG1469
COG 1469 proteins in
mM MgCb,
a total volume of
o f 100 µI
pi at 37 °C (E. coli FoIE
FolE and B. subtilis and N. gonorrhoeae
COG 1469) or 75 °C (T
(71 maritima COG 1469). Reaction products were
dephosphorylated by alkaline phosphatase followed by oxidation upon the addition of
an acidic iodine solution.
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Figure 41. Effect of temperature on the relative activity of
o f COG 1469 proteins. (A) T.
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COG 1469.
maritima COG1469,
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Activity assays were performed in 100 mM phosphate (pH 77.5),
.5), 100 mM KCl,
KC1, 0.5
M nCh, 0.5 mM OTP
GTP and 2 µM
pM protein in a final volume of
o f 100 µl.
pi. Reactions
mM MnCh,
were incubated for 30 min and analyzed by fluorescence. Data points represent the
o f 3 triplicates.
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Figure 50. Substrate Kinetic Analysis of
N gonorrhoeae COG1469. Reactions were
carried out in 100 mM HEPES (pH 8.0), 100 mM KCI,
KC1, 0.5 mM MnCh
MnCl2 at 37°C.
o f OTP
GTP and 2 µM
pM
Assays performed in the presence of (A) varying concentrations of
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pM Protein; (C)
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pM protein; (D) varying concentrations of
o f GDP,
pM protein. Activity was measured every 10 min for a total of
o f 30
1 mM DTT and 0.5 µM
min. Nonlinear regression analysis of the data (minimally 4 sets of
o f triplicates) was
conducted using KaleidaGraph 4.0.

165

A

B
0.04

0.03

0.035

a.ow
0.025

sEc

0.03

!

0.025
□ 025

:1

0 02

j

S
-~
gg r

0.D2
:s.!i1c| 0.02
i~ 0.015

•

.

'ff
V
o
.2

t

~

0015
0.015

0.005

0.01
0.005

0.01

0

10 20
20

10

0
40

30

50

60

70

0

10 2020

0

10

[OTP] 11',MI
<pJV1)

C

~5"
o

•«"
0
o

50

60

2000 .

2500

70

0.012

.

0.00B
0.00B

I

40

D
0.01

c
^

30

[OTP](!'-Ml
[GTP) (jiM)

.. •

0.006

0.01

I£e
1i~TL

0.006
0.D06

0
©
"
'i
>

0 004

I'

0.004

>
>

0002

•
0.00B
0.009

.

•

0.002

o~~-~-~-~-~~

0

o

500

11000
ooo

1500

2000

2soo
2500

0

3000

ItiM)
[GDP] 11',MI

o
0

500

1000
1000

1500

3000

[GDP] {pM)
[ODP]ll,IMI

o f B. subtilis COG
COG1469.
Figure 51. Substrate Kinetic Analysis of
1469. Reactions were
carried out in 100 mM HEPES (pH 8.0), 100 mM KCl,
KC1, 0.5 mM MnCh
MnCl2 at 37°C.
Assays performed in the presence of
o f (A) varying concentrations of
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2’-deoxyGTP: (•)
(• ) 0, (□)
50, (◊)
(0) 100, and (o) 200 µM;
pM; (B) 7-deazaGTP: (•)
( • ) 0, (□) 15, (◊)
(0) 30, and (o) 60 µM;
pM;
(0) 0.25, and (o) 0.5 µM.
pM. Activity was measured
and (C) 8-oxoGTP: (•) 0, (□)
( □) 0.1, (◊)
every 10 min for a total of
o f 30 min. Data (minimally 4 sets of
o f triplicates) were fit to eq
1, competitive inhibition, using KaleidaGraph 4.0.
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Figure 53. SDS;,.PAGE
1469 H245 His6-tag
SDS-PAGE analysis of purified N. gonorrhoeae COG
COG1469
(33.6 kDa) and non-His6-tag (28.7 kDa) mutants. Lane 1, MW markers; lane 2,
H245K His6-tag; lane 3, H245K; lane 4, H245N His6-tag;
Hisg-tag; lane 5, H245N; lane 6,
H245D His
Hise-tag;
His6-tag;
6-tag; lane 9, H245Q.
6-tag; lane 7, H245D; lane 8, H245Q His
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Figure 54. Spectrophotometric based assay for N. gonorrhoeae COG1469 H245
mutant activity. Assays were performed in 100 mM HEPES (pH 8.0), 100 mM KCl,
KC1, 1
mM DTT, 0.5 mM MnCh,
MnCE, and 50 µM
pM mutant N. gonorrhoeae COG1469 protein in a
pi. Reactions were initiated upon the addition of GTP to a final
total volume of 150 µl.
concentration of 0.1 mM and incubated at 37°C. The reactions were allowed to
proceed for 2 h while monitoring the absorbance from 200-400 nm. (A) H245D, (B)
H245Q, (C)H245N, (D) H245K.
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Figure 55. GCYH-I fluorescence activity assay ofH245N
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mutants. Fluorescent spectra of (a) control, (b) H245N, (c) H245K; (d) H245Q; (e)
H245D and (f) wild-type.
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Figure 56. Derivatization of FAPy (or APy, structure not shown) for.
for GCYH-II and III
Fluorescence Analysis. The assay ofH245
N gonorrhoeae COG1469
o f H245 mutants of
o f A.
were boiled in HCl
HC1 for 5 min, followed by a pH adjustment to 8.5 with the addition of
NaOH. After the addition ofbutanedione,
o f butanedione, the samples were incubated for 60 min
m in at
90°C and the resulting formation of
o f 6,7-dimethylpterin was analyzed by fluorescence
(excitation 365 nm, emission 460 nm).
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Figure 57. Fluorescence based assay for GCYH-III activity. GCYH-III activity of
o f N.
gonorrhoeae COG 1469 H245 mutants was measured by fluorescence with excitation
■), H245N (•), H245D (o), H245Q (□),
( □ ),E.coli
at 365 nm. H245K ((■),
E. coli RibA (.~)
( A ) and
wild-type N. gonorrhoeae COG1469 (L.\).
(A). Reactions were carried out at 37°C for 1 h
in 100 mM HEPES (pH 8.0), 100 mM KCl,
KC1, 0.5 mM MnCh,
MnCl2, 1 mM DTT 0.1 mM OTP
GTP
and 2 µM
pM enzyme. Enzyme assays were subjected to post-reaction steps.
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Figure 60. Complementation of
o f the 1::,./alE::KanR
A/o/L::KanR by a plasmid expressing COG1469
gene from B. subtilis and A. baylyi on LB in absence of
o f dT (A) and presence of
o f dT
(B). Complementation of
:KanR by a plasmid expressing COG
1469 gene
o f the 1:-,.fo!E:
AfolE::KmR
COG1469
from T
T. maritima on LB in the presence of
o f dT (C). Image taken from publication by
El Yacoubi, et. al. [123].
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Figure 62. Primary sequence alignment, made by Clustal, of
o f GTP cyclohydrolase I
(from B. subtilis, E. coli, S. pneumoniae, and H.
H irifluenzae)
influenzae) and COG1469
CO G 1469 proteins
(from B. subtilis, N. gonorrhoeae, S. aureus and T. maritima). GCYH-I zinc
coordinating and known catalytic residues are highlighted green and yellow
respectively. Conserved residues are highlighted red.
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Figure 63. The primary and tertiary structure alignment of
o f the C-terminal region of
of
GCYH-IA, GCYH-IB and DHNA. The secondary structural elements from GCYHIA and DHNA derived from their respective crystal structures are shown above
whereas the primary sequences are shown below. Conserved residues in all three
enzyme families are represented by red boxes. The invariant Glu residue is
highlighted in red. Residues involved in zinc binding and catalysis in GCYH-IA are
highlighted yellow and cyan, respectively. Predicted metal binding and catalytic
residues, as determined on their predicted spatial homology to active site residues of
of
GCYH-IA and DHNA, in GCYH-IB are indicated by the bold black boxes. Ec,
Ee, E.
coli; Bs, B. subtilis; Sa, S. aureus; Pa, Pyrococcus abyssi; Ap, Aeropyrum pernix; Tm,
T. maritima; Ng, N.gonorrhoeae; Mt, M.
M tuberculosis. The image was taken from
published work of
o f El Yacoubi [123].
[123],
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N
o f the T-fold Domain. The T-fold domain is
Figure 64. Structural Representation of
o f 4 antiparallel P-sheets
(3-sheets and two antiparallel a-helices that spanning
composed of
between the second and third P-sheet.
[3-sheet. Image taken from published work of
o f Colloc'h
Colloc’h
[139],
[139].

179

a

Figure 65. Representative Structures of T-fold proteins; (a) PTPS, (b) UOX, (c)
DHNA, and (d) GCYH-I. Oligomerization entails the association of
o f 2 multimeric
barrels in a "head-to-head"
“head-to-head” fashion resulting in the formation of
o f a tunnel-like center.
Image taken from publish work of Colloc'h
Colloc’h [139].
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Figure 67. Organization of
o f the T-fold domain region in GCYH-IA, GCYH-IB, 7,8dihydroneopterin triphosphate epimerase (H2NTP), and 77,8-dihydroneopterin
,8-dihydroneopterin aldolase
(DHNA). The substrate and metal binding residues in GCYH-IA along with putative
metal coordinating and substrate binding domains of
o f GCYH-IB are also displayed.
Zinc binding and catalytic residues are represented in black and red, respectively. An
additional conserved sequence found in GCYH-IB but not in GCYH-IA is represented
in pink. Image taken from published work of
o f El Yacoubi [123].
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Appendix A. Plasmids and Proteins
Plasmid
Plasm id

E. coli Expression
Cell Line

Expression Product
P roduct
Ex~ression

pGEX-QA

DHSa
DH5a

E. coli GST-QueA

pET30-EcqueA
pQEAPTI
pK8
pMJ1208
pBRSl
pB R SUlR
R

BL2l(DE3)
BL21(DE3)
DH5a
DHSa
DH5a
BL2l(DE3)
BL21(DE3)
DH5a

E. coli His6-QueA
E. coli APRTase
E. coli MAT
E.coli
M jannaschii MAT
M.
S. typhimurium PRPP synthetase

pTRC99B-Tyr
pBAC-HGPRTase-LD
pB AC-HGPRT ase-LD

K12QueA
S0S6

E. coi tRNA
Tyr specific I
tRNATyr
L. donovani HGPRTase

pET30-EcribA

BL21(DE3)

E. coli His6-RibA

pET30-EcfolE

BL21(DE3)

His6-FolE
E. coli His
6-FolE

pET30-BsfolE2

BL21(DE3)

B. subtilis His6-Fo1E2
His6-FolE2

pET30-N
gfolE2
pET30-NgfolE2

BL21(DE3)

N. gonorrhoeae His6-FolE2

pET30-TmfolE2
:eET30-TmfolE2

BL21(DE3)

T. maritima His6-FolE2
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Appendix B. Primer sequences
Sequence (5'-t3')
(5'—>3')

Sequence Name

Bs-folE2-s
Bs-folE2-as
Ng-folE2-s
Ng-folE2-as
Tm-folE2-s
Tm-folE2-as
Ng-folE2-H245K-s
Ng-folE2-H245K-as
Ng-folE2-H245N-s
Ng-folE2-H245N-as
Ng-folE2-H245Q-s
Ng-folE2-H245Q-as
Ng-fo\E2-H245D-s
N g-folE2 -H245D- s
Ng-fo!E2-H245D-as
N g-fotE2-H245 D-as

GGTATTGAGGGTCGCATGAATCAACATACGCTGCTCCCG
AGAGGAGAGTTAGAGCCTCATATTTTATCCAC
GGTATTGAGGGTCGCATGAACGCCATTGCAG
AGAGGAGAGTTAGAGCCCTACGGGTAGGCGATATAG
GGTATTGAGGGTCGCTTGAAGGATGTTCAGAAC
AGAGGAGAGTTAGAGCCTCATCCCTCCAGAACG
CGAGTCTATCAAGAACCATTCGG
CG AGTCT ATG AAG AACC ATTCGG
GCTCAGATAGTTCTTGGTAAGCC
GCTC AG AT AGTTCTTGGT A AGCC
CGAGTCTATCCAGAACCATTCGG
GCTCAGATAGTTGTTGGTAAGCC
CGAGTCTATCCAGAACCATTCGG
GCTCAGATAGGTCTTGGTAAGCC
GCTCAG AT AGGTCTTGGT AAGCC
CGAGTCTATCGCAACCATTCGG
GCTCAGATAGCTGTTGGTAAGCC
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Appendix C. Buffer designation and components
Buffer

Designation

Components

A

50mM
mMTris-Acetate
Tris-Acetate(pH
(pH8.0),
8.0),100
100mM
mMKC1,
KC!,22mM
mMCaC12
CaC12
50

B

20mM
mMsodium
sodiumacetate
acetate(pH
(pH4.5),
4.5), 10
10mM
mMMgC12,
MgC12,0.5
0.5M
MNaCl
NaCl
20

C

BufferBB++lM
1MNNaCl
Buffer
aCl

D

mMsodium
sodiumacetate
acetate(pH
(pH4.5),
4.5),1010mM
mMMgC12,
MgCl2,0.2
0.2MMNaCl
NaCl
1010mM

E

100mM
mMTris-HCl
Tris-HCI(pH
(pH7.5),
7.5),300
300mM
mMKC1,
KCI,22mM
mM(3-mercaptoethanol,
!3-mercaptoethanol,1%
1%Triton
Triton
100
X-100, 1 mM PMSF, 10% glycerol

F

20mM
mMimidazole
imidazole
BufferEE++20
Buffer

G

BufferFFwithout
withoutTriton
TritonXX-100
andPMSF
PMSF
Buffer
-100 and

H

BufferGG++200
200mM
mMimidazole
imidazole
Buffer

1

50mM
mMTris-HCl
Tris-HCI(pH
(pH8.0),
8.0), 11mM
mMPMSF,
PMSF, 1ImM
mMDTT,
DTT,0.5
0.5mM
mMEDTA
EDTA
50

J

BufferII++10%
10%glycerol
glycerol
Buffer

K

50mM
mMTris-HCl
Tris-HCI(pH
(pH7.8),
7.8), 100
100mM
mMKC1,
KCI, 10
10mM
mMMgC12,
MgC12, 11mM
mMPMSF,
PMSF,22mM
mM
50
DTT, 10% glycerol

L

%Triton
TritonXX-100,
mMPMSF
PMSF
BufferKK++11%
Buffer
-100, 22mM

M

BufferKK++22mM
mMPMSF
PMSF
Buffer

N

BufferKK++22mM
mMPMSF
PMSFand
and20
20mM
mMreduced
reducedglutathione
glutathione
Buffer

0
0

20mM
mMTris-HCl
Tris-HCl(pH
(pH8.0),
8.0), 10
10mM
mMMgC12,
MgCl2,22 mM
glycerol
20
mM DTT, 10%10%
glycerol

p

200mM
mMTris-Acetate
Tris-Acetate(pH
(pH8.0),
8.0), 1.2
1.2M
MKC1,
KCI, 8 mM p-mercaptoethanol,
~-mercaptoethanol,44mM
mM
200
PMSF and 40% glycerol

Q

100 mM
mM Tris-Acetate
Tris-Acetate (pH
(pH 8.0),
8.0), 300
300 mM
mM KC1,
KCl, 22mM
mM |3-mercaptoethanol,
~-mercaptoethanol, 1%
1%
100
Triton X-100, 1 mM PMSF, 10% glycerol

R

Buffer
20mM
mMimidazole
imidazole
BufferQQ++20

S

BufferRRwithout
withoutTriton
TritonXX-100
andPMSF
PMSF
Buffer
-l 00 and

T

Buffer
BufferSS++250
250mM
mMimidazole
imidazole

U
u

KC1, 0.5 mM DTT
100 mM gly-gly (pH 8.7), 100 mM EDTA (pH 8.7), 100 mM KCl,

V
V

50 mM
mM Tris-HCl
Tris-HCI (pH
(pH 8.0),
8.0), 100
100 mM
mM EDTA
EDTA (pH
(pH 8.0),
8.0), 100
100 mM
mM KC1
KCI and
and 0.5
0.5 mM
mM
50
DTT

W
w

100
l 00 mM
mM Tris-HCl
Tris-HCI (pH
(pH 8.0)
8.0) and
and 300
300 mM
mM KC1
KCI

X

BufferW
W++250
250mM
mMimidazole
imidazole
Buffer

yY_______ 50
50 mM
mM Tris-HCl
Tris-HCI (pH
(pH 8.0),
8.0), 50
50 mM
mM KC1,
KCI, 1l mM
mM DTT__________________________
DTT

.196
196

